Artículos publicados

Artículos Publicados (1989-2022)

Año 2023

Año 2022 (FI acumulado = 351.854)

Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, Koopmans F, Magnusson S, Richards AL, Sidorenko J, Wu Y, Zeng J, Grove J, Kim M, Li Z, Voloudakis G, Zhang W, Adams M, Agartz I, Atkinson EG, Agerbo E, Al Eissa M, Albus M, Alexander M, Alizadeh BZ, Alptekin K, Als TD, Amin F, Arolt V, Arrojo M, Athanasiu L, Azevedo MH, Bacanu SA, Bass NJ, Begemann M, Belliveau RA, Bene J, Benyamin B, Bergen SE, Blasi G, Bobes J, Bonassi S, Braun A, Bressan RA, Bromet EJ, Bruggeman R, Buckley PF, Buckner RL, Bybjerg-Grauholm J, Cahn W, Cairns MJ, Calkins ME, Carr VJ, Castle D, Catts SV, Chambert KD, Chan RCK, Chaumette B, Cheng W, Cheung EFC, Chong SA, Cohen D, Consoli A, Cordeiro Q, Costas J, Curtis C, Davidson M, Davis KL, de Haan L, Degenhardt F, DeLisi LE, Demontis D, Dickerson F, Dikeos D, Dinan T, Djurovic S, Duan J, Ducci G, Dudbridge F, Eriksson JG, Fañanás L, Faraone SV, Fiorentino A, Forstner A, Frank J, Freimer NB, Fromer M, Frustaci A, Gadelha A, Genovese G, Gershon ES, Giannitelli M, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, González Peñas J, González-Pinto A, Gopal S, Gratten J, Green MF, Greenwood TA, Guillin O, Gülöksüz S, Gur RE, Gur RC, Gutiérrez B, Hahn E, Hakonarson H, Haroutunian V, Hartmann AM, Harvey C, Hayward C, Henskens FA, Herms S, Hoffmann P, Howrigan DP, Ikeda M, Iyegbe C, Joa I, Julià A, Kähler AK, Kam-Thong T, Kamatani Y, Karachanak-Yankova S, Kebir O, Keller MC, Kelly BJ, Khrunin A, Kim SW, Klovins J, Kondratiev N, Konte B, Kraft J, Kubo M, Kučinskas V, Kučinskiene ZA, Kusumawardhani A, Kuzelova-Ptackova H, Landi S, Lazzeroni LC, Lee PH, Legge SE, Lehrer DS, Lencer R, Lerer B, Li M, Lieberman J, Light GA, Limborska S, Liu CM, Lönnqvist J, Loughland CM, Lubinski J, Luykx JJ, Lynham A, Macek M Jr, Mackinnon A, Magnusson PKE, Maher BS, Maier W, Malaspina D, Mallet J, Marder SR, Marsal S, Martin AR, Martorell L, Mattheisen M, McCarley RW, McDonald C, McGrath JJ, Medeiros H, Meier S, Melegh B, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mitjans M, Molden E, Molina E, Molto MD, Mondelli V, Moreno C, Morley CP, Muntané G, Murphy KC, Myin-Germeys I, Nenadić I, Nestadt G, Nikitina-Zake L, Noto C, Nuechterlein KH, O’Brien NL, O’Neill FA, Oh SY, Olincy A, Ota VK, Pantelis C, Papadimitriou GN, Parellada M, Paunio T, Pellegrino R, Periyasamy S, Perkins DO, Pfuhlmann B, Pietiläinen O, Pimm J, Porteous D, Powell J, Quattrone D, Quested D, Radant AD, Rampino A, Rapaport MH, Rautanen A, Reichenberg A, Roe C, Roffman JL, Roth J, Rothermundt M, Rutten BPF, Saker-Delye S, Salomaa V, Sanjuan J, Santoro ML, Savitz A, Schall U, Scott RJ, Seidman LJ, Sharp SI, Shi J, Siever LJ, Sigurdsson E, Sim K, Skarabis N, Slominsky P, So HC, Sobell JL, Söderman E, Stain HJ, Steen NE, Steixner-Kumar AA, Stögmann E, Stone WS, Straub RE, Streit F, Strengman E, Stroup TS, Subramaniam M, Sugar CA, Suvisaari J, Svrakic DM, Swerdlow NR, Szatkiewicz JP, Ta TMT, Takahashi A, Terao C, Thibaut F, Toncheva D, Tooney PA, Torretta S, Tosato S, Tura GB, Turetsky BI, Üçok A, Vaaler A, van Amelsvoort T, van Winkel R, Veijola J, Waddington J, Walter H, Waterreus A, Webb BT, Weiser M, Williams NM, Witt SH, Wormley BK, Wu JQ, Xu Z, Yolken R, Zai CC, Zhou W, Zhu F, Zimprich F, Atbaşoğlu EC, Ayub M, Benner C, Bertolino A, Black DW, Bray NJ, Breen G, Buccola NG, Byerley WF, Chen WJ, Cloninger CR, Crespo-Facorro B, Donohoe G, Freedman R, Galletly C, Gandal MJ, Gennarelli M, Hougaard DM, Hwu HG, Jablensky AV, McCarroll SA, Moran JL, Mors O, Mortensen PB, Müller-Myhsok B, Neil AL, Nordentoft M, Pato MT, Petryshen TL, Pirinen M, Pulver AE, Schulze TG, Silverman JM, Smoller JW, Stahl EA, Tsuang DW, Vilella E, Wang SH, Xu S; Indonesia Schizophrenia Consortium; PsychENCODE; Psychosis Endophenotypes International Consortium; SynGO Consortium; Adolfsson R, Arango C, Baune BT, Belangero SI, Børglum AD, Braff D, Bramon E, Buxbaum JD, Campion D, Cervilla JA, Cichon S, Collier DA, Corvin A, Curtis D, Forti MD, Domenici E, Ehrenreich H, Escott-Price V, Esko T, Fanous AH, Gareeva A, Gawlik M, Gejman PV, Gill M, Glatt SJ, Golimbet V, Hong KS, Hultman CM, Hyman SE, Iwata N, Jönsson EG, Kahn RS, Kennedy JL, Khusnutdinova E, Kirov G, Knowles JA, Krebs MO, Laurent-Levinson C, Lee J, Lencz T, Levinson DF, Li QS, Liu J, Malhotra AK, Malhotra D, McIntosh A, McQuillin A, Menezes PR, Morgan VA, Morris DW, Mowry BJ, Murray RM, Nimgaonkar V, Nöthen MM, Ophoff RA, Paciga SA, Palotie A, Pato CN, Qin S, Rietschel M, Riley BP, Rivera M, Rujescu D, Saka MC, Sanders AR, Schwab SG, Serretti A, Sham PC, Shi Y, St Clair D, Stefánsson H, Stefansson K, Tsuang MT, van Os J, Vawter MP, Weinberger DR, Werge T, Wildenauer DB, Yu X, Yue W, Holmans PA, Pocklington AJ, Roussos P, Vassos E, Verhage M, Visscher PM, Yang J, Posthuma D, Andreassen OA, Kendler KS, Owen MJ, Wray NR, Daly MJ, Huang H, Neale BM, Sullivan PF, Ripke S, Walters JTR, O’Donovan MC; Schizophrenia Working Group of the Psychiatric Genomics Consortium.
Nature. 2022 Apr;604(7906):502-508. FI 2021: 69.504. (D1 SCIE Multidisciplinary Sciences) doi: 10.1038/s41586-022-04434-5. Free PMC article.

Results of the COVID-19 mental health international for the general population (COMET-G) study.
Fountoulakis KN, Karakatsoulis G, Abraham S, Adorjan K, Ahmed HU, Alarcón RD, Arai K, Auwal SS, Berk M, Bjedov S, Bobes J, Bobes-Bascaran T, Bourgin-Duchesnay J, Bredicean CA, Bukelskis L, Burkadze A, Abud IIC, Castilla-Puentes R, Cetkovich M, Colon-Rivera H, Corral R, Cortez-Vergara C, Crepin P, De Berardis D, Zamora Delgado S, De Lucena D, De Sousa A, Stefano RD, Dodd S, Elek LP, Elissa A, Erdelyi-Hamza B, Erzin G, Etchevers MJ, Falkai P, Farcas A, Fedotov I, Filatova V, Fountoulakis NK, Frankova I, Franza F, Frias P, Galako T, Garay CJ, Garcia-Álvarez L, García-Portilla MP, Gonda X, Gondek TM, González DM, Gould H, Grandinetti P, Grau A, Groudeva V, Hagin M, Harada T, Hasan MT, Hashim NA, Hilbig J, Hossain S, Iakimova R, Ibrahim M, Iftene F, Ignatenko Y, Irarrazaval M, Ismail Z, Ismayilova J, Jacobs A, Jakovljević M, Jakšić N, Javed A, Kafali HY, Karia S, Kazakova O, Khalifa D, Khaustova O, Koh S, Kopishinskaia S, Kosenko K, Koupidis SA, Kovacs I, Kulig B, Lalljee A, Liewig J, Majid A, Malashonkova E, Malik K, Malik NI, Mammadzada G, Mandalia B, Marazziti D, Marčinko D, Martinez S, Matiekus E, Mejia G, Memon RS, Martínez XEM, Mickevičiūtė D, Milev R, Mohammed M, Molina-López A, Morozov P, Muhammad NS, Mustač F, Naor MS, Nassieb A, Navickas A, Okasha T, Pandova M, Panfil AL, Panteleeva L, Papava I, Patsali ME, Pavlichenko A, Pejuskovic B, Pinto Da Costa M, Popkov M, Popovic D, Raduan NJN, Ramírez FV, Rancans E, Razali S, Rebok F, Rewekant A, Flores ENR, Rivera-Encinas MT, Saiz P, de Carmona MS, Martínez DS, Saw JA, Saygili G, Schneidereit P, Shah B, Shirasaka T, Silagadze K, Sitanggang S, Skugarevsky O, Spikina A, Mahalingappa SS, Stoyanova M, Szczegielniak A, Tamasan SC, Tavormina G, Tavormina MGM, Theodorakis PN, Tohen M, Tsapakis EM, Tukhvatullina D, Ullah I, Vaidya R, Vega-Dienstmaier JM, Vrublevska J, Vukovic O, Vysotska O, Widiasih N, Yashikhina A, Prezerakos PE, Smirnova D.
Eur Neuropsychopharmacol. 2022 Jan;54:21-40. FI 2021: 5.415. (Q1 SCIE Clinical Neurology) doi: 10.1016/j.euroneuro.2021.10.004. Free PMC article.

Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia.
Andreu-Bernabeu Á, Díaz-Caneja CM, Costas J, De Hoyos L, Stella C, Gurriarán X, Alloza C, Fañanás L, Bobes J, González-Pinto A, Crespo-Facorro B, Martorell L, Vilella E, Muntané G, Nacher J, Molto MD, Aguilar EJ, Parellada M, Arango C, González-Peñas J.
Nat Commun. 2022 Jan 10;13(1):51. FI 2021: 17.694. (D1 SCIE Multidisciplinary Sciences) doi: 10.1038/s41467-021-27598-6. Free PMC article.

The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study.
Fountoulakis KN, Karakatsoulis GN, Abraham S, Adorjan K, Ahmed HU, Alarcón RD, Arai K, Auwal SS, Berk M, Bjedov S, Bobes J, Bobes-Bascaran T, Bourgin-Duchesnay J, Bredicean CA, Bukelskis L, Burkadze A, Abud IIC, Castilla-Puentes R, Cetkovich M, Colon-Rivera H, Corral R, Cortez-Vergara C, Crepin P, De Berardis D, Delgado SZ, De Lucena D, De Sousa A, Stefano RD, Dodd S, Elek LP, Elissa A, Erdelyi-Hamza B, Erzin G, Etchevers MJ, Falkai P, Farcas A, Fedotov I, Filatova V, Fountoulakis NK, Frankova I, Franza F, Frias P, Galako T, Garay CJ, Garcia-Álvarez L, García-Portilla MP, Gonda X, Gondek TM, González DM, Gould H, Grandinetti P, Grau A, Groudeva V, Hagin M, Harada T, Hasan TM, Hashim NA, Hilbig J, Hossain S, Iakimova R, Ibrahim M, Iftene F, Ignatenko Y, Irarrazaval M, Ismail Z, Ismayilova J, Jacobs A, Jakovljević M, Jakšić N, Javed A, Kafali HY, Karia S, Kazakova O, Khalifa D, Khaustova O, Koh S, Kopishinskaia S, Kosenko K, Koupidis SA, Kovacs I, Kulig B, Lalljee A, Liewig J, Majid A, Malashonkova E, Malik K, Malik NI, Mammadzada G, Mandalia B, Marazziti D, Marčinko D, Martinez S, Matiekus E, Mejia G, Memon RS, Martínez XEM, Mickevičiūtė D, Milev R, Mohammed M, Molina-López A, Morozov P, Muhammad NS, Mustač F, Naor MS, Nassieb A, Navickas A, Okasha T, Pandova M, Panfil AL, Panteleeva L, Papava I, Patsali ME, Pavlichenko A, Pejuskovic B, Da Costa MP, Popkov M, Popovic D, Raduan NJN, Ramírez FV, Rancans E, Razali S, Rebok F, Rewekant A, Flores ENR, Rivera-Encinas MT, Saiz P, de Carmona MS, Martínez DS, Saw JA, Saygili G, Schneidereit P, Shah B, Shirasaka T, Silagadze K, Sitanggang S, Skugarevsky O, Spikina A, Mahalingappa SS, Stoyanova M, Szczegielniak A, Tamasan SC, Tavormina G, Tavormina MGM, Theodorakis PN, Tohen M, Tsapakis EM, Tukhvatullina D, Ullah I, Vaidya R, Vega-Dienstmaier JM, Vrublevska J, Vukovic O, Vysotska O, Widiasih N, Yashikhina A, Prezerakos PE, Smirnova D.
Psychiatry Res. 2022 Sep;315:114702. FI 2021: 11.225. (D1 SSCI Psychiatry) doi: 10.1016/j.psychres.2022.114702. Free PMC article.

Is it possible to stage schizophrenia? A systematic review.
Martínez-Cao C, de la Fuente-Tomás L, García-Fernández A, González-Blanco L, Sáiz PA, Garcia-Portilla MP, Bobes J.
Transl Psychiatry. 2022 May 11;12(1):197. FI 2021: 7.989. (Q1 SCIE Psychiatry) doi: 10.1038/s41398-022-01889-y. Free PMC article.

Smoking in hospitalized patients. A great opportunity.
Carrión Valero F, Martínez González D, Bobes-Bascarán MT, Galán Gil G, Ortega Serrano J, Chorro Gascó FJ, Bobes J, Jiménez Ruiz CA.
Adicciones. 2022 Feb 16;34(1):13-22. FI 2021: 4.102. (Q2 SCIE Substance Abuse) doi: 10.20882/adicciones.1358. Free article.

A polygenic approach to the association between smoking and schizophrenia.
Al-Soufi L, Martorell L, Moltó MD, González-Peñas J, García-Portilla MP, Arrojo M, Rivero O, Gutiérrez-Zotes A, Nácher J, Muntané G, Paz E, Páramo M, Bobes J, Arango C, Sanjuan J, Vilella E, Costas J.
Addict Biol. 2022 Jan;27(1):e13104. FI 2021: 4.093. (Q3 SCIE Substance Abuse) doi: 10.1111/adb.13104.

Sex differences in neurocognitive and psychosocial functioning in bipolar disorder.
Solé B, Varo C, Torrent C, Montejo L, Jiménez E, Bonnin CDM, Clougher D, Verdolini N, Amoretti S, Piazza F, Borràs R, Pomarol-Clotet E, Sáiz PA, García-Portilla MP, Vieta E, Martínez-Arán A.
J Affect Disord. 2022 Jan 1;296:208-215. FI 2021: 6.533. (Q1 SCIE Psychiatry) doi: 10.1016/j.jad.2021.09.066.

Early Impact of the COVID-19 Outbreak on Sleep in a Large Spanish Sample.
Dal Santo F, González-Blanco L, Rodríguez-Revuelta J, Marina González PA, Paniagua G, García-Álvarez L, de la Fuente-Tomás L, Sáiz PA, García-Portilla MP, Bobes J.
Behav Sleep Med. 2022 May-Jun;20(3):100-115. FI 2021: 3.492. (Q3 SCIE Psychiatry) doi: 10.1080/15402002.2021.1890597.

Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI).
Sideli L, Schimmenti A, La Barbera D, La Cascia C, Ferraro L, Aas M, Alameda L, Velthorst E, Fisher HL, Caretti V, Trotta G, Tripoli G, Quattrone D, Gayer-Anderson C, Seminerio F, Sartorio C, Marrazzo G, Lasalvia A, Tosato S, Tarricone I, Berardi D, D’Andrea G, Arango C, Arrojo M, Bernardo M, Bobes J, Sanjuán J, Santos JL, Menezes PR, Del-Ben CM, Jongsma HE, Jones PB, Kirkbride JB, Llorca PM, Tortelli A, Pignon B, de Haan L, Selten JP, Van Os J, Rutten BP, Di Forti M, Morgan C, Murray RM; EU-GEI WP2 Group.
Schizophr Bull. 2022 May 7;48(3):575-589. FI 2021: 7.348. (Q1 SCIE Psychiatry) doi: 10.1093/schbul/sbac004.

Migration history and risk of psychosis: results from the multinational EU-GEI study.
Tarricone I, D’Andrea G, Jongsma HE, Tosato S, Gayer-Anderson C, Stilo SA, Suprani F, Iyegbe C, van der Ven E, Quattrone D, di Forti M, Velthorst E, Rossi Menezes P, Arango C, Parellada M, Lasalvia A, La Cascia C, Ferraro L, Bobes J, Bernardo M, Sanjuán I, Santos JL, Arrojo M, Del-Ben CM, Tripoli G, Llorca PM, de Haan L, Selten JP, Tortelli A, Szöke A, Muratori R, Rutten BP, van Os J, Jones PB, Kirkbride JB, Berardi D, Murray RM, Morgan C.
Psychol Med. 2022 Oct;52(14):2972-2984. FI 2021: 10.592. (D1 SSCI Psychiatry) doi: 10.1017/S003329172000495X. Free PMC article.

Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway.
van Os J, Pries LK, Ten Have M, de Graaf R, van Dorsselaer S, Delespaul P, Bak M, Kenis G, Lin BD, Luykx JJ, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC, Arango C, O’Donovan M, Rutten BPF, Guloksuz S.
Psychol Med. 2022 Jul;52(10):1910-1922. FI 2021: 10.592. (D1 SSCI Psychiatry) doi: 10.1017/S0033291720003748.

Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
García-Álvarez L, Martínez-Cao C, Bobes-Bascarán T, Portilla A, Courtet P, de la Fuente-Tomás L, Velasco Á, González-Blanco L, Zurrón-Madera P, Fonseca-Pedrero E, Sáiz PA, García-Portilla MP, Bobes J.
Rev Psiquiatr Salud Ment (Engl Ed). 2022 Jan-Mar;15(1):14-21. FI 2021: 6.795. (Q1 SCIE Psychiatry) doi: 10.1016/j.rpsmen.2022.01.005.

Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use.
Cunill R, Castells X, González-Pinto A, Arrojo M, Bernardo M, Sáiz PA, Flórez G, Torrens M, Tirado-Muñoz J, Fonseca F, Arranz B, Garriga M, Goikolea JM, Zorrilla I, Becoña E, López A, San L.
Adicciones. 2022 Apr 1;34(2):168-178. FI 2021: 4.102. (Q2 SCIE Substance Abuse) doi: 10.20882/adicciones.1569. Free article.

Clinical practice guideline on pharmacological and psychological management of adult patients with an anxiety disorder and comorbid substance use.
Sáiz PA, Flórez G, Arrojo M, Bernardo M, González-Pinto A, Goikolea JM, Zorrilla I, Cunill R, Castells X, Becoña E, López A, Torrens M, Fonseca F, Tirado-Muñoz J, Arranz B, Garriga M, San L.
Adicciones. 2022 Apr 1;34(2):157-167. FI 2021: 4.102. (Q2 SCIE Substance Abuse) doi: 10.20882/adicciones.1548. Free article.

Clinical practice guideline on pharmacological and psychological management of adult patients with depression and a comorbid substance use disorder.
Torrens M, Tirado-Muñoz J, Fonseca F, Farré M, González-Pinto A, Arrojo M, Bernardo M, Arranz B, Garriga M, Sáiz PA, Flórez G, Goikolea JM, Zorrilla I, Cunill R, Castells X, Becoña E, López A, San L.
Adicciones. 2022 Apr 1;34(2):128-141. FI 2021: 4.102. (Q2 SCIE Substance Abuse) doi: 10.20882/adicciones.1559. Free article.

Clinical practice guideline on pharmacological and psychological management of adult patients with bipolar disorder and comorbid substance use.
González-Pinto A, Goikolea JM, Zorrilla I, Bernardo M, Arrojo M, Cunill R, Castell X, Becoña E, López A, Torrens M, Tirado-Muñoz J, Fonseca F, Arranz B, Garriga M, Sáiz PA, Flórez G, San L.
Adicciones. 2022 Apr 1;34(2):142-156. FI 2021: 4.102. (Q2 SCIE Substance Abuse) doi: 10.20882/adicciones.1528. Free article.

Clinical practice guideline on pharmacological and psychological management of adult patients with schizophrenia spectrum disorders and a comorbid substance use.
Arranz B, Garriga M, Bernardo M, González-Pinto A, Arrojo M, Torrens M, Tirado-Muñoz J, Fonseca F, Sáiz PA, Flórez G, Goikolea JM, Zorrilla I, Cunill R, Castells X, Becoña E, López A, San L.
Adicciones. 2022 Apr 1;34(2):110-127. FI 2021: 4.102. (Q2 SCIE Substance Abuse) doi: 10.20882/adicciones.1504. Free article.

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders.
de Haan L, van Tricht M, van Dijk F, Arango C, Díaz-Caneja CM, Bobes J, García-Álvarez L, Leucht S.
Psychol Med. 2022 Dec 15:1-6. FI 2021: 10.592. (D1 SSCI Psychiatry) doi: 10.1017/S0033291722003142.

Epigenetic clocks in relapse after a first episode of schizophrenia.
Segura ÀG, Prohens L, Mezquida G, Amoretti S, Bioque M, Ribeiro M, Gurriarán-Bas X, Rementería L, Berge D, Rodriguez-Jimenez R, Roldán A, Pomarol-Clotet E, Ibáñez A, Usall J, García-Portilla MP, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M, Mas S; 2EPS group.
Schizophrenia (Heidelb). 2022 Jul 22;8(1):61. doi: 10.1038/s41537-022-00268-2. Free PMC article.

The effect of early life events on glucose levels in first-episode psychosis.
Garcia-Rizo C, Cabrera B, Bioque M, Mezquida G, Lobo A, Gonzalez-Pinto A, Diaz-Caneja CM, Corripio I, Vieta E, Baeza I, Garcia-Portilla MP, Gutierrez-Fraile M, Rodriguez-Jimenez R, Garriga M, Fernandez-Egea E, Bernardo M; PEPs GROUP.
Front Endocrinol (Lausanne). 2022 Dec 5;13:983792. FI 2021: 6.055. (Q1 SCIE Endocrinology & Metabolism) doi: 10.3389/fendo.2022.983792. Free PMC article.

A Naturalistic, European Multi-Center Clinical Study of Electrodermal Reactivity and Suicide Risk Among Patients With Depression.
Carli V, Hadlaczky G, Petros NG, Iosue M, Zeppegno P, Gramaglia C, Amore M, Baca-Garcia E, Batra A, Cosman D, Courtet P, Di Sciascio G, Ekstrand J, Galfalvy H, Gusmão R, Jesus C, Heitor MJ, Constante M, Rad PM, Saiz PA, Wojnar M, Sarchiapone M.
Front Psychiatry. 2022 Jan 5;12:765128. FI 2021: 5.435. (Q2 SCIE Psychiatry) doi: 10.3389/fpsyt.2021.765128. Free PMC article.

Cognitive functioning after six months of follow-up in a sample of alcohol use disorder outpatients.
Villa R, Espandian A, Sáiz Martínez PA, Rodríguez Revuelta J, García-Portilla MP, Bobes J, Flórez G.
Adicciones. 2022 Nov 29;34(4):309-322. FI 2021: 4.102. (Q2 SCIE Substance Abuse) doi: 10.20882/adicciones.1672.

Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial.
Dal Santo F, Fonseca-Pedrero E, García-Portilla MP, González-Blanco L, Sáiz PA, Galderisi S, Giordano GM, Bobes J.
Eur Psychiatry. 2022 Jun 10;65(1):e33. FI 2021: 7.156. (Q1 SCIE Psychiatry) doi: 10.1192/j.eurpsy.2022.25.

Psychopathy, addictions and female gender: Comparative study using the Psychopathy Checklist Revised and the Comprehensive Assessment of Psychopathic Personality.
Flórez G, Ferrer V, García L, Crespo M, Pérez M, Sáiz PA.
Adicciones. 2022 Jul 1;34(3):235-245. FI 2021: 4.102. (Q2 SCIE Substance Abuse) doi: 10.20882/adicciones.1500. Free article.

The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance.
Hidalgo-Figueroa M, Salazar A, Romero-López-Alberca C, MacDowell KS, García-Bueno B, Bioque M, Bernardo M, Parellada M, González-Pinto A, García Portilla MP, Lobo A, Rodriguez-Jimenez R, Berrocoso E, Leza JC; FLAMM-PEPs study; CIBERSAM.
Int J Neuropsychopharmacol. 2022 Aug 16;25(8):666-677. FI 2021: 5.678. (Q1 SCIE Clin Neurology) doi: 10.1093/ijnp/pyac023. Free PMC article.

Utility and validity of the Brief Psychiatric Rating Scale (BPRS) as a transdiagnostic scale.
Hofmann AB, Schmid HM, Jabat M, Brackmann N, Noboa V, Bobes J, Garcia-Portilla MP, Seifritz E, Vetter S, Egger ST.
Psychiatry Res. 2022 Aug;314:114659. FI 2021: 11.225. (D1 SSCI Psychiatry) doi: 10.1016/j.psychres.2022.114659. Free article.

Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.
Martínez-Cao C, García-Álvarez L, Bobes-Bascarán T, de la Fuente-Tomás L, Fernández-Egea E, Velasco Á, González-Blanco L, Zurrón-Madera P, Fonseca-Pedrero E, Sáiz-Martínez PA, García-Portilla MP, Bobes J.
Rev Psiquiatr Salud Ment (Engl Ed). 2022 Jan-Mar;15(1):22-28. FI 2021: 6.795. (Q1 SCIE Psychiatry) doi: 10.1016/j.rpsmen.2020.04.007.

Affective temperaments and sexual functioning in euthymic patients with bipolar disorder.
Cañada Y, García-Blanco A, García-Portilla MP, Fuente-Tomás L, Navalón P, Arranz B, Sánchez-Autet M, Hervás-Marín D, Livianos L, Sierra P.
J Psychiatr Res. 2022 Feb;146:201-209. FI 2021: 5.250. (Q2 SCIE Psychiatry) doi: 10.1016/j.jpsychires.2021.12.008.

Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and C-reactive protein levels and metabolic status in patients with a bipolar disorder.
Sanchez-Autet M, Arranz B, Sierra P, Safont G, Garcia-Blanco A, de la Fuente L, Garriga M, Marín L, García-Portilla MP.
World J Biol Psychiatry. 2022 Jul;23(6):464-474. FI 2021: 3.418. (Q3 SCIE Psychiatry) doi: 10.1080/15622975.2021.2013089.

Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study.
D’Andrea G, Lal J, Tosato S, Gayer-Anderson C, Jongsma HE, Stilo SA, van der Ven E, Quattrone D, Velthorst E, Berardi D, Rossi Menezes P, Arango C, Parellada M, Lasalvia A, La Cascia C, Ferraro L, La Barbera D, Sideli L, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Tripoli G, Llorca PM, de Haan L, Selten JP, Tortelli A, Szöke A, Muratori R, Rutten BP, van Os J, Jones PB, Kirkbride JB, Murray RM, di Forti M, Tarricone I, Morgan C.
Psychol Med. 2022 Oct 28:1-11. FI 2021: 10.592. (D1 SSCI Psychiatry) doi: 10.1017/S003329172200335X.

Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study.
Tripoli G, Quattrone D, Ferraro L, Gayer-Anderson C, La Cascia C, La Barbera D, Sartorio C, Seminerio F, Rodriguez V, Tarricone I, Berardi D, Jamain S, Arango C, Tortelli A, Llorca PM, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Luis Santos J, Arrojo M, Marta Del-Ben C, Rossi Menezes P, van der Ven E, Jones PB, Jongsma HE, Kirkbride JB, Tosato S, Lasalvia A, Richards A, O’Donovan M, Rutten BPF, van Os J, Morgan C, Sham PC, Di Forti M, Murray RM, Murray GK.
Schizophr Bull. 2022 Sep 1;48(5):1104-1114. FI 2021: 7.348. (Q1 SCIE Psychiatry) doi: 10.1093/schbul/sbac022. Free PMC article.

A replication study of JTC bias, genetic liability for psychosis and delusional ideation.
Henquet C, van Os J, Pries LK, Rauschenberg C, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran ES, Kaymak SU, Mihaljevic MM, Petrovic SS, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC, Arango C, O’Donovan M, Rutten BPF, Gülöksüz S.
Psychol Med. 2022 Jul;52(9):1777-1783. FI 2021: 10.592. (D1 SSCI Psychiatry) doi: 10.1017/S0033291720003578. Free PMC article.

Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study.
Fusar-Poli L, Pries LK, van Os J, Erzin G, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Andric-Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Üçok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators; Aguglia E, Arango C, O’Donovan M, Rutten BPF, Guloksuz S.
Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 8;113:110440. FI 2021: 5.201. (Q2 SCIE Psychiatry) doi: 10.1016/j.pnpbp.2021.110440. Free article.

Gender, age at onset, and duration of being ill as predictors for the long-term course and outcome of schizophrenia: an international multicenter study.
Fountoulakis KN, Dragioti E, Theofilidis AT, Wiklund T, Atmatzidis X, Nimatoudis I, Thys E, Wampers M, Hranov L, Hristova T, Aptalidis D, Milev R, Iftene F, Spaniel F, Knytl P, Furstova P, From T, Karlsson H, Walta M, Salokangas RKR, Azorin JM, Bouniard J, Montant J, Juckel G, Haussleiter IS, Douzenis A, Michopoulos I, Ferentinos P, Smyrnis N, Mantonakis L, Nemes Z, Gonda X, Vajda D, Juhasz A, Shrivastava A, Waddington J, Pompili M, Comparelli A, Corigliano V, Rancans E, Navickas A, Hilbig J, Bukelskis L, Stevovic LI, Vodopic S, Esan O, Oladele O, Osunbote C, Rybakowski JK, Wojciak P, Domowicz K, Figueira ML, Linhares L, Crawford J, Panfil AL, Smirnova D, Izmailova O, Lecic-Tosevski D, Temmingh H, Howells F, Bobes J, Garcia-Portilla MP, García-Alvarez L, Erzin G, Karadağ H, De Sousa A, Bendre A, Hoschl C, Bredicean C, Papava I, Vukovic O, Pejuskovic B, Russell V, Athanasiadis L, Konsta A, Fountoulakis NK, Stein D, Berk M, Dean O, Tandon R, Kasper S, De Hert M.
CNS Spectr. 2022 Dec;27(6):716-723. FI 2021: 4.604. (Q2 SCIE Psychiatry) doi: 10.1017/S1092852921000742.

Impact on functionality of the paliperidone palmitate three-month formulation in patients with a recent diagnosis of schizophrenia: a real-world observational prospective study.
Garcia-Portilla MP, Benito Ruiz A, Gómez Robina F, García Dorado M, López Rengel PM.
Expert Opin Pharmacother. 2022 Apr;23(5):629-638. FI 2021: 4.103. (Q2 SCIE Pharmacology & Pharmacy) doi: 10.1080/14656566.2021.2023496.

The impact of school-based screening on service use in adolescents at risk for mental health problems and risk-behaviour.
Lustig S, Kaess M, Schnyder N, Michel C, Brunner R, Tubiana A, Kahn JP, Sarchiapone M, Hoven CW, Barzilay S, Apter A, Balazs J, Bobes J, Saiz PA, Cozman D, Cotter P, Kereszteny A, Podlogar T, Postuvan V, Värnik A, Resch F, Carli V, Wasserman D.
Eur Child Adolesc Psychiatry. 2022 Apr 30. FI 2021: 5.349. (D1 SCIE Pediatrics) doi: 10.1007/s00787-022-01990-z. Free article.

Emotional intelligence: a comparison between patients after first episode mania and those suffering from chronic bipolar disorder type I.
Varo C, Amoretti S, Sparacino G, Jiménez E, Solé B, Bonnin CDM, Montejo L, Serra M, Torrent C, Salagre E, Benabarre A, Salgado-Pineda P, Montoro Salvatierra I, Sáiz PA, García-Portilla MP, Sánchez-Gistau V, Pomarol-Clotet E, Ramos-Quiroga JA, Pacchiarotti I, Garcia-Rizo C, Undurraga J, Reinares M, Martinez-Aran A, Vieta E, Verdolini N.
Psychol Med. 2022 Jan 7:1-12. FI 2021: 10.592. (D1 SSCI Psychiatry) doi: 10.1017/S0033291721005122

The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study.
Fusar-Poli L, Pries LK, van Os J, Radhakrishnan R, Pençe AY, Erzin G, Delespaul P, Kenis G, Luykx JJ, Lin BD, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Andric-Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Üçok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators; Aguglia E, Arango C, Rutten BP, Guloksuz S.
Eur Neuropsychopharmacol. 2022 Oct;63:47-59. FI 2021: 5.415. (Q1 SCIE Clinical Neurology) doi: 10.1016/j.euroneuro.2022.08.003. Free article.

Does COVID-19 psychological fatigue exist? Results of three online cross-sectional studies conducted in Spain from April 2020 to March 2021.
Ruiz FJ, Sáiz PA, García-Portilla MP, González-Blanco L, García-Álvarez L, Madera PZ, Bobes-Bascarán MT, Treviño LJ, García MV, Cao CM, Fernández AG, Revuelta JR, Lacasa CM, Dal Santo F, Calzón GP, Álvarez MS, Bascarán Fernández MT, Zazo ES, García CI, Pedrero EF, Ruiz RM, Bobes J.
J Glob Health. 2022 Apr 2;12:05001. FI 2021: 7.664. (D1 SSCI Public Environmental & Occupational Health) doi: 10.7189/jogh.12.05001. Free PMC article.

Suicidal Ideation Trends and Associated Factors in Different Large Spanish Samples During the First Year of the COVID-19 Pandemic.
Sáiz PA, Dal Santo F, García-Alvarez L, Bobes-Bascarán MT, Jiménez-Treviño L, Seijo-Zazo E, Rodríguez-Revuelta J, González-Blanco L, García-Portilla MP, Bobes J.
J Clin Psychiatry. 2022 Mar 7;83(2):21br14061. FI 2021: 5.906. (Q1 SSCI Psychiatry) doi: 10.4088/JCP.21br14061. Free article.

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study.
Rodriguez V, Alameda L, Quattrone D, Tripoli G, Gayer-Anderson C, Spinazzola E, Trotta G, Jongsma HE, Stilo S, La Cascia C, Ferraro L, La Barbera D, Lasalvia A, Tosato S, Tarricone I, Bonora E, Jamain S, Selten JP, Velthorst E, de Haan L, Llorca PM, Arrojo M, Bobes J, Bernardo M, Arango C, Kirkbride J, Jones PB, Rutten BP, Richards A, Sham PC, O’Donovan M, Van Os J, Morgan C, Di Forti M, Murray RM, Vassos E.
Psychol Med. 2022 Jan 25:1-10. FI 2021: 10.592. (D1 SSCI Psychiatry) doi: 10.1017/S0033291721005456.

The Multi-Component Smoking Cessation Support Programme (McSCSP) is effective in patients with severe mental disorder without gender differences.
Jaén-Moreno MJ, García-Portilla MP, Sarramea F, Bobes Bascarán T, Galván G, Díaz-Mesa EM, Al-Halabi S, Elizagarate E, Sáiz Martínez PA, Bobes J, García-Álvarez L.
Adicciones. 2022 Jul 1;34(3):218-226. FI 2021: 4.102. (Q2 SCIE Substance Abuse) doi: 10.20882/adicciones.1481. Free article.

Año 2021 (FI acumulado 1 de septiembre = 152,775)

Learning and verbal memory: A comparison between patients with alcohol use disorder and major depressive disorder.
Villa R, Rodríguez-Revuelta J, Espandian A, Menéndez-Miranda I, Dal Santo F, García-Portilla MP, Flórez G, Bobes J, Sáiz PA.
Adicciones. 2021 Nov 24;0(0):1696. doi: 10.20882/adicciones.1696.

A 35-year follow-up study of patients admitted to methadone treatment between 1982-1984 in Asturias, Spain.
Jiménez-Treviño L, Martínez-Cao C, Sánchez-Lasheras F, Iglesias C, Antuña MJ, Riera L, Sáiz PA, Bobes J.
Adicciones. 2021 Nov 23;0(0):1662. doi: 10.20882/adicciones.1662.

Exploring the factor structure of the mini-ICF-APP in an inpatient clinical sample, according to the psychiatric diagnosis.
Egger ST, Weniger G, Bobes J, Seifritz E, Vetter S.
Rev Psiquiatr Salud Ment (Engl Ed). 2021 Oct-Dec;14(4):186-195. doi: 10.1016/j.rpsmen.2021.11.002.PMID: 34861928

Screening for anxiety and depression in Primary Care: Utility of 2 brief scales adapted to the ICD-11-PC.
Iglesias García C, López García P, Ayuso Mateos JL, García JÁ, Bobes J.
Rev Psiquiatr Salud Ment (Engl Ed). 2021 Oct-Dec;14(4):196-201. doi: 10.1016/j.rpsmen.2019.12.004.

Results of the COVID-19 mental health international for the general population (COMET-G) study. Free article
Fountoulakis KN, Karakatsoulis G, Abraham S, Adorjan K, Ahmed HU, Alarcón RD, Arai K, Auwal SS, Berk M, Bjedov S, Bobes J, Bobes-Bascaran T, Bourgin-Duchesnay J, Bredicean CA, Bukelskis L, Burkadze A, Abud IIC, Castilla-Puentes R, Cetkovich M, Colon-Rivera H, Corral R, Cortez-Vergara C, Crepin P, De Berardis D, Zamora Delgado S, De Lucena D, De Sousa A, Stefano RD, Dodd S, Elek LP, Elissa A, Erdelyi-Hamza B, Erzin G, Etchevers MJ, Falkai P, Farcas A, Fedotov I, Filatova V, Fountoulakis NK, Frankova I, Franza F, Frias P, Galako T, Garay CJ, Garcia-Álvarez L, García-Portilla MP, Gonda X, Gondek TM, González DM, Gould H, Grandinetti P, Grau A, Groudeva V, Hagin M, Harada T, Hasan TM, Hashim NA, Hilbig J, Hossain S, Iakimova R, Ibrahim M, Iftene F, Ignatenko Y, Irarrazaval M, Ismail Z, Ismayilova J, Jakobs A, Jakovljević M, Jakšić N, Javed A, Kafali HY, Karia S, Kazakova O, Khalifa D, Khaustova O, Koh S, Kopishinskaia S, Kosenko K, Koupidis SA, Kovacs I, Kulig B, Lalljee A, Liewig J, Majid A, Malashonkova E, Malik K, Malik NI, Mammadzada G, Mandalia B, Marazziti D, Marčinko D, Martinez S, Matiekus E, Mejia G, Memon RS, Martínez XEM, Mickevičiūtė D, Milev R, Mohammed M, Molina-López A, Morozov P, Muhammad NS, Mustač F, Naor MS, Nassieb A, Navickas A, Okasha T, Pandova M, Panfil AL, Panteleeva L, Papava I, Patsali ME, Pavlichenko A, Pejuskovic B, Pinto Da Costa M, Popkov M, Popovic D, Raduan NJN, Ramírez FV, Rancans E, Razali S, Rebok F, Rewekant A, Flores ENR, Rivera-Encinas MT, Saiz P, de Carmona MS, Martínez DS, Saw JA, Saygili G, Schneidereit P, Shah B, Shirasaka T, Silagadze K, Sitanggang S, Skugarevsky O, Spikina A, Mahalingappa SS, Stoyanova M, Szczegielniak A, Tamasan SC, Tavormina G, Tavormina MGM, Theodorakis PN, Tohen M, Tsapakis EM, Tukhvatullina D, Ullah I, Vaidya R, Vega-Dienstmaier JM, Vrublevska J, Vukovic O, Vysotska O, Widiasih N, Yashikhina A, Prezerakos PE, Smirnova D.
Eur Neuropsychopharmacol. 2021 Oct 15;54:21-40. doi: 10.1016/j.euroneuro.2021.10.004.

Real-Time Assessment of Stress and Stress Response Using Digital Phenotyping: A Study Protocol. Free article Egeer ST, Knorr M, Bobes J, Bernstein A, Seifritz E, Vetter S.
Front Digit Health. 2020 Oct 15;2:544418. doi: 10.3389/fdgth.2020.544418.

Functional transcranial Doppler: Selection of methods for statistical analysis and representation of changes in flow velocity. Free article
Egger ST, Bobes J, Seifritz E, Vetter S, Schuepbach D.
Health Sci Rep. 2021 Oct 6;4(4):e400. doi: 10.1002/hsr2.400.

Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study.
Fusar-Poli L, Pries LK, van Os J, Erzin G, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Andric-Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Üçok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Aguglia E, Arango C, O’Donovan M, Rutten BPF, Guloksuz S. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Sep 16;113:110440. doi: 10.1016/j.pnpbp.2021.110440.

The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design.
Bernardo M, Amoretti S, Cuesta MJ, Parellada M, Mezquida G; 2EPs Group; acronym 2EPs Group responds to the authorship of the principal investigators of the fifteen centres that have participated in this coordinated multicenter project, González-Pinto A, Bergé D, Lobo A, Aguilar EJ, Usall J, Corripio I, Bobes J, Rodríguez-Jiménez R, Sarró S, Contreras F, Ibáñez Á, Gutiérrez M, Micó JA.Revista de Psiquiatria y Salud Mental (Engl Ed). 2021 Jul-Sep;14(3):164-176. FI 2020: 3.318. (Q2 SSCI Psychiatry).doi: 10.1016/j.rpsmen.2021.08.001.

Real-world functioning in patients with schizophrenia: beyond negative and cognitive symptoms.
García-Portilla P, García-Álvarez L, González-Blanco L , dal Santo F, Bobes-Bascarán T, Martínez-Cao C, García-Fernández A, Sáiz PA , Bobes J. Frontiers in Psychiatry. 2021 July. FI 2020: 4.157. (Q2 SCIE Psychiatry).

The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study.
Ferraro L, La Cascia C, La Barbera D, Sanchez-Gutierrez T, Tripoli G, Seminerio F, Sartorio C, Marrazzo G, Sideli L, Arango C, Arrojo M, Bernardo M, Bobes J, Del-Ben CM, Gayer-Anderson C, Jongsma HE, Kirkbride JB, Lasalvia A, Tosato S, Llorca PM, Menezes PR, Rutten BP, Santos JL, Sanjuán J, Selten JP, Szöke A, Tarricone I, Muratori R, Tortelli A, Velthorst E, Rodriguez V, Quattrone A, Jones PB, Van Os J, Vassos E, Morgan C, de Haan L, Reininghaus U, Cardno AG, Di Forti M, Murray RM, Quattrone D.Schizophrenia Research. 2021 Aug 14;236:69-79. FI 2020:4.939. (Q1 SCIE Psychiatry).doi: 10.1016/j.schres.2021.08.008.

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.
Quattrone D, Reininghaus U, Richards A, Tripoli G, Ferraro L, Quattrone A, Marino P, Rodríguez V, Spinazzola E, Gayer-Anderson C, Jongsma H, Jones P, La Cascia C, La Barbera D, Tarricone I, Bonora E, Tosato S, Lasalvia A, Szöke A, Arango C, Bernardo M, Bobes J, Del-Ben C, Menezes P, Llorca PM, Santos J, Sanjuan J, Arrojo M, Tortelli A, Velthorst E, Berendsen S, de Haan L, Rutten B, Krikbride J, Lynskey M, Freeman T, Sham P, van Os J, O’Donovan M, Cardno A, Vassos E, Morgan C, Murray R, Lewis C, di Forti M. Translational Psychiatry. 2021 August. FI 2020: 6.222. (Q1 SCIE Psychiatry).

Gender, age at onset and duration of being ill as predictors for the long-term course and outcome of Schizophrenia: An international multi-center study.
Fountoulakis KN, Dragioti E, Theofilidis AT, Wiklund T, Atmatzidis X, Nimatoudis I, Thys E, Wampers M, Hranov L, Hristova T, Aptalidis D, Milev R, Iftene F, Spaniel F, Knytl P, Furstova P, From T, Karlsson H, Walta M, Salokangas RKR, Azorin JM, Bouniard J, Montant J, Juckel G, Haussleiter IS, Douzenis A, Michopoulos I, Ferentinos P, Smyrnis N, Mantonakis L, Nemes Z, Gonda X, Vajda D, Juhasz A, Shrivastava A, Waddington J, Pompili M, Comparelli A, Corigliano V, Rancans E, Navickas A, Hilbig J, Bukelskis L, Stevovic LI, Vodopic S, Esan O, Oladele O, Osunbote C, Rybakowski JK, Wojciak P, Domowicz K, Figueira ML, Linhares L, Crawford J, Panfil AL, Smirnova D, Izmailova O, Lecic-Tosevski D, Temmingh H, Howells F, Bobes J, Garcia-Portilla MP, García-Alvarez L, Erzin G, Karadağ H, De Sousa A, Bendre A, Hoschl C, Bredicean C, Papava I, Vukovic O, Pejuskovic B, Russell V, Athanasiadis L, Konsta A, Stein D, Berk M, Dean O, Tandon R, Kasper S, De Hert M.CNS Spectrums. 2021 August 9:1-26. FI 2020: 3.379. (Q2 SCIE Psychiatry).doi: 10.1017/S1092852921000742.

Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis.
González-Blanco L, García-Portilla MP, Gutiérrez M, Mezquida G, Cuesta MJ, Urbiola E, Amoretti S, Barcones F, González-Pinto A, Pina-Camacho L, Corripio I, Vieta E, Baeza I, Toll A, Sáiz PA, Bobes J, Bernardo M; PEPs Group.Schizophrenia Research. 2021 August 5;236:19-28. FI 2020:4.939. (Q1 SCIE Psychiatry).doi: 10.1016/j.schres.2021.07.017.

Excessive and pathological Internet use–risk-behavior or psychopathology?
Kaess M, Klar J, Kindler J, Parzer P, Brunner R, Carli V, Sarchiapone M, Hoven CW, Apter A, Balazs J, Barzilay S, Bobes J, Cozman D, Gomboc V, Haring C, Kahn JP, Keeley H, Meszaros G, Musa GJ, Postuvam V, Saiz P, Sisak M, Varnik P, Resch F, Wasserman, D. Addictive Behaviors. 2021 June 107045. FI 2020: 3.913. (Q1 SCIE Substance Abuse).

Intervention strategies in the prevention of suicidal behavior in substance use disorders patients in times of COVID-19.
Espandian A, Flórez G, Peleteiro LF, Tajes M, Sáiz PA, Villa R, Bobes J. Adicciones. 2021 July 1;33(3):185-192. FI 2020: 2.979. (Q3 SCIE Substance Abuse).doi: 10.20882/adicciones.1717. Free article.

Spanish Validation of the MAP-SR: Two Heads Better Than One for the Assessment of Negative Symptoms of Schizophrenia.
García-Portilla MP, García-Álvarez L, de la Fuente-Tomás L, Dal Santo F, Velasco Á, González-Blanco L, Zurrón-Madera P, Fonseca-Pedrero E, Bobes-Bascarán MT, Bobes, J. Psicothema. 2021 August 33(3), 473-480. FI 2020: 3.890. (Q1 SCCI Psychology, Mutidisciplinary).doi: 10.7334/psicothema2020.457.

Psychopathological Symptom Load and Distinguishable Cerebral Blood Flow Velocity Patterns in Patients With Schizophrenia and Healthy Controls: A Functional Transcranial Doppler Study.
Egger ST, Bobes J, Rauen K, Seifritz E, Vetter S, Schuepbach D. Frontiers in Psychiatry. 2021 June 25;12:679021.12, 960. FI 2020: 4.157. (Q2 SCIE Psychiatry). doi:10.3389/fpsyt.2021.679021.

Cognitive functioning after six months of follow-up in a sample of alcohol use disorder outpatients.
Villa R, Espandian A, Sáiz PA, García-Portilla MP, Bobes J, Flórez G. Adicciones. 2021 June 15;0(0):1672-1672. FI 2020: 2.979. (Q3 SCIE Substance Abuse). doi: 10.20882/adicciones.1672. Free article.

Factors associated with alcohol and tobacco consumption as a coping strategy to deal with the coronavirus disease (COVID-19) pandemic and lockdown in Spain.
Martínez-Cao C, de la Fuente-Tomás L, Menéndez-Miranda I, Velasco A, Zurrón-Madera P, García-Álvarez L, Sáiz PA, Garcia-Portilla MP, Bobes J.
Addict Behav. 2021 June 121:107003. doi: 10.1016/j.addbeh.2021.107003. FI 2020: 3.931. (Q1 SSCI Substance Abuse).

The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings from the Multinational EU-GEI Study
Pignon B, Lajnef M, Kirkbride JB, Peyre H, Ferchiou A, Richard JR, Baudin G, Tosato S, Jongsma H, de Haan L, Tarricone I, Bernardo M, Velthorst E, Braca M, Arango C, Arrojo M, Bobes J, Marta Del-Ben C, Di Forti M, Gayer-Anderson C, Jones PB, La Cascia C, Lasalvia A, Menezes PR, Quattrone D, Sanjuán J, Selten JP, Tortelli A, Llorca PM, van Os J, Rutten BPF, Murray RM, Morgan C, Leboyer M, Szöke M, Schürhoff F.
Schizophr Bull. 2021 May 19. doi: 10.1093/schbul/sbab060. FI 2020: 9.306. (D1 SCIE Psychiatry).

Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study
Misra S, Gelaye B, Williams DR, Koenen KC, Borba CPC, Quattrone D, Di Forti M, Tripoli G, La Cascia C, La Barbera D, Ferraro D, Tarricone I, Berardi D, Lasalvia A, Tosato S, Szöke A, Llorca PM, Arango C, Tortelli A, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Jongsma HE, Kirkbride JB, Rutten BPF, van Os J, Murray RM, Gayer-Anderson C, Morgan C.
Psychol Med. 2021 March 2;1-9. doi: 10.1017/S0033291721000453. FI 2020: 7.723. (D1 SCIE Psychology – Q1 SCIE Psychiatry).

Duration of untreated psychosis in first-episode psychosis is not associated with common genetic variants for major psychiatric conditions: results from the multi-center eu-gei study.
Ajnakina O, Rodriguez V, Quattrone D, di Forti M, Vassos E, Arango C, Berardi D, Bernardo M, Bobes J, de Haan L, Del-Ben CM, Gayer-Anderson C, Jongsma HE, Lasalvia A, Tosato S, Llorca PM, Menezes PR, Rutten BR, Santos JL, Sanjuán J, Selten JP, Szöke A, Tarricone I, D’Andrea G, Richards A, Tortelli A, Velthorst E, Jones PB, Romero MA, La Cascia C, Kirkbride JB, van Os J, O’Donovan M , Murray RB, EU-GEI WP2 Group.
Schizophr Bull. 2021 May 8. doi: 10.1093/schbul/sbab055. FI 2020: 9.306. (Q1 SCIE Psychiatry).

Study to determine relevant health outcome measures in opioid use disorder: Multicriteria decision analysis.
Colom J, Szerman N, Sabater E, Ferre F, Pascual F, Gilabert-Perramon A, Casado MÁ, Bobes J, M C D A-O U D.
Adicciones. 2021 Mar 31;33(2):109-120. FI 2020: 2.979. (Q3 SCIE Substance Abuse). doi: 10.20882/adicciones.1263. Free article.

Clinical practice guideline on pharmacological and psychological management of adult patients with depression and a comorbid substance use disorder.
Torrens M, Tirado-Muñoz J, Fonseca F, Farré M, Gonzalez-Pinto A, Arrojo M, Bernardo M, Arranz B, Garriga M, Saiz PA, Florez G, Goikolea JM, Zorrilla I, Cunill R, Castells X, Becoña E, Lopez A, San L.
Adicciones. 2021 Mar 12;0(0):1559. FI 2020: 2.979. (Q3 SCIE Substance Abuse). doi: 10.20882/adicciones.1559. Online ahead of print.

Clinical Practice Guideline on Pharmacological and Psychological management of adult patients with Schizophrenia Spectrum Disorders and a comorbid substance use.
Arranz B, Garriga M, Bernardo M, Gonzalez-Pinto A, Arrojo M, Torrens M, Tirado-Muñoz J, Fonseca F, Saiz PA, Florez G, Goikolea JM, Zorrilla I, Cunill R, Castells X, Becoña E, Lopez A, San L.
Adicciones. 2021 Mar 11;0(0):1504. FI 2020: 2.979. (Q3 SCIE Substance Abuse). doi: 10.20882/adicciones.1504. Online ahead of print.

Psychopathy, addictions and female gender: comparative study using the Psychopathy Checklist Revised and the Comprehensive Assessment of Psychopathic Personality.
Flórez Menéndez G, Ferrer V, García L, Crespo M, Pérez M, Saiz PA.
Adicciones. 2021 Mar 11;0(0):1500. FI 2020: 2.979. (Q3 SCIE Substance Abuse). doi: 10.20882/adicciones.1500. Online ahead of print.

Suicidal behaviour and cognition: A systematic review with special focus on prefrontal deficits.
Fernández-Sevillano J, González-Pinto A, Rodríguez-Revuelta J, Alberich S, Gónzalez-Blanco L, Zorrilla I, Velasco Á, López MP, Abad I, Sáiz PA.
J Affect Disord. 2021 Jan 1;278:488-496. FI 2019: 4.839. (Q1 SSCI Psychiatry). doi: 10.1016/j.jad.2020.09.044.

Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: results from the EUGEI study.
Erzin G, Pries LK, van Os J, Fusar-Poli L, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Andric-Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O’Donovan MC, Rutten BP, Guloksuz S.
Eur Psychiatry. 2021 Mar 19:1-33. doi: 10.1192/j.eurpsy.2021.19. FI 2020: 5.361. (Q1 SCIE Psychiatry). Online ahead of print.

Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate.
Lencer R, Garcia-Portilla MP, Bergmans P, Gopal S, Mathews M, Wooller A, Pungor K.
Compr Psychiatry. 2021 Mar 2;107:152233. FI 2020: 3.735. (Q2 SCIE Psychiatry). doi: 10.1016/j.comppsych.2021.152233. Online ahead of print.

Difficulties in delivery and depressive symptomatology in schizophrenia.
Mezquida G, Fernández-Egea E, Treen D, Mané A, Bergé D, Savulich G, García-Álvarez L, García-Portilla MP, Bobes J, Bernardo M, García-Rizo C.
Rev Psiquiatr Salud Ment. 2021 Jan-Mar;14(1):66-68. FI 2020: 3.318. (Q2 SSCI Psychiatry). doi: 10.1016/j.rpsm.2019.12.002.

Alcohol use and risk factors for self-harm behavior in Spanish adolescents.
Bousoño M, Al-Halabí S, Burón P, Garrido M, Díaz-Mesa EM, Galván G, García-Álvarez L, Velasco Á, Rodríguez-Revuelta J, Wasserman C, Carli V, Hoven C, Sarchiapone M, Wasserman D, Bousoño M, García-Portilla MP, Iglesias C, Sáiz PA, Bobes J.
Adicciones. 2021 Jan 15;33(1):53-62. FI 2020: 2.979. (Q3 SCIE Substance Abuse). doi: 10.20882/adicciones.1239.

Impact of the coronavirus outbreak on mental health in the different Spanish regions.
Moya-Lacasa C, Alvarez-Vázquez CM, González-Blanco L, Valtueña-García M, Martín-Gil E, Seijo-Zazo E, De la Fuente-Tomás L, García-Alvarez L, Sáiz P, García-Portilla MP, Bobes J. Actas Esp Psiquiatr. 2021 Mar;49(2):64-70. FI 2020: 1.196. (Q4 SCIE Psychiatry).

Early Impact of the COVID-19 Outbreak on Sleep in a Large Spanish Sample.
Dal Santo F, González-Blanco L, Rodríguez-Revuelta J, Marina González PA, Paniagua G, García-Álvarez L, de la Fuente-Tomás L, Sáiz PA, García-Portilla MP, Bobes J. Behav Sleep Med. 2021 Mar 2:1-16. FI 2020: 2.964. (Q3 SCIE Psychiatry). doi: 10.1080/15402002.2021.189059.

Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study.
Misra S, Gelaye B, Williams DR, Koenen KC, Borba CPC, Quattrone D, Di Forti M, Tripoli G, La Cascia C, La Barbera D, Ferraro L, Tarricone I, Berardi D, Lasalvia A, Tosato S, Szöke A, Llorca PM, Arango C, Tortelli A, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Jongsma HE, Kirkbride JB, Rutten BPF, van Os J, Murray RM, Gayer-Anderson C, Morgan C. Psychol Med. 2021 Mar 2:1-9. FI 2020: 7.723. (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S0033291721000453. Online ahead of print.

Chronic Obstructive Pulmonary Disease in severe mental illness: a timely diagnosis to advance the process of quitting smoking.
Jaen-Moreno MJ, Feu N, Del Pozo GI, Gómez C, Carrión L, Chauca GM, Guler I, Montiel FJ, Sánchez MD, Alcalá JA, Gutierrez-Rojas L, Molina V, Bobes J, Balanzá-Martínez V, Ruiz-Rull C, Sarramea F. Eur Psychiatry. 2021 Feb 26:1-26. FI 2020: 5.361. (Q1 SCIE Psychiatry). doi: 10.1192/j.eurpsy.2021.12. Online ahead of print.

The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis.
Arnaiz JA, Rodrigues-Silva C, Mezquida G, Amoretti S, Cuesta MJ, Fraguas D, Lobo A, González-Pinto A, Díaz-Caneja MC, Corripio I, Vieta E, Baeza I, Mané A, García-Rizo C, Bioque M, Saiz J, Bernardo M, Mas S; PEPs group. Psychopharmacology (Berl). 2021 Mar; 238(3):665-676. FI 2020: 4.530. (Q2 SCIE Psychiatry). doi: 10.1007/s00213-020-05715-5.

Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
Eva Velthorst, Josephine Mollon, Robin M. Murray, Lieuwe de Haan, Inez Myin Germeys, David C. Glahn, Celso Arango, Els van der Ven, Marta Di Forti, Miguel Bernardo, Sinan Guloksuz, Philippe Delespaul, Gisela Mezquida, Silvia Amoretti, Julio Bobes, Pilar A. Saiz, María Paz García-Portilla, José Luis Santos, Estela Jiménez-López, Julio Sanjuan, Eduardo J. Aguilar, Manuel Arrojo, Angel Carracedo, Gonzalo López, Javier González-Peñas, Mara Parellada, Cem Atbaşoğlu, Meram Can Saka, Alp Üçok, Köksal Alptekin, Berna Akdede, Tolga Binbay, Vesile Altınyazar, Halis Ulaş, Berna Yalınçetin, Güvem Gümüş-Akay, Burçin Cihan Beyaz, Haldun Soygür, Eylem Şahin Cankurtaran, Semra Ulusoy Kaymak, Nadja P. Maric, Marina M. Mihaljevic, Sanja Andric Petrovic, Tijana Mirjanic, Cristina Marta Del-Ben, Laura Ferraro, Charlotte Gayer-Anderson, Peter B. Jones, Hannah E. Jongsma, James B. Kirkbride,0. Caterina La Cascia, Antonio Lasalvia, Sarah Tosato, Pierre-Michel Llorca, Paulo Rossi Menezes, Craig Morgan, Diego Quattrone, Marco Menchetti, Jean-Paul Selten, Andrei Szöke, Ilaria Tarricone, Andrea Tortelli, Philip McGuire, Lucia Valmaggia, Matthew J. Kempton, Mark van der Gaag, Anita Riecher-Rössler, Rodrigo A. Bressan, Neus Barrantes-Vidal, Barnaby Nelson, Patrick McGorry, Chris Pantelis, Marie-Odile Krebs, Stephan Ruhrmann, Gabriele Sachs, Bart P. F. Rutten, Jim van Os, Behrooz Z. Alizadeh, Therese van Amelsvoort, Agna A. Bartels-Velthuis, Richard Bruggeman, Nico J. van Beveren, Jurjen J. Luykx, Wiepke Cahn, Claudia J. P. Simons, Rene S. Kahn, Frederike Schirmbeck, Ruud van Winkel, EU-GEI High Risk Study & Abraham Reichenberg. Mol Psychiatry (2021). FI 2020: 15.992. (D1 SCIE Psychiatry).doi: 10.1038/s41380-020-00969-z

Migration history and risk of psychosis: results from the multinational EU-GEI study.
Ilaria Tarricone, Giuseppe D’Andrea, Hannah E Jongsma, Sarah Tosato, Charlotte Gayer-Anderson, Simona A. Stilo, Federico Suprani, Conrad Iyegbe, Els van der Ven, Diego Quattrone, Marta di Forti, Eva Velthorst, Paulo Rossi Menezes, Celso Arango , Mara Parellada, Antonio Lasalvia, Caterina La Cascia, Laura Ferraro, Julio Bobes, Miguel Bernardo, Iulio Sanjuán, Jose Luis Santos, Manuel Arrojo, Cristina Marta Del-Ben, Giada Tripoli, Pierre-Michel Llorca, Lieuwe de Haan, Jean-Paul Selten, Andrea Tortelli, Andrei Szöke, Roberto Muratori, Bart P. Rutten, Jim van Os, Peter B. Jones, James B. Kirkbride, Domenico Berardi, Robin M. Murray, Craig Morgan. Psychol Med. 2021 Feb 10:1-13. FI 2020: 7.723. (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S003329172000495X

Año 2020 (FI acumulado = 306,187)

Twelve-month service use, suicidality and mental health problems of European adolescents after a school-based screening for current suicidality.
Kaess M, Schnyder N, Michel C, Brunner R, Carli V, Sarchiapone M, Hoven CW, Wasserman C, Apter A, Balazs J, Bobes J, Cosman D, Haring C, Kahn JP, Keeley H, Kereszteny A, Podlogar T, Postuvan V, Varnik A, Resch F, Wasserman D.
Eur Child Adolesc Psychiatry. 2020 Dec 15. FI 2020: 4.785. (Q1 SSCI Psychiatry). doi: 10.1007/s00787-020-01681-7. Online ahead of print.

The Suicide Prevention and Intervention Study (SURVIVE): study protocol for a Spanish multisite cohort study with nested randomized-controlled trials.
Pérez V, Elices M, Toll A, Bobes J, López-Solà C, Díaz-Marsá M, Grande I, López-Peña P, Rodríguez-Vega B, Ruiz-Veguilla M, de la Torre-Luque A; SURVIVE Group. Rev Psiquiatr Salud Ment. 2020 Dec 7:S1888-9891(20)30127-0. FI 2020: 3.318. (Q2 SSCI Psychiatry). doi: 10.1016/j.rpsm.2020.11.004. Epub ahead of print.

The Mediating Role of Impulsivity in the Relationship Between Suicidal Behavior and Early Traumatic Experiences in Depressed Subjects.
Dal Santo F, Carballo JJ, Velasco A, Jiménez-Treviño L, Rodríguez-Revuelta J, Martínez-Cao C, Caro-Cañizares I, de la Fuente-Tomás L, Menéndez-Miranda I, González-Blanco L, García-Portilla MP, Bobes J, Sáiz PA.
Front Psychiatry. 2020 Nov 10;11:538172. FI 2020: 4.157. (Q2 SCIE Psychiatry). doi: 10.3389/fpsyt.2020.538172.

Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trial
Faay MDM, van Baal GCM, Arango C, Díaz-Caneja CM, Berger G, Leucht S, Bobes J, Sáiz PA, García-Portilla MP, van de Brug R, Petter J, Winter-van Rossum I, Sommer IE. Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trial.
Schizophr Res. 2020 Sep;223:271-278. FI 2020:4.939 (Q1 SCIE Psychiatry). doi: 10.1016/j.schres.2020.08.021.

Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.
Pries LK, Dal Ferro GA, van Os J, Delespaul P, Kenis G, Lin BD, Luykx JJ, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Şahin Cankurtaran E, Ulusoy Kaymak S, Mihaljevic MM, Andric Petrovic S, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Can Saka M; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O’Donovan M, Tosato S, Rutten BPF, Guloksuz S.
Epidemiology and Psychiatric Sciences. 2020 Nov 17;29:e182.FI 2020: 6.892 (Q1 SCIE Psychiatry). https://doi.org/10.1017/s2045796020000943

The King´s neurologist.
Fernández-Menéndez, S., Álvarez-Antuña, V., Bobes, J.
The Lancet Neurology. 2020 Dec 01, 19 (12). FI 2020: 44.182 (D1 SCIE Neurology). https://doi.org/10.1016/S1474-4422(20)30411-7

Are older adults also at higher psychological risk from COVID-19? Free article
García-Portilla P, de la Fuente Tomás L, Bobes-Bascarán T, Jiménez Treviño L, Zurrón Madera P, Suárez Álvarez M, Menéndez Miranda I, García Álvarez L, Sáiz Martínez PA, Bobes J.
Aging Ment Health. 2020 Sep 1:1-8. FI 2019: 3.658. (Q2 SSCI Psychiatry). doi: 10.1080/13607863.2020.1805723.

Early psychological correlates associated with COVID-19 in a Spanish older adult sample.Free article
Bobes-Bascarán T, Sáiz PA, Velasco A, Martínez-Cao C, Pedrosa C, Portilla A, de la Fuente-Tomas L, García-Alvarez L, García-Portilla MP, Bobes J.
American Journal of Geriatric Psychiatry. 2020 Sep 7;S1064-7481(20)30475-9. FI 2020: 4.105 (Q2 SCIE Psychiatry). doi: 10.1016/j.jagp.2020.09.005

Early psychological impact of the 2019 coronavirus disease (COVID-19) pandemic and lockdown in a large Spanish sample.Free article
García-Álvarez L, de la Fuente-Tomás L, García-Portilla González MP, Sáiz PA, Moya Lacasa C, dal Santo F, González-Blanco L, Bobes Bascarán MT, Valtueña García M, Álvarez Vázquez C, Velasco Iglesias A, Martínez Cao C, García Fernández A, Bascarán Fernández MT, Portilla Fernández A, Rodríguez Revuelta J, Seijo Zazo E, Zurrón Madera P, Suárez Álvarez M, Paredes Sánchez A, Fernández Delgado C, Casaprima Suárez S, Menéndez Miranda I, Jiménez Treviño L, Paniagua Calzón G, Abad I, Pedrosa Duque C, Riera L, Marina González P, Fonseca Pedrero E, Bobes J.
Journal of Global Health. 2020 Dec; 10(2): 020505. 2020 Oct 8. FI 2020: 4.413. (Q1 SCIE Public, Environmental & Occupational Health).doi: 10.7189/jogh.10.020505

Prevalence of passive suicidal ideation in the early stage of the coronavirus disease 2019 (COVID-19) pandemic and lockdown in a large Spanish sample.Free article
Sáiz PA, de la Fuente-Tomas L, García-Alvarez L, Bobes-Bascarán MT, Moya-Lacasa C, García-Portilla MP, Bobes J
Journal of Clinical Psychiatry. 2020 Oct 6;81(6):20l13421. FI 2020: 4.384. (Q1 SSCI Psychiatry). doi: 10.4088/JCP.20l13421.

Suicide. The post-COVID era: A time for action.
Padron-Monedero A, Noguer-Zambano I, García TG, Suárez RS, Bobes J, Gili M, Pérez V, Roca M, Saiz-Ruiz J. Revista de Psiquiatria y Salud Mental. 2020 Jul 20:S1888-9891(20)30074-4. FI 2020: 3.318. (Q2 SSCI Psychiatry).doi: 10.1016/j.rpsm.2020.06.005.

COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls? Free article
González-Blanco L, Dal Santo F, García-Álvarez L, de la Fuente-Tomás L, Moya Lacasa C, Paniagua G, Sáiz PA, García-Portilla MP, Bobes J.
Schizophrenia Research. 2020 Jul 25:S0920-9964(20)30409-6. FI 2020: 4.939. (Q1 SSCIE Psychiatry). doi:0.1016/j.schres.2020.07.018.

Psychiatry residency during the COVID-19 pandemic: Navigating uncharted waters. Free article
Dal Santo F, Rodríguez-Revuelta J, García-Portilla MP, Bobes J.
Asian Journal of Psychiatry. 2020 Jun 16;53:102214. FI 2020: 3.543. (Q2 SCIE Psychiatry). doi: 10.1016/j.ajp.2020.102214.

Will changes in alcohol and tobacco use be seen during the COVID-19 lockdown? Free article
García-Álvarez L, Fuente-Tomás L, Sáiz PA, García-Portilla MP, Bobes J.
Adicciones. 2020 Apr 1;32(2):85-89. FI 2020: 2.979. (Q3 SCIE Substance Abuse). doi: 10.20882/adicciones.1546.

Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway.
van Os J, Pries LK, Ten Have M, de Graaf R, van Dorsselaer S, Delespaul P, Bak M, Kenis G, Lin BD, Luykx JJ, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC, Arango C, O’Donovan M, Rutten BPF, Guloksuz S.
Psychological Medicine. 2020 Oct 19:1-13. FI 2020: 7.723 (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S0033291720003748.

The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design.
Bernardo M, Amoretti S, Cuesta MJ, Parellada M, Mezquida G; 2EPs Group; acronym 2EPs Group responds to the authorship of the principal investigators of the fifteen centres that have participated in this coordinated multicenter project, González-Pinto A, Bergé D, Lobo A, Aguilar EJ, Usall J, Corripio I, Bobes J, Rodríguez-Jiménez R, Sarró S, Contreras F, Ibáñez Á, Gutiérrez M, Micó JA.
Revista de Psiquiatria y Salud Mental. 2020 Oct 2:S1888-9891(20)30098-7. FI 2020: 3.318. (Q2 SSCI Psychiatry). doi: 10.1016/j.rpsm.2020.07.004.

A replication study of JTC bias, genetic liability for psychosis and delusional ideation.
Henquet C, van Os J, Pries LK, Rauschenberg C, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran ES, Kaymak SU, Mihaljevic MM, Petrovic SS, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC, Arango C, O’Donovan M, Rutten BPF, Gülöksüz S.
Psychological Medicine. 2020 Oct 13:1-7. FI 2020: 7.723 (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S0033291720003578.

Assessing the severity of psychiatric disorders using the Health of the Nation Outcome Scales (HoNOS): an equipercentile linking analysis.
Egger E, Bobes J, Theodoridou A, Seifritz E, Vetter S.
Australian and New Zealand Journal of Psychiatry. 2020 Oct 9:4867420963725. FI: 5.744 (Q1 SCIE Psychiatry). doi: 10.1177/0004867420963725.

Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trial.
Faay MDM, van Baal GCM, Arango C, Díaz-Caneja CM, Berger G, Leucht S, Bobes J, Sáiz PA, García-Portilla MP, van de Brug R, Petter J, Winter-van Rossum I, Sommer IE.
Schizophrenia Research. 2020 Sep 11:S0920-9964(20)30449-7. FI 2020: 4.939. (Q1 SCIE Psychiatry).doi:10.1016/j.schres.2020.08.021.

A Smart Band for Automatic Supervision of Restrained Patients in a Hospital Environment.
Muñiz R, Díaz J, Martínez JA, Nuño F, Bobes J, García-Portilla MP, Sáiz PA.
Sensors (Basel). 2020 Sep 12;20(18):E5211. FI 2020: 3.576 (Q1 SCIE Instruments & intrumentation). doi: 10.3390/s20185211.

Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences.
Dal Santo F, González-Blanco L, García-Álvarez L, de la Fuente-Tomás L, Velasco A, Álvarez-Vázquez C, Martínez-Cao C, Sáiz P, García-Portilla P, Bobes J.
Scientific Reports. 2020 Sep 29;10(1):15963. FI 2020: 4.379 (Q1 SCIE Multidisciplinary Sciences). doi: 10.1038/s41598-020-73043-x.

Compulsory Admissions of patients with mental disorders: State of the art on ethical and legislative aspects in 40 European countries.
Wasserman D, Apter G, Baeken C, Bailey S, Balazs J, Bec C, Bienkowski P, Bobes J, Bravo Ortiz MF, Brunn H, Bôke Ö, Camilleri N, Carpiniello B, Chihai J, Chkonia E, Courtet P, Cozman D, David M, Dom G, Esanu A, Falkai P, Flannery W, Gasparyan K, Gerlinger G, Gorwood P, Gudmundsson O, Hanon C, Heinz A, Heitor Dos Santos MJ, Hedlund A, Ismayilov F, Ismayilov N, Isometsä ET, Izakova L, Kleinberg A, Kurimay T, Klæbo Reitan S, Lecic-Tosevski D, Lehmets A, Lindberg N, Lundblad KA, Lynch G, Maddock C, Malt UF, Martin L, Martynikhin I, Maruta NO, Matthys F, Mazaliauskiene R, Mihajlovic G, Mihaljevic Peles A, Miklavic V, Mohr P, Munarriz Ferrandis M, Musalek M, Neznanov N, Ostorharics-Horvath G, Pajević I, Popova A, Pregelj P, Prinsen E, Rados C, Roig A, Rojnic Kuzman M, Samochowiec J, Sartorius N, Savenko Y, Skugarevsky O, Slodecki E, Soghoyan A, Stone DS, Taylor-East R, Terauds E, Tsopelas C, Tudose C, Tyano S, Vallon P, Van der Gaag RJ, Varandas P, Vavrusova L, Voloshyn P, Wancata J, Wise J, Zemishlany Z, Öncü F, Vahip S.
European Psychiatry. 2020 Aug;24;63(1):e82. FI 2020: 5.361. (Q1 SCIE Psychiatry). doi: 10.1192/j.eurpsy.2020.79.

A replication study of JTC bias, genetic liability for psychosis and delusional ideation.
Henquet C, van Os J, Pries LK, Rauschenberg C, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran ES, Kaymak SU, Mihaljevic MM, Petrovic SS, Mirjanic T, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC, Arango C, O’Donovan M, Rutten BPF, Gülöksüz S.
Psychol Med. 2020 Oct 13:1-7. FI 2020: 7.723. (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S0033291720003578.

Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia. Free article
Garcia-Portilla MP, Llorca PM, Maina G, Bozikas VP, Devrimci-Ozguven H, Kim SW, Bergmans P, Usankova I, Pungor K.
Therapeutics Advanves in Psychopharmacolgoy. 2020 May 25;10:2045125320926347. FI 2020: 5.000. (Q1 SCIE Psychiatry). doi: 10.1177/2045125320926347.

Sex-dependent grades of hematopoietic modulation in patients with major depressive episodes are associated with suicide attempts.
Velasco A, Martínez-Botía P, Rolle V, Jiménez-Treviño L, de la Fuente-Tomás L, Bernardo A, Arías T, Muñoz-Turrillas MC, García-Álvarez L, González-Blanco L, Rodríguez-Revuelta J, García-Portilla MP, Courtet P, Bobes J, Gutiérrez L, Sáiz PA.
European Neuropsychopharmacology, 2020 Jun 26;S0924-977X(20)30192-9. FI 2020: 4.600. (Q2 SCIE Psychiatry).

Exploring the factor structure of the mini-ICF-APP in an inpatient clinical sample, according to the psychiatric diagnosis.
Egger ST, Weniger G, Bobes J, Seifritz E, Vetter S.
Revista de Psiquiatria y Salud Mental. 2020 Jul 22:S1888-9891(20)30066-5. FI 2020: 3.318. (Q2 SSCI Psychiatry). doi: 10.1016/j.rpsm.2020.05.008.

Smoking in hospitalized patients. A great opportunity. Free article
Carrión Valero F, Martínez González D, Bobes-Bascarán M, Galán Gil G, Ortega Serrano J, Chorro Gascó F, Bobes J, Jiménez Ruiz C.
Adicciones. 2020 Jul 14;0(0):1358.FI 2020: 2.979. (Q3 SCIE Substance Abuse). doi:10.20882/adicciones.1358.

Personalized medicine begins with the phenotype: Identifying antipsychotic response phenotypes in a first-episode psychosis cohort.
Mas S, Gassó P, Rodríguez N, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Castro-Fornieles J, Bobes J, Usall J, Saiz-Ruiz J, Contreras F, Parellada E, Bernardo M; PEPs group.
Acta Psychiatrica Scandinavica. 2020 Jun;141(6):541-552. FI 2020: 6.392. (Q1 SCIE Psychiatry). doi: 10.1111/acps.13131.

Premorbid adjustment and IQ in patients with first-episode psychosis: A multisite case-control study of their relationship with cannabis use. Free article
Ferraro L, La Cascia C, Quattrone D, Sideli L, Matranga D, Capuccio V, Tripoli G, Gayer-Anderson C, Morgan C, Sami MB, Sham P, de Haan L, Velthorst E, Jongsma HE, Kirkbride JB, Rutten BPF, Richards AL, Roldan L, Arango C, Bernardo M, Bobes J, Sanjuan J, Santos JL, Arrojo M, Tarricone I, Tortelli A, Szöke A, Del-Ben CM, Selten JP, Lynskey M, Jones PB, Van Os J, La Barbera D; WP2 EU-GEI GROUP, Murray RM, Di Forti M.
Schizophrenia Bulletin. 2020 Apr 10;46(3):517-529. FI 2020: 9.306. (D1 SCIE Psychiatry). doi: 10.1093/schbul/sbz077.

Smoking cessation improves clinical outcome in severe mental disorders and is modulated by genetic variability at CHRNA5 gene.
Segura AG, Mitjans M, Fatjó-Vilas M, Garcia-Portilla MP, Garcia-Alvarez L, Sarramea F, Bobes-Bascaran T, de la Fuente-Tomás L, Velasco Iglesias A, Martínez-Cao C, González-Blanco L, Dal Santo F, Elizagarate E, Saiz PA, Fañanás L, Bobes J, Arias B.
Schizophrenia Research. 2020 Jun 14;S0920-9964(20)30276-0. FI 2020: 4.939. (Q1 SSCI Psychiatry – Q1 SCIE Psychiatry). doi: 10.1016/j.schres.2020.05.024.

Association of cannabinoid receptor genes (CNR1 and CNR2) polymorphisms and panic disorder.
Peiró AM, García-Gutiérrez MS, Planelles B, Femenía T, Mingote C, Jiménez-Treviño L, Martínez-Barrondo S, García-Portilla MP, Saiz PA, Bobes J, Manzanares J.
Anxiety Stress and Coping. 2020 May;33(3):256-265. FI 2020: 2.887. (Q2 SSCI Psychology, Multidisciplinary). doi: 10.1080/10615806.2020.1732358.

Study to determine relevant health outcome measures in opioid use disorder: multicriteria decision analysis.
Colom J, Szerman N, Sabater Cabrera E, Ferre F, Pascual F, Gilabert-Perramon A, Casado MÁ, Bobes J, McDa-Oud GT. Adicciones. 2020 Nov 30;0(0):1263. FI 2020: 2.979. (Q3 SCIE Substance Abuse). doi: 10.20882/adicciones.1263.

The Multi-Component Smoking Cessation Support Programme (McSCSP) is effective in patients with severe mental disorder without gender differences.
Jaén Moreno MJ, Garcia-Portilla MP, Sarramea F, Bobes Bascarán T, Galvan G, Diaz-Mesa EM, Al-Halabi S, Elizagarate E, Saiz Martínez PA, Bobes J, Garcia-Alvarez L.
Adicciones, aceptado mayo de 2020. FI 2020: 2.979. (Q3 SCIE Substance Abuse).

Sexual dysfunction and mood stabilizers in long-term stable patients with bipolar disorder.
García-Blanco A, García-Portilla MP, Fuente-Tomás L, Batalla M, Sánchez-Autet M, Arranz B, Safont G, Arqués S, Livianos L, Sierra P.
Journal of Sexual Medicine. 2020 May;17(5):930-940. FI 2020: 3.802. (Q2 SCIE Urology & Nephrology). doi: 10.1016/j.jsxm.2020.01.032.

Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
García-Álvarez L, Martínez-Cao C, Bobes-Bascarán T, Portilla A, Courtet P, de la Fuente-Tomás L,Velasco A, González-Blanco L, Zurrón P, Fonseca-Pedrero E, Saiz P, García-Portilla MP, Bobes J.
Revista de Psiquiatría y Salud Mental. 2020 Jun 6:S1888-9891(20)30036-7. FI 2020: 3.318. (Q2 SSCI Psychiatry). doi: 10.1016/j.rpsm.2020.04.011.

Farewell letter from the previous Editor of RPSM.
Bobes J.
Revista de Psiquiatria y Salud Mental. 2020 Apr-Jun;13(2):51-52. FI 2020: 3.318. (Q2 SSCI Psychiatry). doi: 10.1016/j.rpsm.2020.04.003.

Sex differences in bipolar disorder: Impact of lifetime cannabis use on clinical course, functioning, and quality of life in bipolar disorder.
de la Fuente-Tomás L, Arranz B, Velasco A, Sierra P, Sanchez-Autet M, García-Blanco A, Safont G, García-Portilla MP.
Journal of Affective Disorders. 2020 Apr;1;266:258-262. FI 2020: 4.839. (Q1 SSCI Psychiatry). doi: 10.1016/j.jad.2020.01.043.

Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model.
Dal Santo F, Jarratt-Barnham I, González-Blanco L, García-Portilla MP, Bobes J, Fernández-Egea E.
European Neuropsychopharmacology. 2020 Apr;33:158-163. FI 2020: 4.600. (Q2 SCIE Psychiatry). doi: 10.1016/j.euroneuro.2020.01.016.

Modeling psychological function in patients with schizophrenia with the PANSS: an international multi-center study.
Fountoulakis KN, Dragioti E, Theofilidis AT, Wiklund T, Atmatzidis X, Nimatoudis I, Thys E, Wampers M, Hranov L, Hristova T, Aptalidis D, Milev R, Iftene F, Spaniel F, Knytl P, Furstova P, From T, Karlsson H, Walta M, Salokangas RKR, Azorin JM, Bouniard J, Montant J, Juckel G, Haussleiter IS, Douzenis A, Michopoulos I, Ferentinos P, Smyrnis N, Mantonakis L, Nemes Z, Gonda X, Vajda D, Juhasz A, Shrivastava A, Waddington J, Pompili M, Comparelli A, Corigliano V, Rancans E, Navickas A, Hilbig J, Bukelskis L, Stevovic LI, Vodopic S, Esan O, Oladele O, Osunbote C, Rybakowski JΚ, Wojciak P, Domowicz K, Figueira ML, Linhares L, Crawford J, Panfil AL, Smirnova D, Izmailova O, Lecic-Tosevski D, Temmingh H, Howells F, Bobes J, Garcia-Portilla MP, García-Alvarez L, Erzin G, Karadağ H, De Sousa A, Bendre A, Hoschl C, Bredicean C, Papava I, Vukovic O, Pejuskovic B, Russell V, Athanasiadis L, Konsta A, Stein D, Berk M, Dean O, Tandon R, Kasper S, De Hert M.
CNS Spectrums. 2020 Apr;15:1-9. FI 2020: 3.379. (Q2 SCIE Psychiatry). doi: 10.1017/S1092852920001091.

Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.
Martínez-Cao C, García-Álvarez L, Bobes-Bascarán T, de la Fuente-Tomás L, Fernández Egea E, Velasco A, González-Blanco L, Zurrón P, Fonseca-Pedrero E, Saiz P, García-Portilla MP, Bobes J.
Revista de Psiquiatría y Salud Mental. 2020 Jun 4;S1888-9891(20)30033-1. FI 2020: 3.318. (Q2 SSCI Psychiatry). doi: 10.1016/j.rpsm.2020.04.008.

Network structure of psychotic‐like experiences in adolescents: Links with risk and protective factors.
Fonseca-Pedrero E, Muñiz J, García-Portilla MP, Bobes J.
Early Intervention in Psychiatry. 2020 May 17. FI 2020: 2.732. (Q3 SCIE Psychiatry). doi: 10.1111/eip.12989.

The EUropean network of national schizophrenia networks studying Gene-Environment Interactions (EU-GEI) – Incidence and first-episode case-control programme.
Gayer-Anderson C, Jongsma HE, Di Forti M, Quattrone D, Velthorst E, de Haan L, Selten J-P, Szöke A, Llorca P-M, Tortelli A, Arango C, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Parellada M, Tarricone I, Berardi D, Ruggeri M, Lasalvia A, Ferraro L, La Cascia C, La Barbera D, Rossi Menezes P, Del-Ben CM, EU-GEI WP2 Group††, Rutten BP, van Os J, Jones PB, Murray RM, Kirkbride JB, Morgan C
Social Psychiatry and Psychiatric Epidemiology. 2020 May;55(5):645-657. FI 2020: 4.328. (Q1 SSCI Psychiatry). doi: 10.1007/s00127-020-01831-x.

Neutrophil-to-lymphocyte ratio: A potential new peripheral biomarker of suicidal behavior. Free article
Velasco Á, Rodríguez-Revuelta J, Olié E, Abad I, Fernández-Peláez A, Cazals A, Guillaume S, de la Fuente-Tomás L, Jiménez-Treviño L, Gutiérrez L, García-Portilla P, Bobes J, Courtet P, Sáiz PA.
European Psychiatry. 2020 Feb;17;63(1):e14. FI 2020: 5.361. (Q1 SCIE Psychiatry). doi: 10.1192/j.eurpsy.2019.20.

Doing nothing is sometimes worse: Comparing avoidant versus approach coping strategies with peer victimization and their association to depression and suicide ideation.
Benatov J, Brunstein A, Shira B, Apter A, Carli V, Wasserman C, Hoven CV, Sarchiapone M, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Haring C, Kahn JP, Keeley H, Kereszteny A, Podlogar T, Postuvan V, Saiz PA, Sisask M, Varnik A, Wasserman D.
Journal of School Violence, 2020 Apr 3. FI 2020: 2.400 (Q2 SSCI Criminology & Penology). doi: 10.1080/15388220.2020.1738941

Jumping to conclusions, general intelligence, and psychosis liability: Findings from the multi-centre EU-GEI case-control study.
Tripoli G, Quattrone D, Ferraro L, Gayer-Anderson C, Rodriguez V, La Cascia C, La Barbera D, Sartorio C, Seminerio F, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Llorca PM, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP; EU-GEI WP2 Group, Jones PB, Jongsma HE, Kirkbride JB, Lasalvia A, Tosato S, Richards A, O’Donovan M, Rutten BP, Os JV, Morgan C, Sham PC, Murray RM, Murray GK, Di Forti M.
Psychological Medicine. 2020 Apr;24:1-11. FI 2020: 7.723. (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S003329171900357X

Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: Results from the EU-GEI case-control study.
Jongsma HE, Gayer-Anderson C, Tarricone I, Velthorst E, van der Ven E, Quattrone D, di Forti M; EU-GEI WP2 Group, Menezes PR, Del-Ben CM, Arango C, Lasalvia A, Berardi D, La Cascia C, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, de Haan L, Tortelli A, Szöke A, Murray RM, Rutten BP, van Os J, Morgan C, Jones PB, Kirkbride JB.
Psychological Medicine. 2020 Mar;3:1-13. FI 2020: 7.723. (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S003329172000029X.

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study.
Quattrone D, Ferraro L, Tripoli G, La Cascia C, Quigley H, Quattrone A, Jongsma HE, Del Peschio S, Gatto G; EU-GEI group, Gayer-Anderson C, Jones PB, Kirkbride JB, La Barbera D, Tarricone I, Berardi D, Tosato S, Lasalvia A, Szöke A, Arango C, Bernardo M, Bobes J, Del Ben CM, Menezes PR, Llorca PM, Santos JL, Sanjuán J, Tortelli A, Velthorst E, de Haan L, Rutten BPF, Lynskey MT, Freeman TP, Sham PC, Cardno AG, Vassos E, van Os J, Morgan C, Reininghaus U, Lewis CM, Murray RM, Di Forti M.
Psychological Medicine. 2020 Mar;18:1-9. FI 2020: 7.723. (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S0033291720000082.

Psychotic experiences are associated with paternal age but not with delayed fatherhood in a large, multinational, community sample.
Schürhoff F, Pignon B, Lajnef M, Denis R, Rutten B, Morgan C, Murray RM, Leboyer M, van Os J, Szöke A; EU-GEI WP2 Group Author.
Schizophrenia Bulletin. 2020 Feb 12;sbz142. FI 2020: 9.306. (D1 SCIE Psychiatry). doi: 10.1093/schbul/sbz142

Life events predicting the first onset of adolescent direct self-injurious behavior. A prospective multicenter study.
Kaess M, Eppelmann L, Brunner R, Parzer P, Resch F, Carli V, Wasserman C, Sarchiapone M, Hoven CW, Apter A, Balazs J, Barzilay S, Bobes J, Cosman D, Horvath LO, Kahn JP, Keeley H, McMahon E, Podlogar T, Postuvan V, Saiz PA, Tubiana A, Varnik A, Wasserman D.
Journal of Adolescent Health. 2020 Feb;66(2):195-201. FI 2020: 5.012. (D1 SCIE Pediatrics). doi: 10.1016/j.jadohealth.2019.08.018.

Influence of coping strategies on the efficacy of YAM (Youth Aware of Mental Health): a universal school-based suicide preventive program.
Kahn JP, Cohen RF, Tubiana A, Legrand K, Wasserman C, Carli V, Apter A, Balazs J, Banzer R, Baralla F, Barzilai S, Bobes J, Brunner R, Corcoran P, Cosman D, Guillemin F, Haring C, Kaess M, Bitenc UM, Mészàros G, McMahon E, Postuvan V, Saiz P, Varnik A, Varnik P, Sarchiapone M, Hoven CW, Wasserman D.
European Child & Adolescent Psychiatry. 2020 Feb 5. FI 2020: 4.785. (Q1 SCIE Pediatrics – Q1 SCIE Psychiatry). doi: 10.1007/s00787-020-01476-w

A clinical staging model for bipolar disorder: longitudinal approach. Free article
de la Fuente-Tomás L, Sierra P, Sanchez-Autet M, Arranz B, García-Blanco A, Safont G, García-Portilla MP.
Translational Psychiatry. 2020 Jan;29;10(1):45. FI 2020: 6.222. (Q1 SCIE Psychiatry). doi: 10.1038/s41398-020-0718-9.

Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness. Free article
Bergé D, Mané A, Lesh TA, Bioque M, Barcones F, Gonzalez-Pinto AM, Parellada M, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, García-Portilla MP, Usall J, Carter CS, Cabrera B, Bernardo M, Janssen J; PEPs group (collaborators) .
Schizophrenia Bulletin. 2020 Jul 8;46(4):846-856. FI 2020: 9.306. (D1 SCIE Psychiatry). doi: 10.1093/schbul/sbz132.

Screening for anxiety and depression in primary care: Utility of 2 brief scales adapted to the ICD-11-PC.
Iglesias-García C, López-García P, Ayuso-Mateos JL, García JÁ, Bobes J.
Revista de Psiquiatría y Salud Mental. 2020 Jan 30;S1888-9891(20)30014-8. FI 2020: 3.318. (Q2 SSCI Psychiatry). doi: 10.1016/j.rpsm.2019.12.001

Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study.
García-Rizo C, Bioque M, Mezquida G, Amoretti S, Cuesta MJ, Díaz-Caneja CM, Mas S, Lobo A, González-Pinto A, Fraguas D, Corripio I, Vieta E, Baeza I, Bergé D, Fernandez-Egea E, Garriga M, Bernardo M; PEPs GROUP.
Schizophrenia Research. 2020 Apr;218:292-294. FI 2020: 4.939. (Q1 SSCI Psychiatry – Q1 SCIE Psychiatry). doi: 10.1016/j.schres.2019.12.030.

Relevant risk factors of repeated suicidal attempts in a sample of outpatients.
Espandian A, González M, Reijas T, Florez G, Ferrer E, Saiz PA, Salgado-Barreira A, González A, Brenlla J, Docasar L, Bobes J.
Revista de Psiquiatria y Salud Mental. 2020 Jan-Mar;13(1):11-21. FI 2020: 3.318. (Q2 SSCI Psychiatry). doi: 10.1016/j.rpsm.2019.03.003.

Old drugs, new medication. Free article
Jiménez Treviño L, Velasco Á, Rodríguez-Revuelta J, Saiz P.
Adicciones. 2020 Jan 1;32(1):3-6. FI 2020: 2.979. (Q3 SCIE Substance Abuse). doi: 10.20882/adicciones.1474.

Año 2019 (FI acumulado = 189,408)

“Readiness to change” predicts efficacy of reduction among smokers with severe mental illness.
Sarramea Crespo F, Jaén-Moreno M J, Gutierrez-Rojas L, Balanzá-Martinez V, Garcia-Alvarez L, Sáiz Martínez PA, García-Portilla MP, Bobes J.
European Addiction Research. 2019;25(5):256-262. FI 2019: 2.269. (Q3 SCIE Psychiatry). doi: 10.1159/000500450.

Assessing the severity of functional impairment of psychiatric disorders: equipercentile linking the mini-ICF-APP and CGI. Free article
Egger ST, Weniger G, Müller M, Bobes J, Seifritz E, Vetter S.
Health and Quality Life Outcomes. 2019 Nov 19;17(1):174. FI 2019: 2.344 (Q2 Health Policy & Services). doi: 10.1186/s12955-019-1235-5.

Staging of schizophrenia with the use of PANSS: An international multi-center study. Free article
Fountoulakis KN, Dragioti E, Theofilidis AT, Wikilund T, Atmatzidis X, Nimatoudis I, Thys E, Wampers M, Hranov L, Hristova T, Aptalidis D, Milev R, Iftene F, Spaniel F, Knytl P, Furstova P, From T, Karlsson H, Walta M, Salokangas RKR, Azorin JM, Bouniard J, Montant J, Juckel G, Haussleiter IS, Douzenis A, Michopoulos I, Ferentinos P, Smyrnis N, Mantonakis L, Nemes Z, Gonda X, Vajda D, Juhasz A, Shrivastava A, Waddington J, Pompili M, Comparelli A, Corigliano V, Rancans E, Navickas A, Hilbig J, Bukelskis L, Injac Stevovic L, Vodopic S, Esan O, Oladele O, Osunbote C, Rybakowski JΚ, Wojciak P, Domowicz K, Figueira ML, Linhares L, Crawford J, Panfil AL, Smirnova D, Izmailova O, Lecic-Tosevski D, Temmingh H, Howells F, Bobes J, Garcia-Portilla MP, García-Alvarez L, Erzin G, Karadağ H, De Sousa A, Bendre A, Hoschl C, Bredicean C, Papava I, Vukovic O, Pejuskovic B, Russell V, Athanasiadis L, Konsta A, Stein D, Berk M, Dean O, Tandon R, Kasper S, De Hert M.
International Journal of Neuropsychopharmacology. 2019 Nov;1;22(11):681-697. FI 2019: 4.333. (Q1 SCIE Psychiatry). doi: 10.1093/ijnp/pyz053.

Barriers to complete recovery of major depression: cross-sectional, multi-centre study on clinical practice. RECORD study. Free article
Bobes J, Saiz-Ruiz J, Pérez V; el Grupo de Estudio RECORD.
Revista de Psiquiatria y Salud Mental. 2019 Jul-Sep;12(3):141-150. FI 2019: 2.630. (Q2 SCIE Psychiatry). doi: 10.1016/j.rpsm.2018.10.002.

Cognitive functioning in patients with alcohol use disorder who start outpatient treatment. Free article
Villa R, Espandian A, Sáiz PA, Astals M, Valencia JK, Martínez-Santamaría E, Álvarez S, García-Portilla MP, Bobes J, Flórez G.
Adicciones. 2019 Jul 9;0(0):1326. doi: 10.20882/adicciones.1326.

Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology.
Gonzalez-Blanco L, Garcia-Portilla MP, Dal Santo F, Garcia-Alvarez L, de la Fuente-Tomas L, Menendez-Miranda I, Bobes-Bascaran T, Saiz PA, Bobes J.
Psychiatry Research. 2019 Oct;280:112509. FI 2019: 2.118. (Q3 SCIE Psychiatry). doi: 10.1016/j.psychres.2019.112509.

Factors associated with tobacco consumption in patients with depression. Free article
Jiménez-Treviño L, Velasco Á, Rodriguez-Revuelta J, Abad I, De la Fuente-Tomás L, González-Blanco L, García-Álvarez L, Fernández-Peláez A, Menéndez-Miranda I, Flórez G, García-Portilla P, Bobes J, Sáiz PA.
Adicciones. 2019 Sep 1;31(4):298-308. doi: 10.20882/adicciones.1191.

Pharmacological treatment of obsessive compulsive disorder in adults: A clinical practice guideline based on the ADAPTE methodology. Free article
Menchon JM, Bobes J, Alamo C, Alonso P, García-Portilla MP, Ibáñez Á, Real E, Bousoño M, Saiz-Gonzalez MD, Saiz-Ruiz J.
Revista de Psiquiatria y Salud Mental. 2019 Apr-Jun;12(2):77-91. FI 2019: 2.630. (Q2 SCIE Psychiatry). doi: 10.1016/j.rpsm.2019.01.003.

Diagnostic consequences of a new category of anxious depression and a reduced duration requirement for anxiety symptoms in the ICD-11 PHC.
Ziebold C, Mari JJ, Goldberg DP, Minhas F, Razzaque B, Fortes S, Robles R, Lam TP, Bobes J, Iglesias C, García JÁ, Reed GM.
Journal of Affective Disorders. 2019 Feb 15;245:120-125. FI 2019: 3.892. (Q1 SSCI Psychiatry – Q2 SCIE Psychiatry). doi: 10.1016/j.jad.2018.10.082.

Early versus late stage schizophrenia. What markers make the difference?
García-Álvarez L, García-Portilla MP, Caso JR, de la Fuente-Tomás L, González-Blanco L, Sáiz Martínez P, Leza JC, Bobes J.
World Journal of Biological Psychiatry. 2019 Feb;20(2):159-165. FI 2019: 4.164. (Q1 SCIE Psychiatry). doi: 10.1080/15622975.2018.1511920.

Early Parental Death and Risk of Psychosis in Offspring: A Six-Country Case-Control Study. Free article
Misra S, Gelaye B, Koenen K C, Williams D R, Borba C P C, Quattrone D, Di Forti M, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Rossi Menezes P, Selten JP, Jones PB, Kirkbride , EU-GEI WP2 Group, Rutten BPF, van Os J, Murray RM, Gayer-Anderson C, Morgan C.
Journal of Clinical Medicine. 2019;8(7);1081. FI 2019: 3.303. (Q1 SCIE Medicine, General & Internal). doi: 10.3390/jcm8071081.

Estimating exposome score for schizophrenia using predictive modeling approach in two independent simples: The results from the EUGEI study. Free article
Pries LK, Lage Castellanos A, Delespaul P, Kenis G, Luyx JJ , Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin V, Gümüş-Akay1 G, Cihan B, Haldun S , Ulaş H, Cankurtaran ES, Kaymak SU, Mihaljevic MM, Petrovic SA , Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J , Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC, Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O’Donovan M, Rutten BPF, van Os J, Guloksuz S.
Schizophrenia Bulletin. 2019 Sep 11;45(5):960-965. FI 2019: 7.958. (D1 SCIE Psychiatry). doi: 10.1093/schbul/sbz054.

Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis.
González-Ortega I, González-Pinto A, Alberich S, Echeburúa E, Bernardo M, Cabrera B, Amoretti S, Lobo A, Arango C, Corripio I, Vieta E, de la Serna E, Rodriguez-Jimenez R, Segarra R, López-Ilundain JM, Sánchez-Torres AM, Cuesta MJ; PEPs Group:, Zorrilla I, López P, Bioque M, Mezquida G, Barcones F, De-la-Cámara C, Parellada M, Espliego A, Alonso-Solís A, Grasa EM, Varo C, Montejo L, Castro-Fornieles J, Baeza I, Dompablo M, Torio I, Zabala A, Eguiluz JI, Moreno-Izco L, Sanjuan J, Guirado R, Cáceres I, Garnier P, Contreras F, Bobes J, Al-Halabí S, Usall J, Butjosa A, Sarró S, Landin-Romero R, Ibáñez A, Selva G.
Psychological Medicine. 2019 Oct 22:1-9. FI 2019: 5.813. (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S0033291719002794.

Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study.
van Os J, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome Investigators (GROUP), Arango C, O’Donovan M, Rutten BPF, Guloksuz S.
Psychological Medicine. 2019 Aug 15:1-14. FI 2019: 5.813. (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S003329171900196X.

A longitudinal examination of the interpersonal theory of suicide and effects of school-based suicide prevention interventions in a multinational study of adolescents.
Barzilay S, Apter A, Snir A, Carli V, Hoven CW, Sarchiapone M, Hadlaczky G, Balazs J, Kereszteny A, Brunner R, Kaess M, Bobes J, Saiz PA, Cosman D, Haring C, Banzer R, McMahon E, Keeley H, Kahn JP, Postuvan V, Podlogar T, Sisask M, Varnik A, Wasserman D.
Journal of Child Psychology and Psychiatry. 2019 Oct;60(10):1104-1111. FI 2019: 7.035. (D1 SCIE Psychiatry). doi: 10.1111/jcpp.13119.

Transdiagnostic dimensions of psychopathology at first episode psychosis: Findings from the multinational EU-GEI study. Free article
Quattrone D, Di Forti M, Gayer-Anderson C, Ferraro L, Jongsma HE, Tripoli G, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Lasalvia A, Tortelli A, Llorca PM, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP; EU-GEI WP2 Group, Jones PB, Kirkbride JB, Richards AL, O’Donovan MC, Sham PC, Vassos E, Rutten BP, van Os J, Morgan C, Lewis CM, Murray RM, Reininghaus U.
Psychological Medicine. 2019 Jun;49(8):1378-1391. FI 2019: 5.813. (D1 SCIE Psychology – Q1 SCIE Psychiatry). doi: 10.1017/S0033291718002131.

White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder? Free article
Schepers E, Lousberg R, Guloksuz S, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Şahin Cankurtaran E, Ulusoy Kaymak S, Mihaljevic MM, Andric Petrovic S, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Luis Santos J, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Can Saka M, Arango C, Rutten BPF, van Os J.
Frontiers in Psychiatry. 2019 Sep 25;10:676. FI 2019: 2.849. (Q2 SCIE Psychiatry). doi: 10.3389/fpsyt.2019.00676.

Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population.
Jiménez E, Bonnín CDM, Solé B, Sánchez-Moreno J, Reinares M, Torrent C, Torres I, Salagre E, Varo C, Ruíz V, Giménez A, Benabarre A, Gutiérrez-Rojas L, Cervilla J, Sáiz PA, García-Portilla MP, Bobes J, Amann BL, Martínez-Arán A, Vieta E.
Journal of Affective Disorders. 2019 Apr 15;249:199-207. FI 2019: 3.892. (Q1 SSCI Psychiatry – Q2 SCIE Psychiatry). doi: 10.1016/j.jad.2019.02.037.

Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort). Free article
Pandit R, Cianci D, Ter Hark SE, Winter-van Rossum I, Ebdrup BH, Broberg BV, Garcia-Portilla MP, Bobes J, Vinkers CH, Kahn RS, Guloksuz S, Huitema ADR, Luykx JJ.
Acta Psychiatrica Scandinavica. 2019 Sep;140(3):283-290. FI 2019: 5.362. (Q1 SCIE Psychiatry). doi: 10.1111/acps.13074.

Association of childhood trauma and genetic variability of CRH-BP and FKBP5 genes with suicidal behavior in bipolar patients.
Segura AG, Mitjans M, Jiménez E, Fatjó-Vilas M, Ruiz V, Saiz PA, García-Portilla MP, González-Blanco L, Bobes J, Vieta E, Benanarre A, Arias B.
Journal of Affective Disorders. 2019 Aug 1;255:15-22. FI 2019: 3.892. (Q1 SSCI Psychiatry – Q2 SCIE Psychiatry). doi: 10.1016/j.jad.2019.05.014.

Cannabis use and cognitive impairment in schizophrenia and first-episode psychosis. Free article
García Álvarez L, Gomar JJ, García-Portilla MP, Bobes J.
Adicciones. 2019 Apr 1;31(2):89-94. doi: 10.20882/adicciones.1328.

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: Results from the EUGEI study. Free article
Guloksuz S, Pries LK, Delespaul F, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüs -Akay G, Cihan B, Soygür H, Ulas H, Cankurtaran ES, Kaymak SU, Mihaljevic MM , Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Penas J, Parellada M, Maric NP, Atbas C, Ucok A , Alptekin K, Saka MC, Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O’Donovan M, Rutten BPF, van Os J.
World Psychiatry. 2019 June 18:173–182. FI 2019: 40.595. (D1 SCIE Psychiatry). doi:10.1002/wps.20629.

Pharmacological treatment of obsessive compulsive disorder in adults: A clinical practice guideline based on the ADAPTE methodology. Free article
Menchon JM, Bobes J, Alamo C, Alonso P, García-Portilla MP, Ibáñez A, Real E, Bousoño M, Saiz-Gonzalez MD, Saiz-Ruiz J.
Revista de Psiquiatría y Salud Mental. 2019 Apr-Jun;12(2):77- 91. FI 2019: 2.630. (Q2 SCIE Psychiatry). doi: org/10.1016/j.rpsm.2019.01.003.

Prevention of recurrent suicidal behavior: Case management and psychoeducation. Free article
Fernández-Artamendi S, Al-Halabí S, Burón P, Rodríguez Revuelta J, Garrido M, González-Blanco L, García-Álvarez L, García-Portilla P, Sáiz P, Bobes J.
Psicothema. 2019;31(2):107-113. FI 2019: 2.632. (Q1 SSCI Psychology, Multidisciplinary). doi: 10.7334/psicothema2018.247.

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study.
Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group.
Lancet Psychiatry. 2019 May; 6(5):427-436. FI 2019: 16.209. (D1 SCIE Psychiatry). doi: 10.1016/S2215-0366(19)30048-3.

Cross-cultural validation of the 5-Factor structure of negative symptoms in schizophrenia. Free article
Ahmed AO, Kirkpatrick B, Galderisi S, Mucci A, Rossi A, Bertolino A, Rocca P, Maj M, Kaiser S, Bischof M, Hartmann-Riemer MN, Kirschner M, Schneider K, Garcia-Portilla MP, Mane A, Bernardo M, Fernandez-Egea E, Jiefeng C, Jing Y, Shuping T, Gold JM, Allen DN, Strauss GP.
Schizophrenia Bulletin. 2019 Mar 7;45(2):305-314. FI 2019: 7.958. (D1 SCIE Psychiatry). doi: 10.1093/schbul/sby050.

History of lifetime cannabis use is associated with better cognition and worse real-world functioning in schizophrenia spectrum disorders.
Menéndez-Miranda I, García-Alvarez L, Garcia-Portilla P, Gonzalez-Blanco L, Saiz PA, Bobes J.
European Addiction Research. 2019;25(3):111-118. FI 2019: 2.269. (Q3 SCIE Psychiatry). doi: 10.1159/000497317.

Breadth and depth of working memory and executive function compromises in mild cognitive impairment (MCI) and their relationships to frontal lobe and functional competence. Free article
García-Álvarez L, Gomar JJ, Sousa A, García-Portilla MP, Goldberg T.
Alzeimer´s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2019;11:170-179. doi: 10.1016/j.dadm.2018.12.010.

Could structural changes in the retinal layers be a new biomarker of mental disorders? A systematic review and thematic synthesis. Free article
García-Portilla MP, García-Alvarez L, De la Fuente-Tomás L, Velasco-Iglesias A, Sáiz P, González-Blanco L, Bobes-Bascarán MT, Baamonde B, Alcalde I, Jesú Merayo-Llores J, Bobes J.
Revista de Psiquiatría y Salud Mental. 2019 Apr-Jun; 12(2):116-129. FI 2019: 2.630. (Q2 SCIE Psychiatry). doi : 10.1016/j.rpsm.2018.12.001.

Clinical staging in severe mental disorders; bipolar disorder, depression and schizophrenia. Free article
De la Fuente-Tomas L, Sánchez-Autet M, García-Álvarez L, González-Blanco L, Velasco A, Sáiz Martínez PA, Garcia-Portilla MP, Bobes J.
Revista de Psiquiatría y Salud Mental. 2019 Apr-Jun 2019;12(2):106-115. FI 2019: 2.630. (Q2 SCIE Psychiatry). doi: 10.1016/j.rpsm.2018.08.002.

Ten years of collaborative translational research in mental disorders: The CIBERSAM. Free article
Salagre E, Arango C, Artigas F, Ayuso-Mateos JL, Bernardo M, Castro-Fornieles J, Bobes J, Desco M, Fañanás L, González-Pinto A, Haro JM, Leza JC, Mckenna PJ, Meana JJ, Menchón JM, Micó JA, Palomo T, Pazos A, Pérez V, Saiz-Ruiz J, Sanjuán J, Tabarés-Seisdedos R, Crespo-Facorro B, Casas M, Vilella E, Palao D, Olivares JM, Rodriguez-Jimenez R, Vieta E
Revista de Psiquiatría y Salud Mental. 2019 Jan-Mar;12(1):1-8. FI 2019: 2.630. (Q2 SCIE Psychiatry). doi: 10.1016/ j.rpsm.2018. 10.001.

Influence of secondary sources in the Brief Negative Symptom scale.
Treen D, Savulich G, Mezquida G, García-Portilla MP, Toll A, García-Rizo C, García-Álvarez L, Bergé D, Bobes J, Bernardo M, Fernandez-Egea E, Mané A.
Schizophrenia Research. 2019 Feb;204:452-454. FI 2019: 3.759. (Q1 SSCI Psychiatry – Q2 SCIE Psychiatry). doi: 10.1016/j.schres.2018.10.004.

5-HTTLPR-brain-derived neurotrophic factor (BDNF) gene interactions and early adverse life events effect on impulsivity in suicide attempters.
Jiménez-Treviño L, Saiz PA, García-Portilla MP, Blasco-Fontecilla H, Carli V, Iosue M, Jaussent I, López-Castroman J, Vaquero-Lorenzo C, Sarchiapone M, Baca-García E, Courtet P, Bobes J.
World Journal of Biological Psychiatry. 2019 Feb;20(2):137-149. FI 2019: 4.164 .(Q1 SCIE Psychiatry). doi: 10.1080/15622975.2017.1376112.

Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain. Free article
Arango C, Baeza I, Bernardo M, Cañas F, de Dios C, Díaz-Marsá M, García-Portilla MP, Gutiérrez-Rojas L, Olivares JM, Rico-Villademoros F, Rodríguez-Jiménez R, Sánchez-Morla EM, Segarra R, Crespo-Facorro B.
Revista de Psiquiatría y Salud Mental. 2019 Apr-Jun;12(2):92-105. FI 2019: 2.630. (Q2 SCIE Psychiatry). doi: 10.1016/j.rpsm.2018.03.006.

Bi-directional longitudinal associations between different types of bullying victimization, suicide ideation/attempts and depression among a large sample of European adolescents.
Klomek AB, Barzilay S, Apter A, Vladimir C.Hoven C W, Sarchiapone M, Hadlaczky G, Balazs J, Kereszteny A, Brunner R, Kaess M, Bobes J, Saiz PA, Cosman D, Haring C, Banzer R , McMahon E, Keeley H, Kahn J P, Postuvan V, Podlogar T, Sisask M, Varnik A, Wasserman D
Journal of Child Psychology and Psychiatry. 2019 Feb;60(2):209-215. FI 2019: 7.035. (D1 SCIE Psychiatry). doi: 10.1111/jcpp.12951

Patient characteristics driving clinical utility in psychiatric pharmacogenetics: A reanalysis from the AB-GEN multicentric trial.
Menchón JM, Espadaler J, Tuson M, Saiz-Ruiz J, Bobes J, Vieta E, Álvarez E, Pérez V.
Journal of Neural Transmission. 2019 Jan;126(1):95-99. FI 2019: 3.505. (Q2 SCIE Neurosciences). doi: 10.1007/s00702-018-1879-z.

Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia? Free article
González-Blanco L, García-Portilla MP, García-Álvarez L, de la Fuente-Tomás L, Iglesias García C, Sáiz PA, Rodríguez-González S, Coto-Montes A, Bobes J.
Revista de Psiquiatría y Salud Mental. 2019 Jan-Mar;12(1):9-16. FI 2019: 2.630. (Q2 SCIE Psychiatry). doi: 10.1016/j.rpsm.2018.03.004.

Classification of patients with bipolar disorder using k-means clustering. Free article
Fuente-Tomas L, Arranz B, Safont G, Sierra P, Sanchez-Autet M, Garcia-Blanco A, Garcia-Portilla MP.
PLoS ONE. 2019;14(1):e0210314. FI 2019: 2.740. (Q2 SCIE Multidisciplinary Sciences). doi: 10.1371/journal.pone.0210314

Are plasma 25-hydroxyvitamin D and retinol levels and one-carbon metabilism related to metabolic syndrome in patients with a severe disorder?
Arranz B, Sánchez-Autet M, San L, Safont G, de la Fuente-Tomás L, Hernández C, Bogas JL,García-Portilla MP.
Psychiatry Research. 2019 Mar;273:22-29. FI 2019: 2.118. (Q3 SCIE Psychiatry). doi: 10.1016/j.psychres.2019.01.005.

Predictive factors of alcohol consumption in adolescents: Data from 1-year follow-up prospective study. Free article
Bousoño Serrano M, Al-Halabí S, Burón P, Garrido M, Díaz-Mesa EM, Galván G, García-Álvarez L, Velasco Á, Wasserman C, Carli V, Hoven C, Sarchiapone M, Wasserman D, Bousoño M, García-Portilla MP, Iglesias C, Sáiz PA, Bobes J.
Adicciones. 2019 Jan;31(1):52-63. doi: 10.20882/adicciones.998.

Updated European consensus statement on diagnosis and treatment of adult ADHD.
Kooij JJS, Bijlenga DD, Salerno L, Jaeschke R, Bitter I, Balazs J, Thome J, Dom G, Kasper S, Nunes Filipe C, Stes S, Pavel M, Mohr P, Leppamaki S, Casas M, Bobes J, Mccarthy JM, Richarte V, Kjems Philipsen A, Pehlivanidis A, Niemela A, Styr B, Semerci B, Bolea-Alamanac B, Edvinsson D, Baeyens D, Wynchank D, Sobanski E, Philipsen A, McNicholas F, Caci H, Mihailescu I, Manor I, Dobrescu I, Krause J, Fayyad J, Ramos-Quiroga JA, Foeken K, Rad F, Adamou M,Ohlmeier MD, Fitzgerald M, Gill M, Lensing M, Motavalli Mukaddes N, Brudkiewicz P, Gustafsson P, Tani P, Oswald P, Carpentier PJ, De Rossi P, Delorme R, Simoska M, Pallanti S, Young S, Bejerot S, Lehtonen T, Kustow J, Müller-Sedgwick U, Hirvikoski T, Pironti V, Ginsberg Y, Félegyházy Z, Garcia-Portilla MP, Asherson P.
European Psychiatry 2019;56:14-34. FI 2019: 4.464. (Q1 SCIE Psychiatry). doi: 10.1016/j.eurpsy.2018.11.001.

Año 2018 – FI ( 30 Diciembre ) = 144.276

Smoking Status and Cost of Illness in Patients with Depressive Disorder Based on the National Health Survey in Spain.
López Ibáñez de Aldecoa A, Cedillo Gómez S, Bruguera E, García-Portilla MP, Bobes J.
Substance Use & Misuse. : Dec. 2018; 26 : 1-11.
doi.org/10.1080/10826084.2018.1536717. FI 2018 = 1.383

Psychopathology is associated with reproductive health risk in European adolescents. Free article
Gambadauro P, Carli V, Wasserman C, Hadlaczky G, Sarchiapone M, Apter A, Balazs J, Bobes J, Brunner R, Cosman D, Haring C, Hoven CW, Iosue M, Kaess M, Kahn JP, McMahon E, Postuvan V, Värnik A, Wasserman D.
Reprod Health. 2018 Nov 6;15(1):186. FI 2018: 2.295. doi: 10.1186/s12978-018-0618-0.

Obstetric Phenotypes in the Heterogeneity of Schizophrenia.
Mezquida G, Fernandez-Egea E, Treen D, Mané A, Bergé D, Savulich G, Garcia-Alvarez L, García-Portilla P, Bobes J, Bernardo M, Garcia-Rizo C.
J Nerv Ment Dis. 2018 Nov;206(11):882-886. FI 2018: 1.021. doi: 10.1097/NMD.0000000000000897.

Latent profile analysis of psychosis liability in a community derived sample adolescents: Links with mental health difficulties, suicidal ideation, bipolar-like experiences, and psychotic-like experiences.
Fonseca-Pedrero E, Ortuño-Sierra J, Muñiz J, Bobes J.
Early Intervention in Psychiatry. 2018 Oct. doi : 10.1111/eip.12741
FI 2018 = 3.323

Sleep disturbances, functioning, and quality of life in euthymic patients with bipolar disorder.
de la Fuente-Tomas L, Sierra P, Sanchez-Autet M, Garcia-Blanco A, Safont G, Arranz B, Garcia-Portilla MP.
Psychiatr Res.2018 Nov ; 269 : 501-507. doi: 10.1016/j.psychres.2018.08.104.
FI 2018 = 2.208

Psychopatology is associated with reproductive health risk in European adolescents
Pietro Gambadauro, Vladimir Carli, Camilla Wasserman, Gergö Hadlaczky, Marco Sarchiapone, Alan Apter, Judit Balazs, Julio Bobes, Romuald Brunner, Doina Cosman, Christian Haring, Christina W Hoven, Miriam Iosue, Michael Kaess, Jean Pierre Kahn, Elaine McMahon, Vita Postuvan, Airi Värnik and Danuta Wasserman.
Reproductive Health2018 Nov. ; 15 (1) : 186. doi : 10.1186/s12978-018-0618-0
FI 2018 = 2.295

Obstetric Phenotypes in the Heterogeneity of Schizophrenia.
Mezquida G, Fernandez-Egea E, Treen D, Mané A, Bergé D, Savulich G, Garcia-Alvarez L, García-Portilla P, Bobes J, Bernardo M, Garcia-Rizo C.
Journal of Nervous and Mental Disease. 2018 Nov; 206 (11) : 882-886.
doi: 10.1097/NMD.0000000000000897. FI 2018 = 1.859

Diagnostic consequences of a new category of anxious depression and a reduced duration requirement for anxiety symptoms in the ICD-11 PHC
Reed G, Robles R, Minhas F, Razzaque B, Fortes S, Mari J, Iglesias C, Ziebold C, Goldberg D, García JA, Bobes J, Lam T P.
Journal of Affective Disorders . 2018 Oct. 245: 120-125.
doi : 10.1016/j.jad.2018.10.082. FI 2018 = 4.084

Transdiagnostic dimensions of psychopathology 1 underpinning first episodepsychosis: findings from the multinational EU-GEI study
Quattrone D, Di Forti M, Gayer-Anderson C, Ferraro L, Jongsma A E, Tripoli G, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Lasalvia A, Tortelli A, Llorca M P, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Rossi Menezes P, Selten JP, Jones PB, Kirkbride J, Richards AL , O’Donovan MC, Sham PC , Vassos E , Rutten BPF, van Os J, Morgan C, Lewis CM, Murray R M, Reininghaus U.
Psychological Medicine. 2018 Oct. ; 4 : 1-14.
doi : org/10.1017/S0033291718002131. FI 2018 = 5.641

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
Kahn RS, Winter van Rossum I, Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Díaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthøj B, Eijkemans MJC, Fleischhacker WW, Kapur S, Sommer IE; OPTiMiSE study group.
Lancet Psychiatry. 2018 Oct ; 5 (10 ): 797-807
doi: 10.1016/S2215-0366(18)30252-9]. FI 2018 = 18.329

Comorbidity of Physical and Anxiety Symptoms in Adolescent: Functional Impairment, Self-Rated Health and Subjective Well-Being.
Balázs J, Miklósi M, Keresztény A, Hoven CW, Carli V, Wasserman C, Hadlaczky G, Apter A, Bobes J, Brunner R, Corcoran P, Cosman D, Haring C, Kahn JP, Postuvan V, Kaess M, Varnik A, Sarchiapone M, Wasserman D.
International Journal of Environ. Research Public Health. 2018 Aug 9 ; 15 (8).
doi: 10.3390/ijerph15081698. FI 2018 = 2.468

Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables.

Sanchez-Moreno J, Bonnin CM, González-Pinto A, Amann BL, Solé B, Balanzá-Martinez V, Arango C, Jiménez E, Tabarés-Seisdedos R, Garcia-Portilla MP, Ibáñez A, Crespo JM, Ayuso-Mateos JL, Martinez-Aran A, Torrent C, Vieta E; CIBERSAM Functional Remediation Group.
Acta Psychiatrica Scandinava. 2018 Aug ; 138 (2 ): 145-154.
doi: 10.1111/acps.12894. FI 2018 = 4.694

Análisis de decisión multicriterio en programas de tratamiento de sustitución de opiáceos en trastornos por consumo de opiáceos. // Multicriteria decision analysis in opioid substitution treatment programs in opioid use disorders
Bobes J, Pascual F, Sabater E, Colom J, Ferre F, Szerman N, Casado MA ,
Grupo de trabajo MCDA-OUD
Adicciones 2018; 30 (3) : 167-169. doi: 10.20882/adicciones.1120
FI 2018 = 3.167

Genome wide analysis of rare copy number variations in alcohol abuse or dependence
Rodríguez-López J, Flórez G, Blancoc v, Pereirod C, Fernández JM, Fariñas E, Estévez V, Gómez-Trigo J, Gurriarán X, Calvo R, Sáiz P, the GenPol Study Group (Osorio J, Carrera I, Páramo MJ, López N, García A, González AM, Rodríguez JM, Matalobos M, Pomares J, Longo MJ, Álvarez S, Pino C, Martín C, Lorenzo A, Páramo M, Paz E, Díaz-Llenderozas F, Pérez M, Gómez-Ramiro M, Portes J, Serrano M, Miguel D, López-Crecente AM, Bobes J, García-Portilla P, de la Fuente L, Villa R, Rodríguez-Revuelta J, Riera L, Rubio C, Herrero R), Lino Vázquez F, Arrojo M, Costas J
Journal of Psychiatric Research, 2018; 103: 212–218. doi:10.1016/j.jpsychires.2018.06.001.
FI 2018 = 3.917

Characterizing decisión-making and reward processing in bipolar disorder : a cluster analysis.
Jiménez E, Solé B, Arias B, Mitjans M , Varo C, Reinares M, Bonnín CDM, Salagre E , Ruíz V, Saiz PA , García-Portilla MP , Burón P, Bobes J , Martínez-Arán A, Torrent C, Vieta E, Benabarre A^.
European Neuropsychopharmacology (2018); 28 : 863–874.
doi: 10.1016/j.euroneuro.2018.04.001 . FI 2018 = 4.468

Dimensional Analysis of depressive, anxious and somatic symptoms presented by primary care patients and their relationship with ICD-11 PHC proposed diagnoses. Figure 1. Table 1.
Ziebold C,Goldberg DP, Reed GM, Minhas F, Razzaque B, Fortes S, Robles R, Lam TP, Bobes J, Iglesias C, Cogo-Moreira H, García JA, Mari JJ.
Psychological Medicine 2018 Junio ; 4 : 1- 8.
doi: 10.1017/S0033291718001381. FI 2018 = 5.641

Baseline Results from the European Non-Interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) Study.
Llorca PM, Bobes J, Fleischhacker W, Heres S, Moore N, Bent-Ennakhil N, Sapin C, Loze JI, Nylander AG, Patel MX.
European Pychiatry. 2018 Agosto ; 52 : 85-94.
doi: org/10.1016/j.eurpsy.2018.04.004. FI 2018 = 3.941

Validación española de la escala de evaluación de los síntomas negativos-16 (NSA-16) en pacientes con esquizofrenia
Garcia-Alvarez L, Garcia-Portilla MP, Saiz PA, Fonseca-Pedrero E, Bobes-Bascaran MT, Gomar J, Muñiz J, Bobes J.
Revista de Psiquiatría y Salud Mental. 2018 Jul.; 11(3) : 169-175
doi: 10.1016/j.rpsm.2018.03.001. [ FI 2018 = 2.927

Smoking does not impact social and non-social cognition in patients with first episode psychosis.
Sánchez-Gutiérrez T, García-Portilla MP, Parellada M, Bobes J, Calvo A, Moreno-Izco L, González-Pinto A, Lobo A, de la Serna E, Cabrera B, Torrent C, Roldán L, Sanjuan J, Ibáñez Á, Sánchez-Torres AM, Corripio I, Bernardo M, Cuesta MJ; PEPs Group.
Schizophr. Research. 2018 Sep ; 199 : 64-74
doi: 10.1016/j.schres.2018.03.025. FI 2018 = 4.569

The network structure of schizotypal personality traits.
Fonseca-Pedrero E, Ortuño J, Debbané M, Chan R C K, Cicero D, Zhang L C,Brenner C, Barkus E, Linscott R J, Kwapil T, Barrantes-Vidal N, Cohen A, Raine A, Compton M T, Tone E, Suhr J, Inchausti F, Bobes J, Fumero A, Giakoumaki S, Tsaousis I, Preti A, Chmielewski M, Laloyaux J, Mechri A, Lahmar M A, Wuthrich V, Larøi F, Badcock J C, Jablensky A, Isvoranu A M, Epskamp E, Fried EI.
Schizophrenia Bulletin . 2018 Oct 15;44(suppl_2):S468-S479 .
doi : 10.1093/schbul/sby044. FI 2018 = 7.289

Brief Assessment of Schizotypal Traits: A Multinational Study.
Fonseca-Pedrero E, Ortuño-Sierra J, Lucas-Molina, B, Debbané M, Chan RCK, Cicero DC, Zhang LC, Brenner C, Barkus E, Linscott RJ, Kwapil T, Barrantes-Vidal N, Cohen A, Raine A, Compton MT, Tone EB, Suhr J, Bobes J, Fumero A, Giakoumaki S, Tsaousis I, Preti A, Chmielewski M, Laloyaux J, Mechri A, Lahmar MA, Wuthrich V, Larøi F, Badcock JC, Jablensky A, Barron, D, Swami, V, Tran U, and Voracek, M.
Schizophrenia Research.2018; 197: 182-191.
doi : org/10.1016/j.schres.2017.10.043. FI 2018 = 4.569

Biomarcadores de estrés oxidativo y dimensiones clínicas en los 10 primeros años de esquizofrenia Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia
González-Blanco L, García-Portilla MP, García-Álvarez L, de la Fuente
Tomás L, Iglesias García C, Sáiz Martínez PA, Rodríguez González S, Coto Montes A, Bobes García J.
Revista de Psiquiatría y Salud Mental.2018 Jul-Sep; 11 (3) : 130-140
doi : 10.1016/j.rpsm.2018.03.003. FI 2018= 2.927

Cardiovascular Risk in Early Psychosis Relationship with Inflammation and Clinical Features 6 Months after Diagnosis
Barcones MF, MacDowell KS, García-Bueno B, Bioque M, Gutiérrez-Galve L, González-Pinto A, Parellada MJ, Bobes J, Bernardo M, Lobo A, Leza JC.
International Journal of Neuropsychopharmacology,
2018 mayo ; 21 (5) : 410-422. doi: 10.1093/ijnp/pyx110. FI 2018 = 4.207

Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder
Tomioka Y, Jimenez E, Salagre E, Arias B, Mitjans M, Ruiz V, Sáiz P, García-Portilla MP, Burón P, Gomes-de-Castro SP, Bobes J, Vieta E, Benabarre A, Grande I.
Journal of Affective Disorders. 2018 Feb 13 ; 232 : 229-236.
doi: 10.1016/j.jad.2018.02.002. FI 2018 = 4.084

Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
Ballesteros A, Sánchez-Torres AM, López-Ilundain JM, Cabrera B, Lobo A, González-Pinto AM, Díaz-Caneja C, Corripio I, Vieta E, de la Serna E, Bobes J, Usall J, Contreras F, Lorente-Omeñaca R, Mezquida G, Bernardo M, Cuesta MJ; PEPs Group.
Psychological Medicine. 2018 Oct; 48 (13 ): 2247-2256.
doi : 10.1017/S0033291717003774. FI 2018 = 5.641

Regulation of inflammatory pathways in schizophrenia A comparative study with bipolar disorder and healthy controls
García-Álvarez L, Caso JR, García-Portilla MP, de la Fuente-Tomás L, González-Blanco L, Sáiz Martínez P, Leza JC, Bobes J.
European Psychiatry 2018 Jan; 47: 50-59.
doi:10.1016/j.eurpsy.2017.09.007. FI 2018 = 3.941

Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study
Jongsma HE, Gayer-Anderson C, Lasalvia A, Quattrone D, Mulè A, Szöke A, Selten JP, Turner C, Arango C, Tarricone I, Berardi D, Tortelli A, Llorca PM, de Haan L, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Murray RM, Rutten BP, Jones PB, van Os J, Morgan C, Kirkbride JB; European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group.
JAMA Psychiatry. 2018 Jan 1; 75 (1) : 36-46.
doi: 10.1001/jamapsychiatry.2017.3554. FI 2018 = 15.916

Are affective temperaments determinants of quality of life in euthymic patients with bipolar disorder?.
García-Blanco A, Cañada Y, García-Portilla MP, Safont G, Arranz B, Sanchez-Autet M, Livianos L,Fornés-Ferrer V, Sierra P.
Journal of Affective Disorders. 2018 Abril. 230: 101-107.
doi : 10.1016/j.jad.2018.01.007. FI 2018 = 4.084

Deep Brain Stimulation in Patients with Parkinson’s Disease: Effect on Psychiatric Symptoms and Quality of Life.
Seijo Zazo E, Fernandez FS, Liebana ES, Ayala AS, Aragoneses BL, Campa JMT, García-Portilla P, Vega MA.
J. Neurol. Surg A Cent Eur Neurosurg. 2018 Mar; 79(2) : 130-138
doi: 10.1055/s-0037-1606354. FI 2018 = 1.060

Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis.
Bioque M, García-Portilla MP, García-Rizo C, Cabrera B, Lobo A, González-Pinto A, Díaz-Caneja CA, Corripio I, Vieta E, Castro-Fornieles J, Bobes J, Gutiérrez Fraile M, Rodriguez-Jimenez R, Mezquida G, Llerena A, Saiz-Ruiz J, Bernardo M, and PEPs GROUP.
Schizophrenia Research 2018 Mar; 193 : 188-196.
doi: 10.1016/j.schres.2017.06.032. FI 2018 = 4.569

A cost-effectiveness analysis of school-based suicide prevention programmes.
Ahern S, Burke LA, McElroy B, Corcoran P, McMahon EM, Keeley H, Carli V, Wasserman C, Hoven CW, Sarchiapone M, Apter A, Balazs J, Banzer R, Bobes J, Brunner R, Cosman D, Haring C, Kaess M, Kahn JP, Kereszteny A, Postuvan V, Sáiz PA, Varnik P, Wasserman D.
Eur. Child Adolesc Psychiatry. 2018 Oct ; 27 (10 ): 1295-1304.
doi: 10.1007/s00787-018-1120-5.
FI 2018 =3.740

Correlates of sexual initiation among European adolescents
Gambadauro P, Carli V, Hadlaczky G, Sarchiapone M, Apter A, Balazs J, Banzer R, Bobes J, Brunner R, Cosman D, Farkas L, Haring C, Hoven CW, Kaess M, Kahn JP, McMahon E, Postuvan V, Sisask M, Värnik A, Zadravec Sedivy N, Wasserman D.
PLoS One. 2018 Feb 8 ; 13 (2): e0191451. doi: 10.1371/journal.pone.0191451.
FI 2018 = 2.766

Inverse association between negative symptoms and body mass index in chronic schizophrenia.
Mezquida G, Savulich G, Garcia-Rizo C, Garcia-Portilla MP, Toll A, Garcia-Alvarez L, Bobes J, Mané A, Bernardo M, Fernandez-Egea E.
Schizophrenia Research. 2018 Febr. ; 192 : 69–74
doi: 10.1016/j.schres.2017.04.002. FI 2018 = 4.569

Año 2017 – FI (diciembre) = 81.354

Gender differences in C-reactive protein and homocysteine modulation of cognitive performance and real-world functioning in bipolar disorder.
Sanchez-Autet M, Arranza B, Safont G, Sierra P, Garcia-Blanco A, de la Fuente L, Garriga M, García-Portilla MP.
Journal Affective Disorders 2017 Dic. ; 229 : 95-104.
doi: 10.1016/j.jad.2017.12.038. FI 2017 = 3.786

Recommendations for buprenorphine and methadone therapy in opioid use disorder a European consensus
Dematteis M, Auriacombe M, D’Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP, Leonardi C, Maremmani I, Torrens M, Walcher S, Soyka M.
Expert Opin Pharmacother. 2017 Dec; 18(18): 1987-1999.
doi : 10.1080/14656566.2017.1409722. FI 2017 = 3.475

Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.
Puig O, Baeza I, de la Serna E, Cabrera B, Mezquida G, Bioque M, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Bobes J, Usall J, Contreras F, Cuesta MJ, Bernardo M, Castro-Fornieles J, Group TP.
Journal Clinical Psychiatry. 2017Nov/Dec ; 78 (9) : 1414-1422
doi : 10.4088/JCP.16m11122. FI 2017= 4.297

Mental health difficulties and suicidal behaviours among young migrants – a multicentre study of European adolescents
McMahon E. M , Corcoran P, Keeley H , Cannon M, Carli V, Wasserman C, Sarchiapone M, Apter A, Balazs J, Banzer R, Bobes J, Brunner R, Cozman D, Haring C, Kaess M, Kahn JP, Kereszteny A, Mars Bitenc U, Nemes B, Poštuvan V, Sáiz PA, Sisask M, Tubiana A, Värnik P, W. Hoven C, Wasserman D.
B.J Psych Open. 2017 Nov 30 ;3 (6) : 291-299. doi: 10.1192/bjpo.bp.117.005322
FI 2017 = 7.233

5-HTTLPR – Brain-derived neurotrophic factor (BDNF) gene interactions and early adverse life events effect on impulsivity in suicide attempters.
Jiménez-Treviño L, Saiz PA, García-Portilla MP, Blasco-Fontecilla H, Carli V, Iosue M, Jaussent I, López-Castroman J, Vaquero-Lorenzo C, Sarchiapone M, Baca-García E, Courtet P, Bobes J.
World Journal of Biological Psychiatry. 2017 Oct.; 6 : 1-13. doi:10.1080/15622975.2017.1376112. . FI 2017= 3.713

Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project.
Crespo-Facorro B, Bernardo M, Argimon JM, Arrojo M, Bravo-Ortiz MF, Cabrera-Cifuentes A, Carretero-Román J, Franco-Martín MA, García-Portilla P, Haro JM, Olivares JM, Penadés R, Del Pino-Montes J, Sanjuán J, Arango C.
Rev. Psiquiatría y Salud Mental 2017 Jan – Mar; 10(1) : 4-20.
doi: 10.1016/j.rpsm.2016.09.001. FI 2017= 2.223

Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients.
Iglesias García C, Iglesias Alonso A, Bobes J.
Rev Psiquiatr Salud Ment. 2017 Oct – Dec ; 10(4) : 192-196 .
doi: 10.1016/j.rpsm.2017.06.002. FI 2017 = 2.223

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
Pérez V, Salavert A, Espadaler J, Tuson M, Saiz-Ruiz J, Sáez-Navarro C, Bobes J, Baca-García E, Vieta E, Olivares JM, Rodriguez-Jimenez R, Villagrán JM, Gascón J, Cañete-Crespillo J, Solé M, Saiz PA, Ibáñez Á, de Diego-Adeliño J; AB-GEN Collaborative Group, Menchón JM.
BMC Psychiatry. 2017 Jul 14 ; 17 (1) : 250. doi: 10.1186/s12888-017-1412-1.
FI 2017= 2.419

Impact of childhood trauma on cognitive profile in bipolar disorder.
Jiménez E, Solé B, Arias B, Mitjans M, Varo C, Reinares M, Bonnín CDM, Ruíz V, Saiz PA, García-Portilla MP, Burón P, Bobes J, Amann BL, Martínez-Arán A, Torrent C, Vieta E, Benabarre A.
Bipolar Disord. 2017 Aug. ; 19 (5) : 363-374. doi: 10.1111/bdi.12514.
FI 2017 = 4.490

Recomendaciones preventivas sobre el uso de Ácido Valproico en mujeres embarazadas o con capacidad de gestación para tener muy presentes.
García-Portilla MP, Bobes J
Revista de Psiquiatría y Salud Mental 2017 Jul – Sept. ; 10(3) : 129-138.
FI 2017 = 2.223

Risky Drinkers Underestimate their Own Alcohol Consumption.
Gual A, Ángel Arbesú J, Zarco J, Balcells-Oliveró MLM, López-Pelayo H, Miquel L, Bobes J.
Alcohol Alcohol. 2017Jul 1 ; 52(4): 516-517. doi: 10.1093/alcalc/agx029.
FI 2017 = 2.724

Primary care physicians’ use of the proposed classification of common mental disorders for ICD-11.
Goldberg DP, Lam TP, Minhas F, Razzaque B, Robles R, Bobes J, Iglesias C, Fortes S, Mari JJ, Gask L, García JÁ, Dowell AC, Rosendal M, Reed GM.
Fam. Pract. 2017 Sep. 1; 34(5 ) : 574-580. doi : 10.1093/fampra/cmx033.
FI 2017 = 1.675

Bullying Victimization and Suicide Ideation and Behavior Among Adolescents in Europe: A 10-Country Study.
Barzilay S, Brunstein Klomek A, Apter A, Carli V, Wasserman C, Hadlaczky G, Hoven CW, Sarchiapone M, Balazs J, Kereszteny A, Brunner R, Kaess M, Bobes J, Saiz P, Cosman D, Haring C, Banzer R, Corcoran P, Kahn JP, Postuvan V, Podlogar T, Sisask M, Varnik A, Wasserman D.
Journal of Adolescent Health. 2017; 61 : 179-186.
doi: 10.1016/j.jadohealth.2017.02.002. FI 2017= 3.553

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.
Mas S, Gassó P, Torra M, Bioque M, Lobo A, González-Pinto A, Olmeda MS, Corripio I, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Bobes J, Usall J, Llerena A, Saiz-Ruiz J, Bernardo M, Lafuente A, PEPs Group.
European Neuropsychopharmacology 2017 ; 27: 647-656
doi:10.1016/j.euroneuro.2017.03.012. FI 2017= 4.129

Factors associated with different smoking status in European adolescents: results of the SEYLE study.
Banzer R, Haring C, Buchheim A, Oehler S, Carli V, Wasserman C, Kaess M, Apter A, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Hoven CW, Kahn JP, Keeley HS, Postuvan V, Podlogar T, Sisask M, Värnik A, Sarchiapone M, Wasserman D.
European Child &Adolescent Psychiatry. 2017 Apr 6; 26 (11) : 1319-1329
doi : 10.1007/s00787-017-0980-4. FI 2017= 3.553

Suicide, unemployment, and economic recession in Spain.
Iglesias-García C, Sáiz PA, Burón P, Sánchez-Lasheras F, Jiménez-Treviño L, Fernández-Artamendi S, Al-Halabí S, Corcoran P, García-Portilla MP, Bobes J.
Revista de Psiquiatría y Salud Mental 2017 Apr-Jun ; 10 (2) : 70-77
doi : 10.1016/j.rpsm.2016.04.005. Epub 2017 Feb 24. FI 2017 = 2.223

Why prudence is needed when interpreting articles reporting clinical trial results in mental health.
Dal-Ré R, Bobes J, Cuijpers P.
Trials. 2017 Mar 28 ; 18 (1 ): 143. doi: 10.1186/s13063-017-1899-2.
FI 2017 = 1.969

Uso y abuso de sustancias psicotrópicas e internet, psicopatología e ideación suicida en adolescentes // Substance use or abuse, internet use, psychopathology and suicidal ideation in adolescents
Bousoño M, Al-Halabí S, Burón P, Garrido M, Díaz-Mesa EM, Galván G, García-Alvarez L, Carli V, Hoven C, Sarchiapone M, Wasserman D, Bousoño M, García-Portilla MP, Iglesias C, Sáiz PA, Bobes J.
Adicciones 2017; 29(2) : 97-104. FI 2017= 2.021

Evidence-based national suicide prevention task force in Europe:A consensus position paper.
Zalsman G, Hawton K, Wasserman D, van Heeringen K, Arensman E, Sarchiapone M, Carli V, Höschl C, Winkler P, Balazs J, Purebl G, Kahn JP, Sáiz PA, Bobes J, Cozman D, Hegerl U, Rancāns E, Hadlaczky G, Van Audenhove C, Hermesh H, Sisask M, Peschayan AM, Kapusta N, Adomaitiene V, Steibliene V, Kosiewska I, Rozanov V, Courtet P, Zohar J; European Evidence-Based Suicide Prevention Program [EESPP] Group by the Expert Platform on Mental Health, Focus on Depression.
European Neuropsychopharmacology. 2017 Apr ; 27(4) : 418-421.
doi: 10.1016/j.euroneuro.2017.01.012. FI 2017 = 4.129

EPICOG-SCH: A brief battery to screen cognitive impact of schizophrenia in stable outpatients
Zaragoza S, Bobes J, García-Portilla MP, Morralla C.
Schizophrenia Research: Cognition. 2017; 8: 7-20.
doi : 10.1016/j.scog.2017.03.001. FI 2017=3.958

Physical activity in European adolescents and associations with anxiety, depression and well-being
McMahon EM, Corcoran P, O’Regan G, Keeley H, Cannon M, Carli V, Wasserman C, Hadlaczky G, Sarchiapone M, Apter A, Balazs J, Balint M, Bobes J, Brunner R, Cozman D, Haring C, Iosue M, Kaess M, Kahn JP, Nemes B, Podlogar T, Poštuvan V, Sáiz P, Sisask M, Tubiana A, Värnik P, Hoven CW, Wasserman D.
European Child & Adolescent Psychiatry. 2017 Jan ; 26 (1 ): 111-122
doi: 10.1007/s00787-016-0875-9. FI 2017 = 3.553

Año 2016 – FI 2016=75.069

El alcoholismo y su abordaje desde una perspectiva ciudadana // Alcoholism and its treatment approach from a citizen perspective
Gual A, Arbesú JA, Zarco J, López-Pelayo H, Miquel L, Bobes J.
Adicciones. 2016. Jun 14;28(3):163-73. doi: 10.20882/adicciones.742.
FI 2016 = 2.077

Multiple somatic symptoms in primary care: A field study for ICD-11 PHC, WHO’s revised classification of mental disorders in primary care settings
Goldberg DP, Reed GM, Robes R, Bobes J, Iglesias C, Fortes S, de Jesus Mari J, Tai-Pong L, Minhas F, Razzaque B, García JA, Rosendal M, Dowell CA, Gask L, Mbatia JK, Saxena S.
Journal Psychosom Res. 2016 Dec; 91: 48-54.
doi.org/10.1016/j.jpsychores.2016.10.002. FI 2016 = 2.809

Psychosis risk screening: Validation of the youth psychosis at‐risk questionnaire – brief in a community‐derived sample of adolescents
Fonseca‐Pedrero E, Ortuño‐Sierra J, Chocarro E, Inchausti F, Debbané M, Bobes J.
Int J Methods Psychiatr Res. 2016 Oct; 1-10. doi. 10.1002/mpr.1543.
FI 2016 = 3.176

Gender differences in addiction severity
Díaz-Mesa EM, García-Portilla MP, Fernández-Artamendi S, Sáiz PA, Bobes-Bascaran T, Casares MJ, Fonseca E, Al-Halabí S, Bobes J.
Adicciones. 2016 Jun 14;28(4):221-230. doi: 10.20882/adicciones.829.
FI 2016 = 2.077

Smoking cessation programs for persons with schizophrenia: An urgent unmet need
García-Portilla MP, Bobes J.
Rev Psiquiatr Salud Ment. 2016 ;9(4):181-184. doi: 10.1016/j.rpsm.2016.09.002. FI 2016= 2.227

Tobacco and cognitive performance in schizophrenia patients: the design of the COGNICO study
Al-Halabí S, Fernández-Artamendi S, Díaz-Mesa E, García-Alvarez L, Flórez G, Martínez Santamaría E, Arrojo M, Sáiz PA, García-Portilla MP, Bobes J.
Adicciones. 2016 Jun 14;29(1):6-12. doi: 10.20882/adicciones.724.
FI 2016= 2.077

Differential blood-based biomarkers of psychopathological dimensions of schizophrenia
Garcia-Alvarez L, Garcia-Portilla MP, Gonzalez-Blanco L, Saiz Martinez PA, de la Fuente-Tomas L, Menendez-Miranda I, Iglesias C, Bobes J.
Rev Psiquiatr Salud Ment. 2016 Oct – Dec;9(4):219-227. doi: 10.1016/j.rpsm.2016.04.003. FI 2016 = 2.227

Suicide prevention strategies revisited: 10-year systematic review
Zalsman G, Hawton K, Wasserman D, van Heeringen K, Arensman E, Sarchiapone M, Carli V, Höschl C, Barzilay R, Balazs J, Purebl G, Kahn JP, Sáiz PA, Lipsicas CB, Bobes J, Cozman D, Hegerl U, Zohar J.
Lancet Psychiatry. 2016 Jul;3(7):646-59. doi: 10.1016/S2215-0366(16)30030-X. FI 2016 = 11.588

[The dementia of King Ferdinand VI and the year with no king]
Fernandez-Menendez S, Gonzalez-Gonzalez JM, Alvarez-Antuna V, Bobes J.
Rev Neurol. 2016 Jun 1;62(11):516-23. Review. Spanish.
do i: 10.33588/rn.6211.2016040 FI 2016 = 0.743

[The dementia of King Ferdinand VI and the year with no king. Reply].
Fernández Menéndez S, Bobes J.
Revista de Neurologia. Sep. 2016; 63(6):288. doi:10.33588/rn.6306.2016339 FI 2016= 0,743

Validation of a Spanish version of the Columbia-Suicide Severity Rating Scale (C-SSRS)
Al-Halabí S, Sáiz PA, Burón P, Garrido M, Benabarre A, Jiménez E, Cervilla J, Navarrete MI, Díaz-Mesa EM, García-Álvarez L, Muñiz J, Posner K, Oquendo MA, García-Portilla MP, Bobes J.
Rev Psiquiatr Salud Ment. 2016 Jul-Sep;9(3):134-42. doi: 10.1016/j.rpsm.2016.02.002. FI 2016 = 2.227

It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline
Garcia-Portilla MP, Garcia-Alvarez L, Sarramea F, Galvan G, Diaz-Mesa E, Bobes-Bascaran T, Al-Halabi S, Elizagarate E, Iglesias C, Saiz Martínez PA, Bobes J.
Schizophr Res. 2016 Oct;176(2-3):272-80. doi: 10.1016/j.schres.2016.05.011. FI 2016 = 3.986

Pathological Internet Use Is on the Rise Among European Adolescents
Kaess M, Parzer P, Brunner R, Koenig J, Durkee T, Carli V, Wasserman C, Hoven CW, Sarchiapone M, Bobes J, Cosman D, Värnik A, Resch F, Wasserman D.
J Adolesc Health. 2016 Aug;59(2):236-9. doi: 10.1016/j.jadohealth.2016.04.009. FI 2016= 3.974

Cognition and psychopathology in first-episode psychosis: are they related to inflammation?
Cabrera B, Bioque M, Penadés R, González-Pinto A, Parellada M, Bobes J, Lobo A, García-Bueno B, Leza JC, Bernardo M.
Psychol Med. 2016 Apr 8:1-12. FI 2016 = 5.230

Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: A meta-analysis
González-Blanco L, Greenhalgh AM, Garcia-Rizo C, Egea EF, Miller BJ, Kirkpatrick B.
Schizophr Res. 2016 Apr 5; 174 : 156-160. doi: 10.1016/j.schres.2016.03.018. FI 2016= 3.986

Clinical features, impulsivity, temperament and functioning and their role in suicidality in patients with bipolar disorder
Jiménez E, Arias B, Mitjans M, Goikolea JM, Ruíz V, Brat M, Sáiz PA, García-Portilla MP, Burón P, Bobes J, Oquendo MA, Vieta E, Benabarre A.
Acta Psychiatr Scand. 2016 Apr; 133(4) : 266-76. doi: 10.1111/acps.12548.
FI 2016= 6.790

Association between victimization by bullying and direct self injurious behavior among adolescence in Europe: a ten-country study
Brunstein Klomek A, Snir A, Apter A, Carli V, Wasserman C, Hadlaczky G, Hoven CW, Sarchiapone M, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Haring C, Kahn JP, Kaess M, Postuvan V, Sisask M, Tubiana A, Varnik A, Žiberna J, Wasserman D.
Eur Child Adolesc Psychiatry. 2016 Nov;25(11):1183-1193. FI 2016= 3.553

Pathological Internet Use and Risk-Behaviors among European Adolescents
Durkee T, Carli V, Floderus B, Wasserman C, Sarchiapone M, Apter A, Balazs JA, Bobes J, Brunner R, Corcoran P, Cosman D, Haring C, Hoven CW, Kaess M, Kahn JP, Nemes B, Postuvan V, Saiz PA, Värnik P, Wasserman D.
Int J Environ Res Public Health. 2016 Mar 8;13(3). doi: 10.3390/ijerph13030294. FI 2016 = 2.101

Reasons for Attempted Suicide in Europe: Prevalence, Associated Factors, and Risk of Repetition
Burón P, Jimenez-Trevino L, Saiz PA, García-Portilla MP, Corcoran P, Carli V, Fekete S, Hadlaczky G, Hegerl U, Michel K, Sarchiapone M, Temnik S, Värnick A, Verbanck P, Wasserman D, Schmidtke A, Bobes J.
Arch Suicide Res. 2016 Jan-Mar;20(1):45-58. doi: 10.1080/13811118.2015.1004481. FI 2016= 1.901

Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome
Bonnin CM, Torrent C, Arango C, Amann BL, Solé B, González-Pinto A, Crespo JM, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, García-Portilla MP, Ibañez Á, Salamero M, Vieta E, Martinez-Aran A; CIBERSAM Functional Remediation Group.
Br J Psychiatry. 2016 Jan;208(1):87-93. doi: 10.1192/bjp.bp.114.162123.
FI 2016= 6.347

Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory
Bonnin CM, Reinares M, Martínez-Arán A, Balanzá-Martínez V, Sole B, Torrent C, Tabarés-Seisdedos R, García-Portilla MP, Ibáñez A, Amann BL, Arango C, Ayuso-Mateos JL, Crespo JM, González-Pinto A, Colom F, Vieta E; CIBERSAM Functional Remediation Group.
Psychol Med. 2016 Jan;46(2):291-301. doi: 10.1017/S0033291715001713.
FI 2016= 5.230

Año 2015 – FI total = 95.236

SEMERGEN positioning for the treatment of alcohol disorders in primary care
Arbesú JÁ, Gual A, Casquero R, Bobes J, Ortega P.
Semergen. 2015 Dec;41 Suppl 2:1-9. doi: 10.1016/S1138-3593(15)30007-1.

Reading books and watching films as a protective factors against suicidal ideation
Kasahara-Kiritani M, Hadlaczky G, Westerlund M, Carli V, Wasserman C, Apter A, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Farkas L, Haring Ch, Kahn JP, Keeley H, Nemes B, Mars U, Postuvan V, Saiz P, Sisask M, Värnik A, Sarchiapone M, Hoven Ch W, Wasserman D.
Int J Environ Res Public Health. 2015 Dec 15;12(12):15937-42. doi: 10.3390/ijerph121215032. FI 2014= 2.063

First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment
Flórez G, López-Durán A, Triñanes Y, Osorio J, Fraga J, Fernández JM, Becoña E, Arrojo M.
Eur Addict Res. 2015;21(1):19-30. doi: 10.1159/000358194. FI 2014= 1.741

Psychometric properties of a Spanish-version of the Schizophrenia Objective Functioning Instrument (Sp-SOFI) in patients with schizophrenia disorder // Propiedades psicométricas de una versión española de la esquizofrenia Objetivo Instrumento de Funcionamiento (Sp-SOFI) en pacientes con trastorno de la esquizofrenia.
Al-Halabí S, Sáiz PA, Garrido M, Galván G, Casares MJ, Bobes-Bascarán MT, Díaz-Mesa E, Burón P, García-Alvarez L, Suárez-Álvarez J, Muñiz J, García-Portilla MP, Bobes J.
Int J Clin Health Psychol. 2015. doi:10.1016/j.ijchp.2015.07.004. FI 2014= 2.850

Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study
Cuesta MJ, Sánchez-Torres AM, Cabrera B, Bioque M, Merchán-Naranjo J, Corripio I, González-Pinto A, Lobo A, Bombín I, De la Serna E, Sanjuan J, Parellada M, Saiz-Ruiz J, Bernardo M.
Schizophr Res. 2015 May;164(1-3):65-73. doi: 10.1016/j.schres.2015.02.022. FI 2014= 3.923

Exploring genetic variability at PI, GSK3, HPA and glutamatergic pathways in lithium response: association with IMPA2, INPP1 and GSK3B genes
Mitjans M, Arias B, Jimenez E, Goikolea JM, Saiz PA, García-Portilla MP, Burón P, Bobes J, Vieta E, Benabarre A.
J Clin Psychopharmacol. 2015 Oct;35(5):600-4. doi: 10.1097/JCP.0000000000000382. FI 2014= 3.243

Pathological Internet use among adolescents: Comparing gamers and non-gamers
Strittmatter E, Kaess M, Parzer P, Fischer G, Carli V, Hoven C, Wasserman C, Sarchiapone M, Durkee T, Apter A, Bobes J, Brunner R, Cosman D, Sisask M, Varnik P, Wasserman D.
Psychiatry Res. 2015 Jul 30;228(1):128-35. doi: 10.1016/j.psychres.2015.04.029. FI 2014= 2.467

The negative syndrome of schizophrenia: Three- better than two-underlying components
Garcia-Portilla MP, Garcia-Alvarez L, Mané A, Garcia-Rizo C, Sugranyes G, Bergé D, Bernardo M, Fernández-Egea E, Bobes J.
Schizophr Res. 2015 Aug;166(1-3):115-8. doi: 10.1016/j.schres.2015.05.003. FI 2014= 3.923

Cognitive performance associated to functional outcomes in stable outpatients with schizophrenia
Zaragoza S, Bobes J, Garcia-Portilla MP, Morralla C.
Schizophr Res: Cognition 2015;2:146–158. doi:10.1016/j.scog.2015.03.002.

Antipsychotic switching in schizoaffective disorder: A systematic review // Conmutación antipsicóticos en el trastorno esquizoafectivo: Una revisión sistemática
Murru A, Hidalgo D, Bernardo M, Bobes J, Saiz-Ruiz J, Álamo C, Vieta E.
World J Biol Psychiatry. 2016 Oct;17(7):495-513. doi: 10.3109/15622975.2015.1012225. FI 2014= 4.183

Help-seeking behaviour following school-based screening for current suicidality among European adolescents
Cotter P, Kaess M, Corcoran P, Parzer P, Brunner R, Keeley H, Apter A, Balazs J, Bobes J, Cosman D, Durkee T, Haring C, Kahn JP, Postuvan V, Resch F, Värnik A, Sarchiapone M, Hoven C, Wasserman C, Carli V, Wasserman D
Soc Psychiatry Psychiatr Epidemiol. 2015 Jun;50(6):973-82. doi: 10.1007/s00127-015-1016-3. FI 2014= 2.537

Psychometric evaluation of the negative syndrome of schizophrenia
Garcia-Portilla MP, Garcia L, Saiz PA, Al-Halabi S, Bobes-Bascaran T, Bascaran MT, Muñiz J, Bobes J
Eur Arch Psychiatry Clin Neurosci. 2015 Oct;265(7):559-66. doi: 10.1007/s00406-015-0595-z. FI 2014= 3.525

Assessing and treating alcohol relapse risk in liver transplantation candidates: towards a European consensus
Dom G, Wojnar M, Crunelle CL, Thon N, Bobes J, Preuss UW, Addolorato G, Seitz HK , Wurst FM
Alcohol Alcohol. 2015 Mar;50(2):164-72. doi: 10.1093/alcalc/agu096. FI 2014= 2.889

How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview
Stubbs B, Vancampfort D, Bobes J, Mitchell AJ
Acta Psychiatr Scand. 2015 Aug;132(2):122-30. doi: 10.1111/acps.12412. FI 2014= 5.605

Predictive factors of functional capacity and real-world functioning in patients with schizophrenia
Menéndez-Miranda I, García-Portilla MP, Garcia-Alvarez L, Arrojo M, Sanchez P, Sarramea F, Gomar J, Bobes-Bascaran MT, Sierra P, Saiz PA, Bobes J
Eur Psychiatry. 2015 Jul;30(5):622-7. doi: 10.1016/j.eurpsy.2014.12.011. FI 2014= 3.439

School-based suicide prevention programmes: the SEYLE cluster-randomised, controlled trial
Wasserman D, Hoven CW, Wasserman C, Wall M, Kelleher I, Eisenberg R, Sarchiapone M, Hadlaczky G, Apter A, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Guillemin F, Haring C, Iosue M, Kaess M, Kahn J-P, Keeley H, Musa G, Nemes B, Postuvan V, Saiz P, Reiter-Theil S, Varnik A, Varnik P and Carli V
Lancet. 2015 Apr 18;385(9977):1536-44. doi: 10.1016/S0140-6736(14)61213-7. FI 2014= 45.217

Predictors of post-treatment drinking outcomes in patients with alcohol dependence
Florez G, Saiz P, Garcia-Portilla P, De Cos F, Dapia S, Alvarez S, Nogueiras L, Bobes J.
Eur Addict Res. 2015;21(1):19-30. doi: 10.1159/000358194. FI 2014= 2.101

Measuring stages of recovery from psychosis
Lemos-Giráldez S, García-Alvarez L, Paino M, Fonseca-Pedrero E, Vallina-Fernández O, Vallejo-Seco G, Fernández-Iglesias P, Ordóñez-Camblor N, Solares-Vázquez J, Andresen, R.
Compr Psychiatry. 2015 Jan;56:51-8. doi: 10.1016/j.comppsych.2014.09.021. FI 2014= 2.252

Factors associated with hospitalization after suicide spectrum behaviors: results from a multicentre study in Spain
Jimenez-Treviño L, Saiz PA, Corcoran P, Buron P, Garcia-Portilla MP, Chinea ER, Navio-Acosta M, Fernandez V, Jimenez-Arriero MA, Gracia R, Bobes J.
Arch Suicide Res. 2015;19(1):17-34. doi: 10.1080/13811118.2013.824841. FI 2014= 1.639

Reasons for attempted suicide in Europe: prevalence, associated factors, and risk of repetition // Razones para intento de suicidio en Europa: prevalencia, factores asociados, y el riesgo de la repetición
Burón P, Jimenez-Trevino L, Saiz PA, García-Portilla MP, Corcoran P, Carli V, Fekete S, Hadlaczky G, Hegerl U, Michel K, Sarchiapone M, Temnik S, Värnick A, Verbanck P, Wasserman D, Schmidtke A, Bobes J.
Arch Suicide Res. 2016;20(1):45-58. doi: 10.1080/13811118.2015.1004481. FI 2014= 1.639

Año 2014 – FI total = 99.255

Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder
Kasper S, Iglesias-García C, Schweizer E, Wilson J, DuBrava S, Prieto R, Pitman VW, Knapp L.
Int J Neuropsychopharmacol. 17 (5): 685-95. (doi:10.1017/S1461145713001557 ). 2014. FI 2013= 5.264

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations
European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI), van Os J, Rutten BP, Myin-Germeys I, Delespaul P, Viechtbauer W, van Zelst C, Bruggeman R, Reininghaus U, Morgan C, Murray RM, Di Forti M, McGuire P, Valmaggia LR, Kempton MJ, Gayer-Anderson C, Hubbard K, Beards S, Stilo SA, Onyejiaka A, Bourque F, Modinos G, Tognin S, Calem M, O’Donovan MC, Owen MJ, Holmans P, Williams N, Craddock N, Richards A, Humphreys I, Meyer-Lindenberg A, Leweke FM, Tost H, Akdeniz C, Rohleder C, Bumb JM, Schwarz E, Alptekin K, Üçok A, Saka MC, Atbaşoğlu EC, Gülöksüz S, Gumus-Akay G, Cihan B, Karadağ H, Soygür H, Cankurtaran EŞ, Ulusoy S, Akdede B, Binbay T, Ayer A, Noyan H, Karadayı G, Akturan E, Ulaş H, Arango C, Parellada M, Bernardo M, Sanjuán J, Bobes J, Arrojo M, Santos JL, Cuadrado P, Rodríguez Solano JJ, Carracedo A, García Bernardo E, Roldán L, López G, Cabrera B, Cruz S, Díaz Mesa EM, Pouso M, Jiménez E, Sánchez T, Rapado M, González E, Martínez C, Sánchez E, Olmeda MS, de Haan L, Velthorst E, van der Gaag M, Selten JP, van Dam D, van der Ven E, van der Meer F, Messchaert E, Kraan T, Burger N, Leboyer M, Szoke A, Schürhoff F, Llorca PM, Jamain S, Tortelli A, Frijda F, Vilain J, Galliot AM, Baudin G, Ferchiou A, Richard JR, Bulzacka E, Charpeaud T, Tronche AM, De Hert M, van Winkel R, Decoster J, Derom C, Thiery E, Stefanis NC, Sachs G, Aschauer H, Lasser I, Winklbaur B, Schlögelhofer M, Riecher-Rössler A, Borgwardt S, Walter A, Harrisberger F, Smieskova R, Rapp C, Ittig S, Soguel-dit-Piquard F, Studerus E, Klosterkötter J, Ruhrmann S, Paruch J, Julkowski D, Hilboll D, Sham PC, Cherny SS, Chen EY, Campbell DD, Li M, Romeo-Casabona CM, Emaldi Cirión A, Urruela Mora A, Jones P, Kirkbride J, Cannon M, Rujescu D, Tarricone I, Berardi D, Bonora E, Seri M, Marcacci T, Chiri L, Chierzi F, Storbini V, Braca M, Minenna MG, Donegani I, Fioritti A, La Barbera D, La Cascia CE, Mulè A, Sideli L, Sartorio R, Ferraro L, Tripoli G, Seminerio F, Marinaro AM, McGorry P, Nelson B, Amminger GP, Pantelis C, Menezes PR, Del-Ben CM, Gallo Tenan SH, Shuhama R, Ruggeri M, Tosato S, Lasalvia A, Bonetto C, Ira E, Nordentoft M, Krebs MO, Barrantes-Vidal N, Cristóbal P, Kwapil TR, Brietzke E, Bressan RA, Gadelha A, Maric NP, Andric S, Mihaljevic M, Mirjanic T.
Schizophr Bulletin. 40 (4): 729-36. (doi:10.1093/schbul/sbu069 ). 2014. FI 2013= 8.607

Alcohol consumption patterns among adolescents are related to family structure and exposure to drunkenness within the family: Results from the SEYLE Project
Rüütel E, Sisask M, Värnik A, Värnik P, Carli V, Wasserman C, Hoven CW, Sarchiapone M, Apter A, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Haring C, Iosue M, Kaess M, Kahn JP, Poštuvan V, Saiz PA, Wasserman D.
International Journal of Environmental Research and Public Health (IJERPH). 11: 12700-12715. (doi:10.3390/ijerph111212700 ). 2014. FI 2013= 1.993

Pathological Internet use among European adolescents: psychopathology and self-destructive behaviors // El uso de Internet entre los adolescentes europeos Patológica: psicopatología y conductas autodestructivas
Kaess M, Durkee T, Brunner R, Carli V, Parzer P, Wasserman C, Sarchiapone M, Hoven C, Apter A, Balazs J, Balint M, Bobes J, Cohen R, Cosman D, Cotter P, Fischer G, Floderus B, Iosue M, Haring C, Kahn J-P, Musa G, Nemes B, Postuvan V, Resch F, Saiz P, Sisask M, Snir A, Värnik A, Ziberna J, Wasserman D
European Child & Adolescent Psychiatry. 23 ( 11): 1093-1102. 2014. (doi:10.1007/s00787-014-0562-7 ). FI 2013= 3.554

Consenso español de salud física del paciente con depression // Spanish consensus on the physical health of patients with depressive disorders
Giner J, Saiz Ruiz J, Bobes J, Zamorano E, López F, Hernando T, Rico-Villademoros F, Alamo C, Cervilla JA, Ibáñez Cuadrado A, Ibáñez Guerra E, López S, Morán P, Palao DJ, Romacho M; Grupo para el Desarrollo de Recomendaciones sobre Salud Física en el Paciente con Depresión
Rev Psiquiatr Salud Ment. 7 (4): 195-207. 2014. (doi:10.1016/j.rpsm.2014.05.003 ). FI 2013= 1.044

Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case control study // Efecto de un año de una dieta libre de gluten en la evolución clínica del síndrome del intestino irritable, más fibromialgia en pacientes con enteritis linfocítica asociada: un estudio de casos y controles
Rodrigo L, Blanco I, Bobes J, de Serres FJ.
Arthritis Res Ther. 16 (5): 421. 2014. FI 2013= 4.120

Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain
Ivorra JL, Rivero O, Costas J, Iniesta R, Arrojo M, Ramos-Rios R, Carracedo A, Palomo T, Rodriguez R, Cervilla J, Gutierrez B, Molina E, Arango C, Alvarez M, Pascual JC, Perez V, Saiz PA, Garcia-Portilla MP, Bobes J, Gonzalez-Pinto A, Zorrilla I, Haro JM, Bernardo M, Baca-Garcia E, Gonzalez C, Hoenicka J, Molto MD, Sanjuan J
Schizophrenia Research. 159: 107–113. 2014. FI 2013= 4.426

Pro/anti-inflammatory dysregulation in early psychosis: results from 1 year follow-up study
García-Bueno B, Bioque M, MacDowell K, Santabárbara J, Martínez-Cengotitabengoa M, Moreno C, Sáiz PA, Berrocoso E, Gasso P, Barcones F, González-Pinto AM, Parellada M, Bobes J, Mico J, Bernardo M, Leza J from the FLAMM-PEPs* study, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
The International Journal of Neuropsychopharmacology. 2014, 1–10. (doi:10.1093/ijnp/pyu037). 2014. IF 2013= 5.264

Key factors of recovery in psychotic disorders // Factores clave de la recuperación en psicosis
García-Álvarez L, Lemos-Giráldez S, Vallejo-Seco G, Ordóñez-Camblor N, Paino M, Burón-Fernández P, Vallina-Fernández O, Fernández-Iglesias P, Solares-Vázquez J
Anuario de Psicología. 44 (2): 135-149. 2014.

Pharmacogenetic study of Second-generation antipsychotic Long-term treatment Metabolic side effects (The SLiM study): Rationale, objectives, design and sample description // Estudio farmacogenético del tratamiento a largo plazo con antipsicóticos de segunda generación y sus efectos adversos metabólicos (Estudio SLiM): justificación, objetivos, diseno˜ y descripción de la muestra
Pina-Camacho L, Díaz-Caneja CM, Saiz PA, Bobes J, Corripio I, Grasa E, Rodriguez-Jiménez R, González-Pinto A, Sanjuán J, García A, Tapia-Casellas C, Álvarez-Blázquez M, Fraguas D, Arias B, Mitjans M, Arango C
Rev Psiquiatr Salud Ment. 7(4): 166-178. 2014. (doi:10.1016/j.rpsm.2014.05.004). FI 2013= 1.044

A newly identified group of adolescents at «invisible» risk for psychopathology and suicidal behaviour: findings from the SEYLE study
Carli V, Hoven CW, Wasserman C, Chiesa F, Guffanti G, Sarchiapone M, Apter A, Balazs J, Brunner R, Corcoran P, Cosman D, Haring C, Iosue M, Kaess M, Kahn JP, Keeley H, Postuvan V, Saiz PA, Varnik A, Wasserman D
World Psychiatry. 13: 78–86. 2014. FI 2013= 12.846

EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness
Rüther T, Bobes J, De Hert M, Svensson TH, Mann K, Batra A, Gorwood P, Möller HJ.
Eur Psychiatry. 29 (2): 65-82. (doi:10.1016/j.eurpsy.2013.11.002). 2014. FI 2013= 3.210

Spanish adaptation and validation of the Brief Negative Symptoms Scale
Mané A, García-Rizo C, Garcia-Portilla MP, Bergé D, Sugranyes G, Garcia-Alvarez, Bernardo M, Bobes J, Fernandez-Egea E
Comprehensive Psychiatry. 55: 1726–1729. (doi:10.1016/j.comppsych.2014.05.024). 2014. FI 2013= 2.256

Development of the Spanish Brief-version of the University of California Performance Skills Assessment (Sp-UPSA-Brief) in patients with schizophrenia and bipolar disorder // Desarrollo del Brief-versión en español de la Universidad de California Performance Evaluación de Habilidades (Sp-UPSA-Breve) en pacientes con esquizofrenia y trastorno bipolar
Garcia-Portilla MP, Gomar JJ, Bobes-Bascaran MT, Menendez-Miranda I, Saiz PA, Muñiz J, Arango C, Patterson TL, Harvey PD, Bobes J, Goldberg TE
Revista de Psiquiatría y Salud Mental. 7 (3): 113-120. (doi:10.1016 / j.rpsm.2014.02.0). 2014. FI 2013= 1.044

Prevención del suicidio en España: una necesidad clínica no resuelta // Suicide prevention in Spain: An uncovered clinical need
Sáiz PA, Bobes J
Revista de Psiquiatría y Salud Mental. 7 (1): 1-4. 2014. FI 2013= 1.044

Study protocol of a prevention of recurrent suicidal behaviour program based on case management (PSyMAC) // Protocolo de estudio de un programa para la prevención de la recurrencia del comportamiento suicida basado en el manejo de casos (PSyMAC)
Sáiz PA, Rodríguez-Revuelta J, González-Blanco L, Burón P, Al-Halabí S, Garrido M, García L, García-Portilla MP, Bobes J.
Revista de Psiquiatría y Salud Mental. 7 (3): 131-138. 2014. (doi:10.1016/j.rpsm.2014.01.001). FI 2013= 1.044

Pro/anti-inflammatory disregulation in patients with first episode of psychosis. Towards an integrative inflammatory hypothesis of schizophrenia
Garcia-Bueno B, Bioque M, Mac-Dowell KS, Barcones MF, Martinez-Cengotitabengoa M, Pina-Camacho L, Rodriguez-Jimenez R, Saiz PA, Castro C, Lafuente A, Santabarbara J, Gonzalez-Pinto A, Parellada M, Rubio G, Garcia-Portilla MP, Mico JA, Bernardo M, Leza JC.
Schizophrenia Bulletin. 40 (2): 376-387. 2014. (doi:10.1093/schbul/sbt001). FI 2013= 8.607

Antipsychotic switching in bipolar disorders: A systematic review
Grande I, Bernardo M, Bobes J, Saiz-Ruiz J, Alamo C, Vieta E
The International Journal of Neuropsychopharmacology. 17 (3): 497-507. 2014. (doi:10.1017/S1461145713001168). IF 2013= 5.264

Life-time prevalence and psychosocial correlates of adolescent direct self-injurious behavior: A comparative study of findings in 11 European countries
Brunner R, Kaess M, Parzer P, Fischer G, Carli V, Hoven CW, Wasserman C, Sarchiapone M, Resch F, Apter A, Balazs J, Barzilay S, Bobes J, Corcoran P, Cosman D, Haring C, Iosue M, Kahn J-P, Keeley H, Meszaros G, Nemes B, Podlogar T, Postuvan V, Saiz PA, Sisask M, Tubiana A, Varnik A, Wasserman D
Journal of Child Psychology and Psychiatry. 55 (4): 337-48. 2014. (doi:10.1111/jcpp.12166). FI 2013= 5.669

Association between GSK-3β gene and increased impulsivity in bipolar disorder
Jimenez E, Arias B, Mitjans M, Perez A, Goikolea JM, Roda E, Saiz PA, Garcia-Portilla MP, Burón P, Bobes J, Vieta E, Benabarre A
European Neuropsychopharmacology. 24: 510–518. 2014. (doi:10.1016/j.euroneuro.2014.01.005). FI 2013= 5.395

Risk-behavior screening for identifying adolescents with mental health problems in Europe
Kaess M, Brunner R, Parzer P, Carli V, Apter A, Balazs J, Bobes J, Coman HG, Cosman D, Cotter P, Durkee T, Farkas L, Feldmann D, Haring C, Iosue M, Kahn JP, Keely H, Podlogar T, Postuvan V, Resch F, Saiz PA, Sisask M, Tubiana A, Värnick P, Sarchiapione M, Hoven CW, Wasserman D
European Child & Adolescent Psychiatry. 23 (7): 611-20. 2014. (doi:10.1007/s00787-013-0490-y). FI 2013= 3.554

Long-term outcomes of pharmacological treatments for opioid dependence: Does methadone still lead the pack?
Garcia-Portilla MP, Bobes-Bascaran MT, Bascaran MT, Saiz PA, Bobes J.
British Journal of Clinical Pharmacology. 77 (2): 272–284. 2014. (doi:10.1111/bcp.12031). FI 2013= 3.688

Hours of sleep in adolescents and its association with anxiety, emotional concerns, and suicidal ideation
Sarchiapone M, Mandelli L, Iosue M, Carli V, Wasserman C, Hoven C, Apter A, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Haring C, Kaess M, Keeley H, Keresztény A, Kahn JP, Postuvan V, Mars U, Saiz PA, Varnik P, Sisask M, Wasserman D
SLEEP Medicine. 15 (2): 248–254. 2014. (doi:10.1016/j.sleep.2013.11.780). FI 2013= 3.100

Immigration and recommended care after a suicide attempt in Europe: equity or bias?
Bursztein Lipsicas C, Makinen IH, Wasserman D, Apter A, Bobes J, Kerkhof A, Michel K, Salander Renberg E, van Heeringen K, Varnik A, Schmidtke A
The European Journal of Public Health. 24 (1): 63-65. 2014. (doi:10.1093/eurpub/ckt090). FI 2013= 2.459

Effectiveness of a Multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: Study design
Garcia-Portilla MP, Garcia-Alvarez L, Saiz PA, Diaz-Mesa E, Galvan G, Sarramea F, Garcia-Blanco J, Elizagarate E, Bobes J.
Int Journal of Environmental Research and Public Health. 11: 373-389. (doi:10.3390/ijerph110100373). 2014. FI 2013= 1.993

Teacher satisfaction with school and psychological well-being affects their readiness to help children with mental health problems
Sisask M, Värnik P, Värnik A, Apter A, Balazs J, Balint M, Bobes J, Brunner R, Corcoran P, Cosman D, Feldman D, Haring Ch, Kahn JP, Poštuvan V, Tubiana A, Sarchiapone M, Wasserman C, Carli V, Hoven Ch W, Wasserman D
Health Education Journal. 73 (4): 382–393. 2014. (doi:10.1177/0017896913485742). FI 2013= 0.694

Effects of the economic crisis on demand due to mental disorders in Asturias: data from the Asturias Cumulative Psychiatric Case Register (2000-2010) // Efectos de la crisis económica en la demanda por trastornos mentales en Asturias: datos del registro acumulativo de casos psiquiátricos (2000-2010)
Iglesias C, Sáiz PA, Garcia-Portilla MP, Bousoño M, Jimenez-Treviño L, Sanchez F, Bobes J
Actas Españolas de Psiquiatría. 42 (3): 108-15. 2014. FI 2013= 0.759

Treatment adherence and quality of sleep in schizophrenia outpatients
Afonso P, Brissos S, Cañas F, Bobes J, Bernardo-Fernandez I
Int J Psychiatry Clin Pract. 18 (1): 70-6. 2014. ( doi:10.3109/13651501.2013.845219). FI 2013= 1.313

Año 2013 – FI total = 55.453

Peripheral endocannabinoid system dysregulation in first-episode psicosis
Bioque M, García-Bueno B, Mac-Dowell KS, Meseguer A, Sáiz PA, Parellada M, González-Pinto A, Rodríguez Jiménez R, Lobo A, Leza JC, Bernardo M.
Neurosychopharmacology. 38: 2568-77. doi:10.1038/npp.2013.165. 2013. FI 2012= 8.678

Efficacy of Functional Remediation in Bipolar Disorder: A Multicentre, Randomized-Controlled Study
Torrent C, Bonnin C, Martinez-Aran A, Valle J, Amann B, Gonzalez-Pinto A, Crespo J, Ibañez A, García-Portilla MP, Tabares-Seisdedos R, Arango C, Colom F, Solé B, Pacchiarotti I, Rosa A, Ayuso JL, Anaya C, Fernandez P, Landin-Romero R, Alonso S, Ortiz-Gil J, Segura B, Barbeito S, Vega P, Fernandez M, Ugarte A, Subirá M, Cerrillo E, Custal N, Menchon J, Saiz-Ruiz J, Isella S, Rodao J, Alegria A, Al-Halabi S, Bobes J, Galvan G, Saiz P, Balanza-Martinez V, Selva G, Fuentes-Dura I, Correa P, Mayoral M, Chiclana G, Merchan J, Rapado M, Salamero M, Vieta E.
American Journal of Psychiatry. 170 (8): 852-859. 2013. doi:10.1176/appi.ajp.2012.12070971. FI 2012= 14.721

Adolescent Subthreshold-Depression and Anxiety: Psychopathology, Functional Impairment and Increased Suicide Risk
Balazs J, Miklosi M, Kereszteny A, Apter A, Avigal S, Bobes J, Brunner R, Corcoran P, Cosman D, Cotter P, Haring C, Kaess M, Kahn JP, Marusic D, Sisask M, Postuvan V, Resch F, Saiz PA, Tubiana A, Varnik A, Sarchiapone M, Iosue M, Hoven Ch, Wasserman C, Carli V, Wasserman D.
Journal of Child Psychology and Psychiatry. 54 (6):670–677. 2013. doi:10.1111/jcpp.12016. FI 2012= 5.422

Genetic variability at IMPA2, INPP1 and GSK-3β increases the risk of suicidal behaviour in bipolar patients
Jimenez E, Arias B, Mitjans M, Goikolea JM, Saiz PA, Garcia-Portilla MP, Buron P, Bobes J, Oquendo MD, Vieta E, Benabarre A.
Eur Neuropsychopharmacol. 23: 1452–1462. 2013. doi:10.1016/j.euroneuro.2013.01.007. FI 2012= 4.595

Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia
de la Serna E, Andres-Perpiña S, Puig O, Baeza I, Bombin I, Bartres-Faz D, Arango C, Gonzalez-Pinto A, Parellada M, Mayoral M, Graell M, Otero S, Guardia J, Castro-Fornieles J
Schizophrenia Research. 143 (1): 125-131. 2013. doi:10.1016/j.schres.2012.10.026. FI 2012= 4.590

Validation of a European Spanish-version of the University of California Performance Skills Assessment (UPSA) in patients with schizophrenia and bipolar disorder
Garcia-Portilla MP, Gomar J, Bobes-Bascaran MT, Menendez-Miranda I, Saiz PA, Muñiz J, Arango C, Patterson TL, Harvey PD, Bobes J, Goldberg T
Schizophrenia Research. 150 (1): 421-426. 2013. doi:10.1016/j.schres.2013.07.049. FI 2012= 4.590

Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study
Rodrigo L, Blanco I, Bobes J, De Serres F.
Arthritis Research; Therapy. 15: R201. 2013. doi:10.1186/ar4391. FI 2012= 4.302

Clinical Impact of a Gluten-Free Diet on Health-Related Quality of Life in Fibromyalgia plus Irritable Bowel Syndrome Patients with Underlying Celiac Disease
Rodrigo L, Blanco I, Bobes J, De Serres F
BMC Gastroenterology. 13: 157. 2013. doi:10.1186/1471-230X-13-157. FI 2012= 2.110

The Saving and Empowering Young Lives in Europe (SEYLE) Randomized Controlled Trial (RCT): methodological issues and participant characteristics
Carli V, Wasserman C, Wasserman D, Sarchiapone M, Apter A, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Guillemin F, Haring C, Kaess M, Kahn JP, Keeley H, Kereszteny A, Iosue M, Ursa M, Musa G, Nemes B, Postuvan V, Reiter-Theil S, Saiz P, Varnick P, Varnik A, Hoven Ch W.
BMC Public Health. 13: 479. 2013. doi:10.1186/1471-2458-13-479 . FI 2012= 2.076

A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs
Darba J, Kaskens L, Aranda P, Arango C, Bobes J, Carmena R, Rejas J.
Ann Clin Psychiatry. 25 (1): 17-26. 2013. FI 2012= 1.544

Switching to ziprasidone in the clinical practice setting: an open-label study
Gutierrez M, De la Gandara JJ, Bobes J.
International Journal of Psychiatry in Medicine. 45 (2): 125-42. 2013. doi:10.2190/PM.45.2.c. FI 2012= 1.154

Changes in administrative prevalence of mental disorders over a 13-year period in Asturias (northern Spain) // Evolución de la Prevalencia administrativa de trastornos mentales durante 13 años en Asturias (norte de España)
Bobes J, Iglesias C, Garcia-Portilla MP, Bascaran MT, Jimenez L, Pelayo-Teran JM, Rodriguez J, Sanchez F, Saiz P.
Revista de Psiquiatría y Salud Mental. 6 (2):60-66. 2013. doi:10.1016/j.rpsm.2012.10.002. FI 2012= 0.667

Face recognition in schizotypy // Reconocimiento de caras en la esquizotipia
Garcia L, Lemos S, Paino M, Fonseca-Pedrero E, Ordoñez N, Buron P.
Anales de Psicología. 29: 3. 2013. FI 2012= 0.552

Recidiva de un síndrome neuroléptico maligno
Gonzalez-Blanco L, Santamaria S, Jimenez-Treviño L, Bobes J
Actas Españolas de Psiquiatría. 41 (5): 314-8. 2013. FI 2012= 0.452

Satisfaction with life of schizophrenia outpatients and their caregivers: differences between patients with and without self-reported sleep complaints
Brissos S, Afonso P, Bobes J, Cañas F, Bernardo-Fernandez I, Guzman C
Schizophrenia Research and Treatment. 2013: 502172 (3 pages). 2013. doi:10.1155/2013/502172.

Año 2012 – FI total = 42.294

Prevalence of pathological Internet use among adolescents in Europe: demographic and social factors
Durkee T, Kaess M, Carli V, Parzer P, Despalins R, Floderus B, Balazs J, Barzilay S, Bobes J, Brunner R, Corcoran P, Cosman D, Cotter P, Feldman D, Graber N, Guillemin F, Haring C, Kahn J-P, Mandelli L, Marusic D, Meszaros G, Musa G, Postuvan V, Resch F, Saiz P, Sisask M, Varnik A, Sarchiapone M, Wasserman C, Hoven C, Wasserman D.
Addiction. 107 (12): 2210-2222. 2012. (doi: 10.1111/j.1360-0443.2012.03946.x). FI 2011= 4.313

The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety-related traits
Arias B, Aguilera M, Moya J, Saiz PA, Villa H, Ibañez MI, Garcia-Portilla MP, Bobes J, Ortet G, Fañanas L.
Acta Psychiatrica Scandinavica. 125 (3): 194-202. 2012. (doi: 10.1111/j.1600-0447.2011.01764.x). FI 2011= 4.220

New Treatment Guidelines for Acute Bipolar Mania: A Critical Review
Nivoli A, Murru A, Goikolea JM, Crespo JM, Montes JM, Gonzalez-Pinto AM, Garcia-Portilla MP, Bobes J, Saiz-Ruiz J, Vieta E.
Journal of Affective Disorders. 140 (2): 125-141. 2012. (doi:10.1016/j.jad.2011.10.015). FI 2011= 3.517

Development of the Insight Scale for Affective Disorders (ISAD): Modification from the scale to assess unawareness of mental disorder
Olaya B, Marsa F, Ochoa S, Balanza-Martinez, Barbeito-Resa, Garcia-Portilla MP, Gonzalez-Pinto A, Lobo A, Lopez-Anton R, Usall J, Arranz B, the ISAD group, Haro JM.
Journal of Affective Disorders. 142 (1-3): 65-71. 2012. doi: 10.1016/j.jad.2012.03.041). FI 2011= 3.517

Depressive disorders and the menopause transition
Llaneza P, Garcia-Portilla MP, Llaneza-Suarez D, Armotta B, Perez-Lopez FR.
Maturitas. 71 (2): 120-130. 2012. doi:10.1016/j.maturitas.2011.11.017)). FI 2011= 2.767

Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depresion
Möller HJ, Bitter I, Bobes J, Fountoulakis K, Höschl C, Kasper S.
European Psychiatry. 27 (2): 114-128. 2012. (doi:10.1016/j.eurpsy.2011.08.002). FI 2011= 2.766

Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study
Bobes J, Arango C, Aranda P, Carmena R, García-García M, Rejas J, on behalf of the CLAMORS Study Collaborative Group.
European Psychiatry. 27 (4): 267-274. 2012.(doi:10.1016/j.eurpsy.2010.09.001). FI 2011= 2.766

Pregabalin for the discontinuation of longterm benzodiazepines use: an assessment of its effectiveness in daily clinical practice
Bobes J, Rubio G, Teran A, Cervera G, López-Gomez V, Vilardaga, Perez M.
European Psychiatry. 27 (4): 301-307. 2012. (doi:10.1016/j.eurpsy.2010.12.004). FI 2011= 2.766

Psychometric Properties of the Spanish Version of the B-WISE® Questionnaire in Patients with Severe Mental Disorders
Al-Halabi S, Garcia-Portilla MP, Saiz PA, Fonseca E, Bobes-Bascaran MT, Galvan G, Iglesias C, Arrojo M, Benabarre A, Goikolea JM, Sanchez E, Sarramea F, Bobes J.
Comprehensive Psychiatry. 53 (2012): 1237-1242. 2012. (doi: 10.1016/j.comppsych.2012.04.001). FI 2011= 2.257

Functional Impairment as Amnestic MCI defining feature: cognitive, emotional, and demographic correlates
Bombin I, Santiago-Ramajo S, Garolera M, Vega-Gonzalez EM, Cerulla N, Caracuel A, Cifuentes A, Bascaran MT, Bobes J.
International Psychogeriatrics. 24 (9): 1494-504. 2012. (doi: 10.1017/S1041610212000622). FI 2011= 2.240

Suicide prevention for youth – a mental health awareness program: lessons learned from the Saving and Empowering Young Lives in Europe (SEYLE) intervention study
Wasserman C, Hoven C, Wasserman D, Carli V, Al-Halabi S, Apter A, Bobes J, Balazs J, Cosman D, Farkas L, Feldman D, Fischer G, Graber N, Haring C, Herta D, Iosue M, Kahn JP, Keeley H, Klug K, McCarthy J, Varnik A, Varnik P, Tubiana A, Ziberna J, Sarchiapone M, Postuvan V.
BMC Public Health. 12 (1): 776. 2012. (doi: 10.1186/1471-2458-12-776). FI 2011= 1.997

The state of psychiatry in Spain
Bobes J, Garcia-Portilla MP, Bobes-Bascaran MT, Parellada M, Bascaran MT, Saiz PA, Bousoño M, Arango C.
International Review of Psychiatry. 24(4): 347–355. 2012. (doi: 10.3109/09540261.2012.691090). FI 2011= 1.798

The incidence of hospital-treated attempted suicide in Oviedo (Spain)
Jimenez-Treviño L, Saiz PA, Corcoran P, Garcia-Portilla MP, Burón P, Garrido M, Diaz-Mesa E, Al-Halabi S, Bobes J.
Crisis: The Journal of Crisis Intervention and Suicide Prevention. 33 (1): 46-53. 2012. (doi:10.1027/0227-5910/a000094). FI 2011= 1.084

Editorial: Efectividad a largo plazo de los tratamientos de mantenimiento con metadona en personas con adicción a derivados opiáceos
Bobes J, Bobes-Bascaran MT.
Adicciones. 24 (3): 179-184. 2012. FI 2011= 0.800

Consenso DELPHI sobre la salud física del paciente con esquizofrenia: valoración por un panel de expertos de las recomendaciones de las sociedades españolas de psiquiatría y de psiquiatría biológica
Bobes J, Saiz J, Bernardo M, Caballero F, Gilaberte I, Ciudad A.
Actas Españolas de Psiquiatría. 40 (3): 114-128. 2012. FI 2011= 0.589

Impacto del tabaquismo en el trastorno bipolar
Díaz-Jiménez R, García-Portilla González P, García-Álvarez L, Bobes García J
Revista Latinoamericana de Psiquiatría. 11 (4). 2012.

Recomendaciones preventivas y manejo del comportamiento suicida en España// Recomendaciones preventivas y manejo del comportamiento suicida en España(SPA)
Ayuso-Mateos JL, Baca-Garcia E, Bobes J, Giner J, Giner L, Perez V, Saiz PA, Saiz J, Grupo RECOMS.
Revista de Psiquiatría y Salud Mental. 5 (1): 8-23. 2012. (doi: 10.1016/j.rpsm.2012.01.001). FI 2011= 0.308

Protocolo breve de evaluación del suicidio: fiabilidad interexaminadores
Garcia-Nieto R, Parra I, Palao D, Lopez-Castroman J, Saiz PA, Garcia-Portilla MP, Saiz-Ruiz J, Ibañez A, Tiana T, Duran S, Perez V, De Diego-Otero Y, Perez-Costillas L, Fernandez R, Saiz-Gonzalez D, Jimenez MA, Navio M, Giner L, Guija JA, Escobar JL, Cervilla JA, Quesada M, Braquehais D, Blasco H, Legido T, Aroca F, Baca-Garcia E, Grupo GEICS.
Revista de Psiquiatría y Salud Mental. 5 (1): 24-36. 2012. (doi: 10.1016/j.rpsm.2011.10.001). FI 2011= 0.308

The cost-effectiveness of Paliperidone Extended Release in Spain
Treur M, Baca E, Bobes J, Cañas F, Salvador L, Gonzalez B, Heeg B.
Journal of Medical Economics. 15 (s1): 26-34. 2012. (doi: 10.3111/13696998.2012.734884).

Longitudinal study of neurological soft signs in first-episode early-onset psychosis
Mayoral M, Bombin I, Castro-Fornieles J, Gonzalez-Pinto A, Otero S, Parellada M, Moreno D, Baeza I, Graell M, Rapado M, Arango C.
J Child Psychol Psychiatry. 53(3): 323-31. 2012. (doi: 10.1111/j.1469-7610.2011.02475.x). FI 2011= 4.281

Año 2011 – FI total = 56.516

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care // Enfermedades físicas en pacientes con trastornos mentales graves. 1. Prevalencia, repercusión de los medicamentos y discrepancias en la asistencia sanitaria
De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Möller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S.
World Psychiatry. 10 (1): 52-77. 2011. FI 2011= 6.233

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Möller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S.
World Psychiatry. 10 (2): 138-151. 2011. FI 2011= 6.233

Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS Study
Arango C, Bobes J, Kirkpatrick B, Garcia-Garcia M, Rejas J, on behalf of the CLAMORS Study Collaborative Group.
Eur Neuropsychopharmacol. 21: 867-875. 2011. (doi:10.1016/j.euroneuro.2011.03.005). FI 2011= 4.046

Sexual function assessment in postmenopausal women with the 14-item Changes in Sexual Functioning Questionnaire
Llaneza P, Fernandez-Iñarrea JM, Arnott B, Garcia-Portilla P, Chedraui P, Perez-Lopez FR.
Journal of Sexual Medicine. 8: 2144-2151. 2011. (doi:10.1111/j.1743-6109.2011.02309.x). FI 2011= 3.552

Psychometric properties of the Spanish versión of the Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14) in patients with severe mental disorders
Garcia-Portilla P, Saiz PA, Fonseca E, Al-Halabi S, Bobes-Bascaran MT, Arrojo M, Benabarre A, Goikolea JM, Sanchez E, Sarramea F, Bobes J.
Journal of Sexual Medicine. 8: 1371-1382. 2011. (doi:10.1111/j.1743-6109.2010.02043.x). FI 2011= 3.552

Role of serotonergic-related systems in suicidal behaviour: data from a case-control association study
Saiz PA, Garcia-Portilla MP, Paredes B, Corcoran P, Arango C, Morales B, Sotomayor E, Alvarez V, Coto E, Florez G, Bascaran MT, Bousoño M, Bobes J.
Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1518-1524. 2011. (doi:10.1016/j.pnpbp.2011.04.011). FI 2011= 3.247

Sixth version of the Addiction Severity Index: Assessing sensitivity to therapeutic change and retention predictors
Casares-Lopez MJ, Diaz-Mesa E, Garcia-Portilla P, Saiz PA, Bobes-Bascaran MT, Fonseca-Pedrero E, Carreño E, Marina P, Bascaran MT, Cacciola J, Alterman A, Bobes J.
International Journal of Clinical and Health Psychology. 11 (3): 495-508. 2011. FI 2011= 2.787

Change in psychiatrists’ attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the Consensus on Physical Health in Patients with Schizophrenia
Bobes J, Alegria AA, Saiz-Gonzalez MD, Barber I, Luque Perez J, Saiz-Ruiz J.
European Psychiatry. 26: 305-312. 2011. FI 2011= 2.766

Topiramate for the treatment of alcohol dependence, a comparative with naltrexone
Florez G, Saiz PA, Garcia-Portilla MP, Alvarez S, Nogueiras L, Bobes J.
Eur Addict Res. 17: 29-36. 2011. (doi:10.1159/000320471). FI 2011= 2.525

Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use
Rubio G, Bobes J, Cervera G, Teran A, Perez M, Lopez-Gomez V, Rejas J.
Eur Addict Res. 17 (5): 262-270. 2011. (doi:10.1159/000324850). FI 2011= 2.525

Interconnection between biological abnormalities in Borderline Personality Disorder. Use of the Bayesian Networks Model
De la Fuente JM, Bengoetxea E, Navarro F, Bobes J, Alarcon RD.
Psychiatry Research. 186: 315-331. 2011. (doi:10.1016/j.psychres.2010.08.027). FI 2011= 2.524

A cross-cultural comparison between Spain and the USA: Temperament and character distribution by sex and age
Al-Halabi S, Herrero R, Saiz PA, Garcia-Portilla MP, Errasti JM, Corcoran P, Bascaran MT, Bousoño M, Lemos S, Bobes J.
Psychiatry Research. 186: 397–401. 2011. (doi:10.1016/j.psychres.2010.07.021). FI 2011= 2.524

Borderline Personality Traits in nonclinical young adults
Fonseca-Pedrero E, Paino M, Lemos-Giraldez S, Sierra-Baigrie S, Gonzalez-Portilla MP, Bobes J, Muñiz J.
Journal of Personality Disorders. 25 (4): 542-556. 2011. FI 2011= 2.306

A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences
Jimenez-Treviño L, Saiz PA, Garcia-Portilla P, Diaz-Mesa E, Sanchez-Lasheras F, Buron P, Casares MJ, Marina P, Gutierrez E(†), Bobes J.
Addictive Behaviors. 36 (12): 1184–1190. 2011. (doi:10.1016/j.addbeh.2011.07.019). FI 2011= 2.085

Evolutionary Fuzzy Rule Extraction for Subgroup Discovery in a Psychiatric Emergency Department
Carmona CJ, Gonzalez P, Del Jesus MJ, Navio-Acosta M, Jimenez-Trevino L.
Soft Computing – A Fusion of Foundations, Methodologies and Applications. 15: 2435–244. 2011. (doi:10.1007/s00500-010-0670-3). FI 2011= 1.880

Self-perceived needs are related to violent behavior among schizophrenia outpatients
Martinez-Martin N, Fraguas D, Garcia-Portilla MP, Saiz PA, Bascaran MT, Arango C, Bobes J.
Journal of Nervous and Mental Disease. 199 (9): 666-671. 2011. FI 2011= 1.682

Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: Is there still room for improvement?
Bobes J, Caballero L, Vilardaga I, Rejas J.
Annals of General Psychiatry. 10 (1): 7. 2011. (doi:10.1186/1744-859X-10-7). FI 2011= 1.450

Necesidad de evaluación de la patología dual en contexto penitenciario
Casares-Lopez MJ, Gonzalez-Menendez A, Bobes-Bascaran MT, Secades R, Martinez-Cordero A, Bobes J.
Adicciones. 23: 37-44. 2011. FI 2011= 0.800

Amisulpride en el tratamiento de la dependencia alcohólica
Florez G, Saiz P, Garcia-Portilla MP, Alvarez S, Nogueiras L, Bobes J.
Adicciones. 23 (2): 149-156.2011. FI 2011= 0.800

Endofenotipos y conductas suicidas
Jimenez-Treviño L, Blasco-Fontecilla H, Braquehais MD, Ceverino-Dominguez A, Baca-Garcia E.
Actas Españolas de Psiquiatría. 39 (1): 61-9. 2011. FI 2011= 0.589

Cannabis and mental health (ENG) // Cannabis y salud mental (SPA)
Fernandez-Artamendi S, Fernandez-Hermida JR, Secades-Villa R, Garcia-Portilla P.
Actas Españolas de Psiquiatría. 39 (3): 180-90. 2011. FI 2011= 0.589

Walking capacity is associated with health related quality of life and physical activity level in patients with schizophrenia: a preliminary report
Martin-Sierra A, Vancampfort D, Probst M, Bobes J, Maurissen K, Sweers K, De Schepper E, De Hert M
Actas Españolas de Psiquiatría. 39 (4): 211-216. 2011. FI 2011= 0.589

Validación de la versión española de la escala de Funcionamiento Personal y Social en pacientes ambulatorios con esquizofrenia estable o inestable
Garcia-Portilla MP, Saiz PA, Bousoño M, Bascarán MT, Guzman-Quilo C, Bobes J en nombre del grupo de validación de la versión española de la escala de Funcionamiento Personal y Social (PSP).
Revista de Psiquiatría y Salud Mental. 4 (1): 9-18. 2011. (doi:10.1016/j.rpsm.2010.11.003). FI 2011= 0.308

Clinical meaningful outcomes in schizophrenia: remission and recovery (ENG) // Resultados clínicos relevantes en esquizofrenia: remisión y recuperación (SPA)
Ciudad A, Bobes J, Alvarez E, San L, Novick D, Gilabertea I.
Revista de Psiquiatría y Salud Mental. 4 (1): 53-65. 2011. (doi:10.1016/S2173-5050(11)70008-5). FI 2011= 0.308

Recomendaciones para el cambio de antipsicóticos. Posicionamiento de la Sociedad Española de Psiquiatría y Sociedad Española de Psiquiatría Biológica
Bernardo M, Vieta E, Sáiz-Ruiz J, Rico-Villademoros F, Álamo C, Bobes J, Grupo RECAP.
Revista de Psiquiatría y Salud Mental. 4 (3): 150-168. 2011. (doi:10.1016/j.rpsm.2011.07.003). FI 2011= 0.308

Informe del 3.er Foro sobre Políticas de Actuación del Consejo Europeo del Cerebro Report of the 3rd European Brain Policy Forum
Bobes J, Cavada C, Luquin R, Morales G, Manrique M, Arango C, Saiz J, Molero J, Carbone G.
Revista de Psiquiatría y Salud Mental. 4 (4): 212-217. 2011. (doi:10.1016/j.rpsm.2011.07.003). FI 2011= 0.308

Año 2010– FI total = 39.772

Impacto del Consenso Español sobre la Salud Física de Paciente con Esquizofrenia
Saiz-Ruiz J, Saiz-Gonzalez MD, Alegria AA, Mena E, Luque J, Bobes J.
Revista de Psiquiatría y Salud Mental. 3 (4): 119-127. 2010. FI 2010=0.435

Measurement invariance of the Reynolds Depression Adolescent Scale across gender and age in adolescents
Fonseca-Pedrero E, Wells C, Paino M, Lemos-Giraldez S, Villazon-Garcia U, Sierra S, Gonzalez-Portilla MP, Bobes J, Muñiz J.
International Journal of Testing. 10 (2): 133-48. 2010. (doi:10.1080/15305050903580822).

Rare Genotype Combination of the Serotonin Transporter Gene Associated With Treatment Response in Severe Personality Disorder
Perroud N, Salzmann A, Saiz PA, Baca-Garcia E, Sarchiapone M, Garcia-Portilla MP, Carli V, Vaquero-Lorenzo C, Jaussent I, Mouthon D, Vessaz M, Huguelet P, Courtet P, Malafosse A, and European Research Consortium for Suicide (EURECA).
American Journal of Medical Genetics Part B (Neuropsychiatric Genetics). 153B (8): 1494-7. 2010. FI 2010=4.156

Extended release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
Bandelow B, Chouinard G, Bobes J, Ahokas A, Eggens I, Liu S, Eriksson H.
Int J Neuropsychopharmacol. 13 (3): 305-20. 2010. FI 2010=4.699

Rendimiento psicométrico de la 6ª versión del Addiction. Severity Index en español (ASI-6)
Diaz-Mesa E, Garcia-Portilla P, Saiz Pa, Bobes MT, Casares MJ, Fonseca E, Carreño E, Florez G, Guardia J, Ochoa E, Pereiro C, Rubio G, Tern A, Fernandez JR, Bobes J.
Psicothema. 22 (3): 513-519. 2010. FI 2010=0.939

Narcisismo manifiesto, narcisismo encubierto y trastornos de personalidad en una Unidad de Conductas Adictivas: validez predictiva de respuesta a tratamiento // Open Narcissism, covered narcissism and personality disorders as predictive factors of treatment response in an out-patient Drug Addiction Unit
Salazar-Fraile J, Ripoll-Alandes C, Bobes J.
Adicciones 22(2): 107-12. 2010. FI 2010=1.127

Interactions between functional serotonergic polymorphisms and demographic factors influence personality traits in healthy Spanish Caucasians
Saiz PA, Garcia-Portilla MP, Herrero R, Arango C, Corcoran P, Morales B, BascarAn MT, Alvarez V, Coto E, Paredes B, FernAndez JM, Bobes J.
Psychiatric Genetics 20, 4: 171-178. 2010. FI 2010=2.061

Saving and Empowering Young Lives in Europe (SEYLE): a randomized controlled trial
Wasserman D, Carli V, Wasserman C, Apter A, Balazs J, Bobes J, Bracale R, Brunner R, Bursztein-Lipsicas C, Corcoran P, Cosman D, Durkee T, Feldman D, Gadoros J, Guillemin F, Haring C, Kahn JP, Kaess M, Keeley H, Marusic D, Nemes B, Postuvan V, Reiter-Theil S, Resch F, Saiz P, Sarchiapone M, Sisask M, Varnik A, Hoven C.
BMC Public Health. 10(1): 192. 2010. FI 2010=2.364

Validity of the Spanish version of the Hypersensitive Narcissism Scale (HSNS) in subjects attended at an Addiction Treatment Unit
Ripoll C, Salazar J, Bobes J.
Adicciones. 22 (1): 29-36. 2010. FI 2010=1.127

Impact of substance use on the physical health of patients with bipolar disorder
Garcia-Portilla MP, Saiz PA, Benabarre A, Florez G, Bascaran MT, Diaz-Mesa E, Bousoño M, Bobes J.
Acta Psychiatrica Scandinavica. 121: 437-445. 2010. FI 2010=3.795

Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
Bobes J, Arango C, Garcia-Garcia M, Rejas J.
Schizophrenia Research. 119: 101-109. 2010. FI 2010=4.374

Sociodemographic factors associated with personality traits assessed through the TCI
Al-Halabi S, Herrero R, Saiz PA, Garcia-Portilla P, Corcoran P, Bascaran MT, Errasti JM, Lemos S, Bobes J.
Personality and Individual Differences. 48: 809–814. 2010. FI 2010=1.820

Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS Study
Bobes J, Arango C, Garcia-Garcia M, Rejas J, on behalf of the CLAMORS Study Collaborative Group.
The Journal of Clinical Psychiatry. 71 (3): 280-286. 2010. FI 2010=5.023

Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study
Saiz PA, Garcia-Portilla MP, Arango C, Morales B, Arias B, Corcoran P, Fernandez JM, Alvarez V, Coto E, Bascaran MT, Bousoño M, Fañanas L, Bobes J.
Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 26–31. 2010. FI 2010=2.877

Dimensionality of hallucinatory predisposition: Confirmatory factor analysis of the Launay-Slade Hallucination Scale-revised in college students
Fonseca-Pedrero E, Lemos-Giraldez S, Paino M, Sierra-Baigrie S, Villazón-Garcia U, Garcia-Portilla MP, Muñiz J.
Anales de Psicología. 26 (1): 41-48. 2010. FI 2010=1.338

Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups
Zabala A, Rapado M, Arango C, Robles O, de la Serna E, Gonzalez C, Rodriguez-Sanchez JM, Andres P, Mayoral M, Bombin I.
Eur Arch Psychiatry Clin Neurosci. 260 (3): 225-33. 2010. (doi:10.1007/s00406-009-0046-9). FI 2010=3.637

Año 2009

Oxcarbazepine treatment of restless legs syndrome: three case reports
Jimenez-Treviño L.
Clin Neuropharmacol. 32 (3): 169-70. 2009. FI 2009=2.349

Use of small incentives for increasing participation and reducing drop out in a family drug-use prevention programme in a Spanish sample
Al-Halabi S, Errasti JM.
Substance Use & Misuse. 44 (14): 1990-2000. 2009. FI 2009=0.725

Clinical prevalence and reason for visit of patients with generalized anxiety disorder seen in the psychiatry out-patient clinics in Spain. Results of the LIGANDO study
Caballero L, Bobes J, Vilardaga I, Rejas J.
Actas Esp Psiquiatr. 37 (1): 17-20. 2009. FI 2009=0.515

Depresión y perimenopausia: Una revisión
Garcia-Portilla MP.
Actas Esp Psiquiatr. 37 (4): 213-221. 2009. FI 2009=0.515

Rendimiento psicométrico del Cuestionario Oviedo de Sueño en pacientes con trastorno mental grave
Garcia-Portilla MP, Saiz PA, Diaz-Mesa EM, Fonseca E, Arrojo M, Sierra P, Sarramea F, Sanchez E, Goikolea JM, Balanza V, Benabarre A, Bobes J.
Rev Psiquiatr Salud Ment. 2 (4): 169-177. 2009.

Polymorphisms of the IL-1 gene complex are associated with alcohol dependence in Spanish Caucasians, data from an association study
Saiz PA, Garcia-Portilla MP, Florez G, Corcoran P, Arango C, Morales B, Leza JC, Alvarez S, Diaz-Mesa EM, Alvarez V, Coto E, Nogueiras L, Bobes J.
Alcoholism Clin Exp Res. 33: 2147-2153. 2009. FI 2009=3.392

Association study of serotonergic gene variants with antipsychotic-induced adverse reactions
Al-Janabi I, Arranz MJ, Blakemore AIF, Saiz PA, Susce MT, Glaser PEA, Clark D, de Leon J.
Psychiatric Genetics. 19 (6): 306-311. 2009. FI 2009=2.327

Recovery from schizophrenia: Prevalence and factors associated with functional outcome of patients in symptomatic remission in a 1-year follow-up study
Bobes J, Ciudad A, Alvarez E, San L, Polavieja P, Gilaberte I.
Schizophrenia Research. 115: 58–6. 2009. FI 2009=4.458

Psychometric Properties of the Revised Physical and Social Anhedonia Scales in Non-Clinical Young Adults
Fonseca-Pedrero E, Paino M, Lemos-Giraldez S, Garcia-Cueto E, Villazon-Garcia U, Bobes J, Muñiz J.
The Spanish Journal of Psychology. 12 (2): 815-822. 2009. FI 2009=0.835

Versión reducida del Cuestionario TPSQ de Estilos Perceptuales y de Pensamiento
Fonseca-Pedrero, E, Paino, M, Lemos-Giraldez, S, Villazon-Garcia, U, Garcia-Cueto, E, Bobes, J, Muñiz, J.
Psicothema. 21 (3): 499-505. 2009. FI 2009=0.910

EDITORIAL: ISSUES FOR DSM-V
De la Fuente JM, Bobes J.
International Journal of Social Psychiatry. 55 (3): 195-197. 2009. FI 2009=0.966

Role of serotonergic polymorphisms in the clinical severity of the panic disorder – (English version)
Saiz PA, Martinez-Barrondo S, Garcia-Portilla MP, Corcoran P, Morales B, Bascaran MT, Paredes B, Alvarez V, Coto E, Fernandez JM, Bousoño M, Bobes J.
Revista de Psiquiatría y Salud Mental. 2 (1): 35-41. 2009

Differential role of serotonergic polymorphisms in alcohol and heroin dependence. Prog Neuropsychopharmacol
Saiz PA, Garcia-Portilla MP, Florez G, Arango C, Corcoran P, Morales B, Bascaran MT, Alvarez C, San Narciso G, Carreño E, Alvarez V, Coto E, Bobes J.
Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 695-700. 2009. FI 2009=2.823

Cardiovascular risk in patients with bipolar disorder
Garcia-Portilla MP, Saiz PA, Bascaran MT, Martinez S, Benabarre A, Sierra, Torres P, Montes JM, Bousoño M, Bobes J; on behalf of the General Health Status in Bipolar Disorder Collaborative Group.
Journal of Affective Disorders. 115: 302-308. 2009. FI 2009=3.763

Violence among schizophrenic outpatients compliant with medication: prevalence and associated factors
Bobes J, Fillat O, Arango C.
Acta Psychiatrica Scandinavica. 119 (3): 218-225. 2009. FI 2009=3.733

Remission in schizophrenia: Results from a 1-year follow-up large observational study in naturalistic settings
Ciudad A, Alvarez E, Bobes J, San L, Polavieja P, Gilaberte I.
Schizophrenia Research. 108: 214-222. 2009. FI 2009=4.458

Prevención familiar del consumo de drogas: “Familias que Funcionan”
Errasti JM, Al-Halabi S, Fernandez JR, Secades R, Carballo JL, Garcia O.
Psicothema. 21 (1): 45-50. 2009. FI 2009=0.910

El colegio y los factores de riesgo familiar en la asistencia a programas de prevención familiar del consumo de drogas
Al-Halabi S, Errasti JM, Fernandez JR, Carballo JL, Secades R, Garcia O.
Adicciones. 21 (1): 39-48. 2009.

Effects of Voucher-Based Intervention on Abstinence and Retention in an Outpatient Treatment for Cocaine Addiction: A Randomized Controlled Trial
Garcia O, Secades R, Higgins ST, Fernandez JR, Carballo JL, Errasti JM, Al-Halabi S.
Experimental and Clinical Psychopharmacology. 17: 131–138. 2009. FI 2009=2.713

Año 2008

Consenso español de Salud Física del Paciente con Trastorno Bipolar
Bobes J, Saiz J, Montes JM, Mostaza J, Rico-Villademoros F, Vieta E; en representación del Grupo de Expertos para el Informe de Consenso de la Salud Física del Paciente con Trastorno Bipolar.
Revista de Psiquiatría y Salud Mental. 1: 26-37. 2008.

DRD3, but Not COMT or DRD2, Genotype affects Executive Functions in Healthy and First-Episode Psychosis Adolescents
Bombin I, Arango C, Mayoral M, Castro-Fornieles J, Gonzalez-Pinto A, Gonzalez-Gomez C, Moreno D, Parellada M, Baeza I, Graell M, Otero S, Saiz PA, Patiño-Garcia A.
American Journal of Medical Genetics Part B (Neuropsychiatric Genetics). 147B: 873–879. 2008. FI 2008=3.932

Consenso sobre la salud física del paciente con esquizofrenia de las Sociedades Españolas de Psiquiatría y de Psiquiatría Biológica – (English version)
Saiz J, Bobes J, Vallejo J, Giner J, Garcia-Portilla MP; Grupo de Trabajo sobre la Salud Física del Paciente con Esquizofrenia.
Actas Esp Psiquiatr. 36 (5): 251-264. 2008. FI 2008=0.446

Using topiramate or naltrexone for the treatment of alcohol-dependent patients
Florez G, GarciaPortilla MP, Alvarez S, Saiz PA, Nogueiras L, Bobes J.
Alcohol Clinical and Experimental Research; 32(7):1251-9. Jul 2008. FI 2008=3.166

A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study
Arango C, Bobes J, Aranda P, Carmena R, Garcia-Garcia M, Rejas J.
Schizophrenia Research. 104: 1–12. 5 Jul 2008. FI 2008=4.424

Remission and relapse in the ambulatory treatment of patients with schizophrenia. Outcomes at 3 years
Haro JM, Ciudad A, Alonso J, Bousoño M, Suarez D, Novick D, Gilaberte I.
Actas Esp Psiquiatr. 36 (4): 187-96. Jul-Ago 2008. FI 2008=0.446

Association between the STin2 VNTR polymorphism of the serotonin transporter gene and treatment outcome in alcohol-dependent patients
Florez G, Saiz PA, GarciaPortilla MP, Alvarez S, Nogueiras L, Morales B, Alvarez V, Coto E, Bobes J.
Alcohol & Alcoholism. 43 (5): 516-522. 14 Jun 2008. FI 2008=2.137

Association study of the interleukin-1 gene complex and tumor necrosis factor alpha gene with suicide attempts
Saiz PA, Garcia-Portilla MP, Paredes B, Arango C, Morales B, Alvarez V, Coto E, Bascaran MT, Bousoño M, Bobes J.
Psychiatric Genetics. 18 (3): 147-150. 2008. FI 2008=2.696

Association between the A-1438G polymorphism of the serotonin 2A receptor gene and nonimpulsive suicide attempts
Saiz PA, Garcia-Portilla MP, Paredes B, Arango C, Morales B, Alvarez V, Coto E, Bascaran MT, Bousoño M, Bobes J.
Psychiatric Genetics. 18 (5): 213-218. 2008. FI 2008=2.696

Asociación entre el polimorfismo A-1438G del gen del receptor de serotonina 2A (5-HT2A) e impulsividad del comportamiento suicida
Paredes B, Saiz PA, Garcia-Portilla MP, Morales B, Pajin M, Fernandez I, Garcia I, Alvarez V, Coto E, Bascaran MT, Bousoño M, Bobes J.
Emergencias. 20: 93-100. 2008. FI 2008=2.696

Is attempted suicide different in adolescent and adults?
Parellada M, Saiz PA, Moreno D, Vidal J, Llorente C, Alvarez M, GarciaPortilla MP, Ruiz-Sancho A, Arango C, Bobes J.
Psychiatry Res. 157: 131–137. 2008. FI 2008=2.666

Validity and reliability of the Spanish versions of the Bech-Rafaelsen’s mania and melancholia scales for bipolar disorders
Vieta E, Bobes J, Ballesteros J, Gonzalez-Pinto A, Luque A, Ibarra N, the Spanish Group for Psychometric Studies (GEEP).
Acta Psychiatr Scand. 117: 207–215. 2008. FI 2008=3.525

Association between Heroin Dependence and 5-HT(2A) Receptor Gene Polymorphisms
Saiz PA, Garcia-Portilla MP, Arango C, Morales B, Martinez-Barrondo S, Alvarez C, San Narciso G, Carreño E, Alvarez V, Coto E, Bobes J.
Eur Addict Res. 14 (1): 47-52. 2008. FI 2008=1.328

Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: A corollary from the CLAMORS study
Rejas J, Bobes J, Arango C, Aranda P, Carmena R, Garcia-Garcia M
Schizophr Res. 99: 23–28. 2008. FI 2008=4.174

The prevalence of metabolic syndrome in patients with bipolar disorder
Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A, Livianos L, Torres P, Bobes J.
Journal of Affective Disorders. 106: 197–201. 2008. FI 2008=3.271

Association study between obsessive–compulsive disorder and serotonergic candidate genes
Saiz PA, Garcia-Portilla MP, Paredes B, Arango C, Morales B, Bascaran MT, Martinez-Barrondo S, Florez G, Sotomayor E, Paredes B, Alvarez C, San Narciso G, Carreño E, Bombin I, Alvarez V, Coto E, Fernandez JM, Bousoño M, Bobes J.
Psychopharmacol Biol Psychiatry. 32: 765–770. 2008. FI 2008=2.638

An investigation of the alfa1A-adrenergic receptor gene and antipsychotic-induced side-effects
Saiz PA, Susce MT, Clark DA, Kerwin RW, Molero P, Arranz MJ y De Leon J.
Hum. Psychopharmacol Clin Exp. 23: 107–114. 2008. FI 2008=2.080

The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain
Ciudad A, Haro JM, Alonso J, Bousoño M, Suarez D, Novick D, Gilaberte I.
Eur Psychiatry. 23 (1): 1-7. 2008. FI 2008=2.433

Differences among substance abusers in Spain who recovered with treatment or on their own
Carballo JL, Fernandez JR, Sobell LC, Dum M, Secades R, Garcia O, Errasti JM, Al-Halabi S.
Addictive Behaviors. 33: 94–105. 2008. FI 2008=1.752

Recruitment characteristics influencing parental participation in family-based drug-abuse prevention programs: The Spoth and Redmond model in Spain
Errasti JM, Al-Halabi S, Fernandez JR, Secades R, Garcia O, Carballo JL.
Substance Use & Misuse. 43: 850-857. 2008. FI 2008=0.917

Effect of incentives on retention in an outpatient treatment programme for cocaine addicts
Garcia-Rodriguez O, Secades-Villa R, Alvarez H, Rio A, Fernandez JL, Carballo JL, Errasti JM, Al-Halabi S.
Psychology in Spain. 12 (1): 63–69. 2008.

Año 2007

Efecto de los incentivos sobre la retención en un tratamiento ambulatorio para adictos a la cocaína
Garcia O, Secades R, Alvarez H, Rio A, Fernandez JR, Carballo JL, Errasti JM, Al-Halabi S.
Psicothema. 19(1): 134-139. 2007. FI 2008=1.213

The «Seroquel» Outcomes Study (SOS): Efficacy and tolerability oí quetiapine in a long-term, naturalistic study oí patients with schizophrenia
Gibert J, Giner J, Bobes J, Tafalla M, Herranz S, Ovejero C, Rico-Villademoros F; for the SOS GROUP.
International Journal of Psychiatry in Clinical Practice. 11 (3): 222-232. 2007. FI 2008=0.446

Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study
San L, Ciudad A, Alvarez E, Bobes J, Gilaberte I.
European Psychiatry. 22: 490-498. 2007. FI 2008=2.433

Quality of life in schizophrenic patients
Bobes J, Garcia-Portilla MP, Bascaran MT, Saiz PA, Bousono M.
Dialogues Clin Neurosci. 9 (2): 215-26. 2007.

Lack of association between endothelial nitric oxide synthase (NOS3) gene polymorphisms and suicide attempts
Saiz PA, Garcia-Portilla MP, Paredes B, Arango C, Morales B, Alvarez V, Coto E, Bascaran T, Bousoño M, Bobes J.
Behav Brain Funct. 3: 32. 2007. FI 2008=2.340

Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms
Gurpegui M, Alvarez E, Bousoño M, Ciudad A, Carlos Gomez J, Olivares JM.
Eur Neuropsychopharmacol. 17 (11): 725-34. 2007. FI 2008=3.661

Safety and tolerability of olanzapine versus risperidone: a one-year randomized study in outpatients with schizophrenia with prominent negative symptoms
Ciudad A, Alvarez E, Bousoño M, Olivares JM, Gomez JC.
Actas Esp Psiquiatr. 35 (2): 105-14. 2007. FI 2008=0.446

Topiramate as add-on therapy in non-respondent alcohol dependant patients: a 12 month follow-up study
Fernandez JJ, Marina PA, Montes M , Diaz T, Gutierrez E, Antuna MJ, Bobes J.
Actas Esp Psiquiatr. 35 (4): 236-42. 2007. FI 2008=0.446

[2-COM: presentation of an instrument facilitating communication between physicians and carers in daily practice]
Robert PH, Michel E, Van Os J, Altamura AC, Bobes J, Gerlach J, Hellewell JS, Kasper S, Nabel D.
Encephale. 33 (1): 60-4. 2007. FI 2008=0.203

Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia
Saiz PA, Garcia-Portilla MP, Arango C, Morales B, Alvarez V , Coto E, Fernandez JM, Bascaran MT , Bousoño M, Bobes J.
Prog Neuropsychopharmacol Biol Psychiatry. 31 (3): 741-5. 2007. FI 2008=2.638

Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD)
Ballesteros J, Bobes J, Bulbena A, Luque A, Dal-Re R, Ibarra N, Guemes I.
J Affect Disord. 102 (1-3): 93-9. 2007. FI 2008=3.271

Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study
Bobes J, Arango C, Aranda P, Carmena R, Garcia-Garcia M, Rejas J; CLAMORS Study Collaborative Group
Schizophr Res. 90(1-3): 162-73. 2007. FI 2008=4.174

Recuperación natural del abuso de alcohol y drogas ilegales en una muestra española
Carballo JL, Fernandez JR, Secades R, Garcia O, Errasti JM, Al-Halabi S.
International Journal of Clinical and Health Psychology. 7 (3): 661-678. 2007. FI 2008=1.649

Drogas de diseño: conceptos básicos y prevención
Errasti JM, Al-Halabi S.
Padres y Maestros. 308: 32-35. 2007.

Prevención del consumo de drogas: la asistencia a los programas familiares llevados a cabo en el aula
Al-Halabi S, Errasti JM.
Típica, Boletín Electrónico de Salud Escolar. 3 (1): 1-10. 2007.

Año 2006

Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial
Ciudad A, Olivares JM, Bousono M, Gomez JC, Alvarez E.
Prog Neuropsychopharmacol Biol Psychiatry. 30 (8): 1515-22. 2006. FI 2008=2.638

Depression in the elderly living in a rural area and other related factors
Fernandez C, Caballer J, Saiz PA, Garcia-Portilla MP, Martinez S, Bobes J.
Actas Esp Psiquiatr. 34 (6): 355-61. 2006. FI 2008=0.446

Interleukin-1 gene complexes in schizophrenia: an association study
Saiz PA, Garcia-Portilla M, Arango C, Morales B, Martinez-Barrondo S, Alvarez V , Coto E, Fernandez J, Bousoño M, Bobes J.
Am J Med Genet B Neuropsychiatr Genet. 141 (6): 678-80. 2006. FI 2008=3.932

Analysis of prescription patterns of antipsychotic agents in psychiatry
Montejo AL, Majadas S, Mayoral F, Sanjuan J, Ros S, Olivares JM, Gonzalez-Torres MA, Bousono M.
Actas Esp Psiquiatr. 34 (5): 323-9. 2006. FI 2008=0.446

Predictive validity of the Scale of Prodromal Symptoms (SOPS)
Lemos S, Vallina O, Fernandez P, Ortega JA, Garcia P, Gutierrez A, Bobes J, Garcia A, Miller T.
Actas Esp Psiquiatr. 34 (4): 216-23. 2006. FI 2008=0.446

A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia
Alvarez E, Ciudad A, Olivares JM, Bousono M, Gomez JC.
J Clin Psychopharmacol. 26 (3): 238-49. 2006. FI 2008=4.371

Dimensions of personality disorders and neurophysiological correlates
Inda-Caro M, Lemos-Giraldez S, Paino-Pineiro M, Besteiro-Gonzalez E, Alonso-Rionda JL, Bobes-Garcia J.
Actas Esp Psiquiatr. 34 (3): 175-84. 2006. FI 2008=0.446

Neurological soft signs in borderline personality disorder
De la Fuente JM, Bobes J , Vizuete C, Morlan I, Bascaran MT, Mendlewicz J.
The Journal of Clinical Psychiatry. 67 (4): 541-46. 2006. FI 2008=5.053

N-acetyltransferase-2 polymorphisms and schizoprenia
Saiz PA, Garcia-Portilla MP, Arango C, Morales B, Alvarez V, Coto E, Fernandez JM, Bousoño M, Bobes J.
Eur Psychiatry. 21 (5): 333-7. 2006. FI 2008=2.433

Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 year follow-up naturalistic study
Mayoral F, Montejo AL, Bousono M, Gonzalez-Torres MA, Olivares JM, Ros S, Sanjuan J, Escobar R, Lara N.
Actas Esp Psiquiatr. 34 (1): 7-15. 2006. FI 2008=0.446

Randomised clinical trial comparing oral and depot formulation of zuclopenthixol in patients with schizophrenia and previous episodes of violence
Arango C, Bombin I, Gonzalez-Salvador T, Garcia-Cabeza I, Bobes J.
European Psychiatry. 21 (1): 34-40. 2006. FI 2008=2.433

Propiedades psicométricas de la versión española de la escala de detección del trastorno de ansiedad generalizada según DSM-IV de Carroll y Davidson
Bobes J, Garcia-Calvo C, Prieto R, Garcia-Garcia M, Rico-Villademoros F; grupo español de trabajo para la validación de la version española de la escala de deteccion del trastorno de ansiedad generalizada según DSM-IV (escala del TAG de Carroll y Davidson).
Actas Esp Psiquiatr. 34 (2): 83-93. 2006. FI 2008=0.446

Subjective perception of cognitive deficit in psychotic patients
Sanjuan J, Aguilar EJ, Olivares JM, Ros S, Montejo AL, Mayoral F, Gonzalez-Torres MA, Bousono M.
J Nerv Ment Dis. 194 (1): 58-60. 2006. FI 2008=1.810

Negative evidences in association between apolipoprotein E polymorphism and panic disorder
Martinez-Barrondo S, Saiz PA, Morales B, Garcia-Portilla MP, Coto E, Alvarez V , Bascaran MT, Bousono M, Bobes J.
Eur Psychiatry. 21 (1): 59-61. 2006. FI 2008=2.433

Family predictors of parent participation in an adolescent drug abuse prevention program
Al-Halabi S, Secades R, Errasti JM, Fernandez JR, Garcia O, Carballo JL.
Drug and Alcohol Review. 25 (July): 323-327. 2006. FI 2008=1.926

Año 2005

Polimorfismos serotoninérgicos en pacientes con trastorno de angustia
Martinez-Barrondo S, Saiz PA, Morales B, GarciaPortilla MP, Coto E, Alvarez V, Bobes J.
Actas Esp Psiquiatr. 33 (4): 210-215. 2005. FI 2008=0.446

Safety and effectiveness of olanzapine in monotherapy: a multivariate analysis of a naturalistic study
Ciudad A, Gutierrez M, Cañas F, Gibert J, Gascon J, Carrasco JL, Bobes J, Gomez JC, Alvarez E.
Prog Neuropsychopharmacol Biol Psychiatry. 29 (6): 944-51. 2005. FI 2008=2.638

Quality of life measures in schizophrenia
Bobes J, GarciaPortilla MP, Saiz PA , Bascaran MT, Bousoño M.
European Psychiatry. 20 (Suppl 3): 313-317. 2005. FI 2008=2.433

Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study
Novick D, Bousoño M, Suarez D, Olivares JM, Montejo AL, Haro JM, Edgell ET, Ratcliffe M; The SOHO Advisoy Board
Prog Neuropsychopharmacol Biol Psychiatry. 29 (6): 972-82. 2005. FI 2008=2.638

Safety, effectiveness, and patterns of use of olanzapine in the inpatient treatment of acute schizophrenia: a multivariate analysis of a large naturalistic study
Cañas F, Gutierrez M, Ciudad A, Gibert J, Gascón J, Carrasco JL, Bobes J, Gomez JC, Alvarez E.
Medicina Clínica (Barc). 124 (13): 481-6. 2005. FI 2008=1.258

Efectividad de venlafaxina en el tratamiento de la dependencia de alcohol con depresión comórbida
GarciaPortilla MP, Bascaran MT, Saiz P, Mateos M, Gonzalez-Quiros M, Perez P, Avila JJ, Torres MA, Bombin B, Caso C, Marin R, Prieto R, Bobes J.
Actas Esp Psiquiatr. 33 (1): 41-45. 2005. FI 2008=0.446

Análisis coste-efectividad de risperidona inyectable de larga duración vs. olanzapina y vs. decanoato de flufenazina en el tratamiento de la esquizofrenia
Baca E, Bobes J, Cañas F, Leal C, Salvador L, Badia X, Alagon Y.
Rev Esp Econ Salud. 4 (5): 273-285. 2005.

Comparación de pacientes cocainómanos y heroinómanos en el EuropASI
Garcia O, Secades R, Fernandez JR, Carballo JL, Errasti JM, Al-Halabi S.
Adicciones. 17 (1): 33-42. 2005.

Instrumentos de evaluación de la dependencia de la heroína
Saiz PA, GarciaPortilla MP, Bascaran MT, Paredes B, Martinez S, Jimenez-Treviño L, Bobes J.
Adicciones. 17 (2): 81-94. 2005.

Situación actual de los Programas de Desintoxicación. ¿Cuándo y cómo desintoxicar
Carreño JE, Campos R, Bobes J.
Adicciones. 17 (2): 205-222. 2005

Aspectos conceptuales del TAG
GarciaPortilla MP, Bobes J.
Monografías de Psiquiatría. XVII (1): 1-4. 2005.

Epidemiología del TAG
Bascaran MT, GarciaPortilla MP.
Monografías de Psiquiatría. XVII (1): 5-8. 2005.

Cormobilidad del TAG
Bousoño M, Jimenez-Treviño L.
Monografías de Psiquiatría. XVII (1): 9-13. 2005.

Evaluación del TAG
García-Portilla MP, Bascarán MT, Sáiz PA.
Monografías de Psiquiatría. XVII (1): 14-17. 2005.

Manifestaciones clínicas del TAG
Saiz PA, Paredes B, Jimenez-Treviño L.
Monografías de Psiquiatría. XVII (1): 18-24. 2005.

TAG en ancianos
Martinez S, Saiz PA.
Monografías de Psiquiatría. XVII (1): 25-28. 2005.

Tratamiento del TAG
Bobes J, GarciaPortilla MP, Bousoño M
Monografías de Psiquiatría. XVII (1): 29-36. 2005.

Pronóstico, discapacidad e impacto del TAG
Jimenez-Treviño L, Saiz PA, Bascaran MT.
Monografías de Psiquiatría. XVII (1): 37-40. 2005.

Año 2004

Is the biological nature of depressive symptoms in borderline patients without concomitant Axis I pathology idiosyncratic? Sleep EEG comparison with recurrent brief, major depression and control subjects
De la Fuente JM, Bobes J, Morlan I, Bascaran MT, Vizuete C, Linkowski P, Mendlewicz J.
Psychiatry Res. 129 (1): 65-73. 2004. FI 2008=2.666

Evaluation of the two-way communication checklist as a clinical intervention: Results of a multi-national randomised controlled trial
Van Os J, Altamura A, Bobes J, Gerlach J, Hellewell J, Kasper S, Naber S, Robert P, Tarrier N.
British Journal Of Psychiatry. 184: 79-83. 2004. FI 2008=5.077

Construcción y validación de un cuestionario de factores de riesgo interpersonales para el consumo de drogas en la adolescencia
Carballo JL, Garcia O, Secades R, Fernandez JR, Garcia E, Errasti JM, Al-Halabi S.
Psicothema. 16 (4): 680-688. 2004. FI 2008=1.213

Managing acute exacerbations of schizophrenia: focus on quetiapine
Arango C, Bobes J.
Current medical research and opinions. 20 (5): 619-626. 2004. FI 2008=2.596

Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain
Bobes J, Cañas F, Rejas J, Mackell J.
Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 1287–1297. 2004. FI 2008=2.638

Estudio de la efectividad del control del craving con topiramato en pacientes con trastornos por dependencia de sustancias
Bobes J, Carreño JE, Gutierrez CE, San Narciso GI, Antuña MJ, Diaz T, Fernandez JJ, Cerceda A, Alvarez CE, Marina P, Garcia-Garcia M.
Actas Esp Psiquiatr. 32 (5): 299-306. 2004. FI 2008=0.446

Polypharmacy in the antipsychotic prescribing in practices psychiatric out-patient clinic
Florez G, Blanco M, Gomez-Reino I, Ganoso P, Bobes J.
Actas Esp Psiquiatr. 32 (6): 333-339. 2004. FI 2008=0.446

Impact of olanzapine on quality of life of patients with schizophrenia: one-year follow-up with the Seville Quality of Life Questionnaire
Giner J, Bobes J, Cervera S, Leal C, Baca E, Ibañez E.
Actas Esp Psiquiatr. 32 (1): 1-7. 2004. FI 2008=0.446

Estudio de investigación de resultados de factores de riesgo metabólico y cardiovascular en pacientes con trastorno de esquizofrenia, esquizofreniforme o esquizoafectivo (Estudio CLAMORS): diseño y metódos del estudio
Rejas J, Aranda P, Arango C, Bobes J, Carmena R, Garcia M, Rico F.
Inv. Clin. Farm. 1 (4): 13-23. 2004.

La nicotina como droga
Jimenez-Treviño L, Bascaran MT, Garcia MP, Saiz PA, Bousoño M, Bobes J.
Adicciones. 16 (Supl.2): 143-153. 2004.

Tratamiento farmacológico. Psicofármacos
Saiz PA, GarciaPortilla MP, Martinez S, Bascaran MT, Paredes B, Bobes J.
Adicciones. 16 (Supl.2): 275-285. 2004.

Trastornos de personalidad en patología dual
Bobes J, Saiz PA, GarciaPortilla MP.
Monografías de psiquiatría. 16 (4): 28-31. 2004.

Año 2003

Maintenance treatment with depot opioid antagonists in subcutaneous implants: An alternative in the treatment of opioid dependence
Carreño J, Alvarez C, Narciso GS, Bascaran MT, Diaz M, Bobes J.
Addict Biol. 8 (4): 429-438. 2003. FI 2008=4.953

Genotipo de apolipoproteína E y esquizofrenia: nuevos resultados negativos
Saiz PA, Morales B, GarciaPortilla MP, Alvarez Y, Coto E, Fernandez JM, Bousoño M, Bobes J; Apolipoprotein E genotype and schizophrenia: further negative evidence.
Acta Psychiatr Scand. 2 (1): 23-27. 2003. FI 2008=3.525

Use of cocaine by secondary school students in Northern Spain
Saiz PA, GarciaPortilla MP, Paredes B, Delgado J, Martinez S, Bascaran MT, Bobes J.
Eur Addict Res. 9 (3): 138-43 . 2003. FI 2008=1.328

GEOPTE, escala de cognición social para psicosis
Sanjuan J, Prieto L, Olivares JM, Montejo A, Ferrer F, Mayoral F, Gonzalez-Torres MA, Bousoño M.
Actas Esp Psiquiatr. 31 (3): 120-28. 2003. FI 2008=0.446

Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study
Alvarez E, Bobes J, Gomez JC, Sacristan JA, Cañas F, Carrasco JL, Gascon J, Gibert J, Gutierrez M.
Eur Neuropsychopharmacology. 13 (1): 39-48. 2003. FI 2008=3.661

Frequency of sexual dysfunction and hyperprolactinemia-related adverse effects in schizophrenic patients treated with risperidone, olanzapine, quetiapine or haloperidol: Results of the Eire Study
Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, GarciaPortilla MP, Porras A, Hernandez G; for the Eire Study Group.
J Sex & Marital. 29 (2): 125-147. 2003. FI 2008=2.214

Evaluación psicométrica comparativa de las versiones en español de 6, 17 y 21 ítems de la Escala de Valoración de Hamilton para la evaluación de la Depresión
Bobes J, Bulbena A, Luque A, Dal-Re R, Ballesteros J, Ibarra N; Grupo de Validación en Español de Escalas Psicométricas (GVEEP).
Med Clin (Barc). 120 (18): 693-700. 2003. FI 2008=1.258

Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first episode schizophrenic inpatients
Bobes J, Gibert J, Ciudad A, Alvarez E, Cañas F, Carrasco JL, Gascon J, Gomez J, Gutierrez M.
Progress in Neuro-Psychopharmacology & Biológical Psychiatry. 27: 473-481. 2003. FI 2008=2.638

Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the Eire Study
Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, GarciaPortilla MP, Fernandez I, Hernandez G; for the Eire Study Group.
Schizoprenia Research. 1848: 1-12. 2003. FI 2008=4.174

Trastorno de estrés postraumático
GarciaPortilla MP, Saiz PA, Bobes J.
Med Clin Monogr (Barc). 4 (1): 40-44. 2003. FI 2008=1.258

Validación de las versiones en español de la Clinical Anxiety Scale y del Physician Questoinnaire para la evaluación de los trastornos de ansiedad
Bulbena A, Bobes J, Luque A, Dal-Re R, Ballesteros J, Ibarra N; Grupo de Validación en Español de Escalas Psicométricas (GVEEP).
Med Clin (Barc). 121 (10): 367-374. 2003. FI 2008=1.258

Evolución histórica del uso y abuso de MDMA
Saiz PA, GarciaPortilla MP, Paredes B, Bobes J.
Adicciones. 15 (Supl.2): 35-49. 2003.

Personalidad y uso-abuso de éxtasis (MDMA)
GarciaPortilla MP, Saiz PA, Paredes B, Martinez S, Bobes J.
Adicciones. 15 (Supl.2): 199-205. 2003.

Complicaciones psicopatológicas asociadas al consumo de drogas recreativas
Saiz PA, Garcia-Portilla MP, Martinez S, Bascaran MT, Bousoño M, Bobes J.
Adicciones. 15 (Supl.2): 217-231. 2003.

Trastorno de ansiedad social: actualización clínica y terapéutica
Bobes J, Bascaran MT, Bousoño M, GarciaPortilla MP, Saiz PA.
Salud Global. Año III, nº 6: 1-7. 2003.

Año 2002

Resultados de una encuesta de salud pública aplicada a trabajadores de un hospital general
Fernandez N, Hinojal R, D íaz J, Saiz PA, GarciaPortilla MP, Bobes J.
Medicina del Trabajo. 11 (4): 207-218. 2002.

Arbol de decisión: insomnio
GarciaPortilla MP, Saiz PA, Fernandez JM, Martinez S, Bascaran MT, Bousoño M, Bobes J.
Psiquiatría y Atencion Primaria. 3 (4): 1-3. 2002.

[Mental disorders related to media influence: phobia and delusional disorder focused on the bovine spongiform encephalopathy mad cow disease]
Ibáñez-Cuadrado A, Jimenez-Treviño L, Correas J, Saiz-Ruiz J.
Med Clin (Barc). 118 (17): 677-678. 2002. FI 2008=1.258

24-Hour opiate detoxification and antagonist induction at home – The «Asturian Method»: A report on 1368 procedures
Carreño E, Bobes J, Brewer C, Alvarez CE, San Narciso GI, Bascaran MT, Sanchez del Rio J.
Addiction Biology. 7 (2): 243-250. 2002. FI 2008=4.953

Apolipoproteine E genotype and schizophrenia: Further negative evidence
Saiz PA, Morales B, GarciaPortilla MP, Alvarez V, Coto E, Fernandez JM, Bousoño M, Bobes J.
Acta Psychiatrica Scandinavica. 105 (1): 71-5. 2002. FI 2008=3.525

2-Com: An instrument to facilitate patient-professional communication in routine clinical practice
Van Os J, Altamura AC, Bobes J, Owens DC, Gerlach J, Hellewell JSE, Kasper S, Naber S, Tarrier N, Robert P.
Acta Psychiatrica Scandinavica. 106 (6): 446-452. 2002. FI 2008=3.525

Use of MDMA and other illicit drugs by young adult males in northern Spain: A five-year study
Bobes J, Saiz PA, GarciaPortilla MP, Bascaran MT, Bousoño M; Ricaurte Ga Mccann Ud.
European Addiction Research. 8 (3): 147-54. 2002. FI 2008=1.328

Effects of carbamezepine on dexamethasone suppression and sleep-EEG in Borderline Personality Disorder
De la Fuente JM ,Bobes J, Vizuete C, Mendlewicz J.
Neuropsychobiology. 45: 113-119. 2002. FI 2008=1.752

Evaluating changes in sexual functioning in depressed patients: Sensitivity to change of the CSFQ
Bobes J, GarciaPortilla MP, Bascaran MT, Clayton A, Garcia M, Rico-Villademoros F, Banus S; on behald of the Tessex Collaborative Study Group.
Journal of Sexual & Marital Therapy. 28 (2): 93-103. 2002. FI 2008=2.214

Biological nature of depressive symptoms in borderline personality disorder: Endocrine comparison to recurrent brief and major depression
De la Fuente JM ,Bobes J, Vizuete C, Mendlewicz J.
Journal Psychiatric Research. 36: 137-145. 2002. FI 2008=4.679

Treatment of severely psychotic in-patients with schizophrenia: Olanzapine versus other antipsychotic drugs
Carrasco JL, Gutierrez M, Gomez JC, Escobar R, Alvarez E, Cañas F, Bobes J, Gascon J, Gibert J.
International Clinical Psychopharmacology. 17 (6): 287-295. 2002. FI 2008=2.928

Frequency of extrapyramidal adverse reactions in schizophrenic patients treated with risperidone, olanzapine, quetiapine or haloperidol: Results of the Eire Study
Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, GarciaPortilla MP, Madrigal M, Hernandez G; on behalf of the Eire Study Group.
Clinical Drug Investigation. 22 (9): 609-622 . 2002. FI 2008=1.301

High Degree of Tolerability for Monotherapy With High Doses of Quetiapine: A Case Report
Bobes J, GarciaPortilla MP, Saiz PA, Bascaran MT, Arango C, Bousoño M.
The Journal of Clinical Psychiatry. 63 (11): 1048-9. 2002. FI 2008=5.053

Evaluación del comportamiento sexual en los pacientes psiquiátricos
Bobes J, GarciaPortilla MP, Saiz PA, Bascaran MT, Fernandez JM, Bousoño M.
Actas Esp Psiquiatr. 30 (Monográfico 1): 32-37. 2002. FI 2008=0.446

Distrés psicológico en trabajadores de un hospital general
Fernandez N, GarciaPortilla MP, Diaz J, Saiz PA, Hinojal R, Bobes J.
Medicina del Trabajo. 11(4): 207-218. 2002.

Instrumentos de evaluación en alcoholismo
Saiz PA, GarciaPortilla MP, Paredes M, Bascaran MT, Bobes J.
Adicciones. 14 (Supl 1): 387-403. 2002.

Tratamiento de mantenimiento con antagonistas opiáceos depot. Una alternativa en el tratamiento de dependientes de opiáceos.
Carreño JE, Alvarez CE, San Narciso GI, Bascaran MT, Cereceda A, Hoyos M, Brewer C, Bobes J.
Salud y Drogas. 2 (1): 83-101. 2002.

Año 2001

Calidad de vida en el ámbito de los pacientes psiquiátricos.
Bobes J, GarciaPortilla MP, Saiz PA, Bascaran MT, Bousoño M.
I Reunión de Metodología de la Investigación En Ciencias de la Vida. Pp :35-39. ISBN 84-607-3299-1. 2001.

Sleep-EEG in borderline patients without concomitant major depression. A comparison with major depressives and controls
De la Fuente JM , Bobes J, Vizuete C, Mendlewicz J
Journal Psychiatry Research. 105 (1-2): 87-95. 2001. FI 2008=4.679

Current status of quality of life assessment in schizophrenic patients
Bobes J.
European Archives of Psychiatry and Clinical Neuroscience. 251 (Suppl 2): 38-42. 2001. FI 2008=2.856

Quality of life and disability in patients with obsessive-compulsive disorder
Bobes J, GarciaPortilla MP, Bascaran MT, Arango C, Saiz PA, Bousoño M.
European Psychiatry. 16: 239-245. 2001. FI 2008=2.433

Revisión conceptual a propósito de la fobia social (Trastorno de ansiedad social) Bobes J, GarciaPortilla MP, Saiz PA, Bascaran MT, Bousoño M.
Actas Esp Psiquiatr. 29 (3): 195-198. 2001. FI 2008=0.446

Influencia de los trastornos psiquiátricos en la efectividad de un programa de mantenimiento prolongado con metadona
Fernandez JJ, GarciaPortilla MP, Sáiz PA, Gutierrez E, Bobes J.
Actas Esp Psiquiatr. 29 (4): 228-32. 2001. FI 2008=0.446

Risperidona en el tratamiento de pacientes psicóticos con abuso y dependencia de opiáceos
Casas M, Gutierrez M, Gibert J, Bobes J, Roncero C, Octavio I.
Actas Esp Psiquiatr. 29 (6): 380-385. 2001. FI 2008=0.446

Calidad de vida relacionada con el tratamiento antipsicótico
Bobes J, GarciaPortilla MP, Fernandez JM, Bascaran MT, Saiz PA, Martinez S, Sanchez A, Bousoño M.
Actas Esp Psiquiatr. 29(Supl. 1): 46-50. 2001. FI 2008=0.446

Calidad de vida en los trastornos mentales y del comportamiento
GarciaPortilla MP, Saiz PA, Paredes B, Martinez S, Bobes J.
Revista Siete Días Médicos 500: 75-84. 2001

Efectividad y seguridad de risperidona a largo plazo en pacientes diagnosticados de esquizofrenia
Gibert J, Gutierrez M, Bobes J.
Psiquiatría Biológica 8, 4: 129-134. 2001.

Polimorfismos serotoninergicos y trastorno obsesivo-compulsivo
Saiz PA, Morales B, GarciaPortilla MP, Bascaran MT, Coto E, Alvarez V, Fernandez JM, Bousoño M, Bobes J.
Psiquiatría Biológica. 8 (6): 219-224. 2001.

Alteraciones del sueño en la menopausia
Garcia-Portilla MP , Saiz PA , Bascaran MT, Del Fresno A, Fernandez JM, Bousoño M, Bobes J.
Salud Total de la Mujer. 3(3): 163-171. 2001.

Evolución de la gravedad de la adicción a los dos años de tratamiento en pacientes heroinómanos
Gutierrez E, Saiz PA, Garcia N, Fernandez P, GarciaPortilla MP, Fernandez JJ, Bobes J.
Adicciones. 13 (1): 51-60. 2001.

Epidemiología del uso/abuso de cocaína
Bobes J, Saiz PA, GarciaPortilla MP, Bascaran MT.
Adicciones. 13 (Supl 2): 23-36. 2001.

Personalidad y uso-abuso de cocaína
Saiz PA, GarciaPortilla MP, Paredes B, Martinez S, Delgado JM.
Adicciones. 13 (2): 47-59. 2001.

Consumo de MDMA (éxtasis) en estudiantes de secundaria
Saiz PA, GarciaPortilla MP, Paredes B, Delgado JM, Lopez JL, Martinez S, Bobes J.
Adicciones. 13 (2): 159-71. 2001.

Consumo de drogas ilegales y alcohol antes y a lo largo de 6 años de mantenimiento con metadona y variables relacionadas
Fernandez JJ, GarciaPortilla MP, Saiz PA, Gutierrez E, Bobes J.
Adicciones. 13 (2): 179-88. 2001.

Imagen del drogodependiente y el enfermo mental entre los profesionales de la salud
Braña B, Rodriguez FJ, Cuesta M, Bobes J, Gomez P, Saiz PA.
Adicciones. 13 (3): 289-296. 2001.

Retención a los 6 años en un programa de mantenimiento con metadona y variables relacionadas
Fernandez JJ, Garcia-Portilla MP, Saiz PA, Gutierrez E, Bobes J.
Revista Española de Drogodependencias. 26 (1): 43-56. 2001.

Año 2000

Etiopatogenia del trastorno obsesivo-compulsivo
Bousoño M, Bascaran MT, Fernandez JM, Bobes J.
Actas Esp Psiquiatr. (Supl 2): 14-19. 2000. FI 2008=0.446

Social Anxiety Disorder – Our current understanding
Den Boer J, Baldwin D, Bobes J, Katschnig H, Westenberg H, Wittchen H-U.
International Journal of Psychiatry in Clinical Practice. 3 (Supl 3): S3-S12. 2000. FI 2008=0.410

Social Anxiety Disorder/Social Phobia – The course of illness prior to treatment
Bobes J.
International Journal of Psychiatry in Clinical Practice. 3 (Supp 3): S21-S24. 2000. FI 2008=0.410

Qualité de vie des enfants: Interet de son evaluation. Comparaison d’enfants en bonne santé et dans des situations de vulnerabilité (Psychologique, sociale, somatique)
Dazord A, Manificat S, Escoffier C, Kadour J-L, Bobes J, GarciaPortilla MP, Nicolas J, Cochat P.
L’Encephale XXVI: 46-55. 2000. FI 2008=0.203

Trastornos del espectro obsesivo-compulsivo: anorexia y bulimia nerviosa
Bousoño M, Bascaran MT, GarciaPortilla MP, Saiz PA, Bobes J.
Masson Newsletter de Psiquiatría. 5: 1-14. 2000.

Repercusiones psicosociales de la distimia
Bobes J, GarciaPortilla MP, Saiz PA, Bascaran MT, Fernandez JM, Bousoño M.
Revista Electrónica de Psiquiatría. 2. 2000.

Calidad de vida en niños con tumores hematológicos
Garcia E, Saiz PA, Perez L, Llorca G, Bobes J.
Revista Española de Pediatria. 56 (3): 247-252. 2000.

Developments in the treatment of drug dependence
Bobes J, McCann UD.
Current Opinion in Psychiatry. 13 (3): 333-338. 2000. FI 2008=3.744

Therapeutic advances: Paroxetine for the treatment of Social Anxiety Disorder
Lydiard RB, Bobes J.
Depression And Anxiety. 11: 99-104. 2000. FI 2008=2.526

A European perspective on Social Anxiety Disorder
Lecrubier Y, Wittchen H-U, Faravelli C, Bobes J, Patel A, Knapp M.
European Psychiatry. 5: 5-16. 2000. FI 2008=2.433

Validation of the Spanish version of the Changes in Sexual Functioning Questionnaire – CSFQ
Bobes J, GarciaPortilla MP, Rico-Villademoros F, Bascaran MT, Sarasa P, Clayton A.
Journal Of Sex & Marital Therapy. 26 (2): 119-131. 2000. FI 2008=2.214

Disability as a long-term outcome measure in schizophrenic outpatients
Bobes J, Bascaran T, GarciaPortilla MP, Arango C, Saiz PA, Bousoño M.
International Journal Methods in Psychiatric Research. 9 (Suppl 1): 37-45. 2000. FI 2008=1.979

Propiedades psicométricas del Cuestionario Oviedo de Sueño (COS)
Bobes J, GarciaPortilla MP, Saiz PA, Bascaran MT, Iglesias C, Fernandez JM.
Psicothema. 12 (1): 107-112. 2000. FI 2008=1.213

Factores asociados con la calidad de vida relacionada con la salud de pacientes en terapia sustitutiva
Rebollo P, Bobes J, GarciaPortilla MP, Saiz PA, Ortega F.
Nefrología. 20 (2): 171-81. 2000. FI 2008=0.674

Interpretación de los resultados de la calidad de vida relacionada con la salud de pacientes en terapia sustitutiva de la insuficiencia renal terminal
Rebollo P, GarciaPortilla MP, Bobes J, Saiz PA, Ortega F.
Nefrología. 20 (5): 431-39. 2000. FI 2008=0.674

Risperidona: Una alternativa real en pacientes tratados con neurolepticos depot
Bobes J, Gonzalez MP, Saiz PA, Octavio I, Fernandez JM, Bousoño M.
Actas Esp Psiquiatr. 28 (6): 367-372. 2000. FI 2008=0.446

Evaluación de las propiedades psicométricas de la versión española de cinco cuestionarios para la evaluación del trastorno de estrés postraumático
Bobes J, Calcedo-Barba A, Garcia M, François M, Rico-Villademoros E, GarciaPortilla MP, Bascaran MT, Bousoño M; Grupo español de trabajo para el estudio del trastorno por estrés postraumático.
Actas Esp Psiquiatr. 28 (4): 207-18. 2000. FI 2008=0.446

Tentativa suicida versus intención suicida: un estudio de las características diferenciales
Fernandez C, Saiz PA, GarciaPortilla MP, Gonzalez JC, Bobes J.
Actas Esp Psiquiatr. 28: 224-230. 2000. FI 2008=0.446

Schizophrenia: Diagnosis and continuing treatment. Principles of practice from the European Expert Panel on the contemporary treatment of schizophrenia
Altamura C, Bobes J, Owens DC, Gerlach J, Hellewell Jse, Kasper S, Naber D, Tarrier N, Van Os J.
International Journal of Psychiatry in Clinical Practice. 4 (Suppl 1): S1-S11. 2000. FI 2008=0.410

The importance of psychosocial interventions and patient involvement in the treatment of schizophrenia
Tarrier N, Bobes J.
International Journal of Psychiatry in Clinical Practice. 4 (Suppl 1): S35-S51. 2000. FI 2008=0.410

Sexual dysfunction in depressed patients undergoing treatment with different antidepressant
Merino MJ, GarciaPortilla MP, Muñiz J, Bobes J.
International Journal of Psychiatry in Clinical Practice. 4: 311-317. 2000. FI 2008=0.410

Efectividad y tolerabilidad de mirtazapina en un estudio abierto de 1019 pacientes depresivos.
Bobes J, Cañas F, Gutierrez M, Masegoza M, Rey A, Vallejo J, Ballus C.
Psiquiatría Biológica. 7 (5): 182-188. 2000.

Moxonidina en las pautas de antagonización rápida ambulatoria en adictos a heroina
Alvarez C, Saiz PA, Carreño JE, San Narciso GI, GarciaPortilla MP, Bascaran MT, Bobes J.
Psiquiatría Biológica. 7 (2): 57-64. 2000.

Variación de los genes 5-HT2a y enzima convertidora de angiotensina en pacientes esquizofrénicos
Morales B, Saiz PA, Alvarez V, Coto E, Fernandez JM, GarciaPortilla MP, Bousoño M, Bobes J.
Psiquiatría Biológica. 7 (1): 11-17. 2000.

Valoración trasversal tras quince años en una muestra de adictos a opiáceos en Asturias
Jimenez-Treviño L, Saiz PA, Gutierrez E, Bascaran MT, Carreño E, Gonzalez-Quiros M, GarciaPortilla MP, Bobes J.
Adicciones. 12 (4): 507-513. 2000.

Personalidad y uso – abuso de cannabis
Garcia-Portilla MP, Saiz PA, Gonzalez-Quiros M, Lopez JL.
Adicciones 12 (2): 185-196. 2000.

Aproximación terapéutica del uso-abuso de MDMA (Extasis)
Saiz PA, Garcia-Portilla MP, Martinez S, Bascaran MT, Bousoño M, Bobes J.
Adicciones. 12 (2): 167-175. 2000.

Epidemiología del uso – abuso de cannabis
Bobes J, Bascaran MT, GarciaPortilla MP, Saiz PA.
Adicciones. 12 (2): 31-40. 2000.

Evaluación de trastornos de la personalidad en pacientes heroinómanos mediante el International Personality Disorders (IPDE)
San Narciso GI, Gutierrez E, Saiz PA, GarciaPortilla MP, Bascaran MT, Bobes J.
Adicciones 12 (1): 43-56. 2000.

Abordaje terapéutico de los alcoholismos
Saiz PA, GarciaPortilla MP, Bobes J.
Trastornos Adictivos. 2 (3): 183-193. 2000.

Factores pronósticos de los trastornos depresivos
Bobes J, Saiz PA, GarciaPortilla MP, Bousoño M.
JANO EMC- La medicina hoy. 58 (1327): 38-42. 2000

Año 1999

Validación de las versiones en español de los cuestionarios Liebowitz Social Anxiety Scale, Social Anxiety and Distress Scale, Sheehan Disability Inventory para la evaluación de la fobia social
Bobes J, Badia X, Luque A, Garcia M, GarciaPortilla MP, Dal-Re R.
Medicina Clínica. 112 (14): 530-538. 1999. FI 2008=1.225

Tres maneras de analizar los resultados de la calidad de vida relacionada con la salud de pacientes en terapia sustitutiva de la insuficiencia renal terminal
Rebollo P, GarciaPortilla MP, Bobes J, Badia X, Saiz PA, Ortega F.
Medicina Clinica. 1999. FI 2008=1.225

Capacidad de control del drogodependiente
Gonzalez EI, GarciaPortilla MP, Saiz PA, Bobes J.
Psicothema. 11 (2): 375-384. 1999. FI 2008=1.213

Evolución a largo plazo de la discapacidad en pacientes esquizofrénicos en tratamiento de mantenimiento con risperidona
Bobes J, GarciaPortilla MP, Gibert J, Gutierrez M, Herraiz ML.
Actas Esp Psiquiatr. (27) 1: 1-7. 1999. FI 2008=0.446

El Cuestionario Sevilla de Calidad de Vida: Perspectiva histórica de su instauración
Giner J, Ibañez E, Cervera S, Leal C, Baca E, Bobes J.
Actas Esp Psiquiatr. (27) 1: 8-13. 1999. FI 2008=0.446

Disfunción sexual con antidepresivos. Efecto del cambio a amineptino en pacientes con disfunción sexual secundaria a ISRS
Montejo AL, Llorca G, Izquierdo JA, Carrasco JL, Daniel E, Perez-Sola V, Vicens E, Bousoño M, Sanchez-Iglesias S, Franco M, Cabezudo A, Rubio V, Ortega MA, Puigdellivol M, Domenech JR, Allue B, Saez C, Mezquita B, Galvez I, Pacheco L, De Miguel E.
Actas Esp Psiquiatr. (27) 1: 23-34. 1999. FI 2008=0.446

Validación de la version española de la Escala de Adaptación Social en pacientes depresivos
Bobes J, GarciaPortilla MP, Bascaran MT, Corominas A, Adan A, Sanchez J, Such P; Grupo de Validación En Español de la Escala de Adaptación Social.
Actas Esp Psiquiatr. (27) 2: 71-80. 1999. FI 2008=0.446

Calidad de vida y discapacidad en pacientes esquizofrénicos crónicos en tratamiento con risperidona y previamente tratados con neurolepticos depot
Bobes J, Gutierrez M, Gibert J, GarciaPortilla MP, Herraiz ML.
Actas Esp Psiquiatr. (27) 4: 229-234 . 1999. FI 2008=0.446

Prevalencia de trastornos de conducta alimentaria en jóvenes de enseñanza secundaria: un estudio preliminar
Sáiz P, GarciaPortilla MP, Bascaran MT, Fernandez JM, Bousoño M, Bobes J.
Actas Esp Psiquiatr. (27) 4: 367-374. 1999. FI 2008=0.446

Paroxetine in Social Phobia/Social Anxiety Disorder
Baldwin D, Bobes J, Stein DJ, Scharwächer I, Faure M; On Behalf Of The Paroxetine Study Group.
British Journal Of Psychiatry. 175: 120-126. 1999. FI 2008=5.077

Impacto psicopatológico (ansioso-depresivo) en padres de niños con tumores hematologicos
Garcia E, Garcia-Portilla MP, Saiz PA, Llorca G, Bobes J.
Anales de Psiquiatría. 15 (4): 153-158. 1999.

Fobia social
Jimenez-Treviño L, GarciaPortilla MP, Saiz PA, Bascaran MT, Bousoño M, Bobes J.
Monografias de Psiquiatría. Año Xi, 5: 44-49. 1999.

La disfunción sexual como pieza clave en los tratamientos con antidepresivos a largo plazo
Bousoño M, Bascaran MT, Saiz PA, GarciaPortilla MP, Bobes J.
Psiquiatría Biológica. 6 (1): 14-20. 1999.

Eficacia y tolerancia de venlafaxina en un estudio abierto de 985 pacientes
Baca E, Roca M, Bobes J, Casais L.
Psiquiatría Biológica. 6 (3): 99-105. 1999.

Calidad de vida y severidad de la adicción en heroinómanos en mantenimiento prolongado con metadona
Fernandez Miranda JJ, GarciaPortilla MP, Saiz PA, Gutierrez E, Bobes J.
Adicciones. 11 (1): 43-52. 1999.

Consumo de alcohol, tabaco y otras drogas y rasgos de personalidad en jóvenes de enseñanza secundaria
Saiz PA, GarciaPortilla MP, Jimenez-Treviño L, Delgado Y, Liboreiro MJ, Granda B, Bobes J.
Adicciones. 11 (3): 209-220. 1999.

Evaluación del tratamiento con Tiapride en los ancianos con crisis de agitación
Bobes J, GarciaPortilla MP, Onieva C
Geriátrika. 15 (3) – 117: 43-47. 1999.

Trastornos de ansiedad
Bobes J, Saiz PA, GarciaPortilla MP, Bousoño M.
Medicine. 7 (106): 4952-4962. 1999.

Protocolo diagnóstico de los estados de ansiedad
Bousoño M, Saiz PA, GarciaPortilla MP, Bobes J.
Medicine. 7 (106): 4969-4971. 1999.

Protocolo de actuación ante el intento de suicidio
Bobes J, Saiz PA, GarciaPortilla MP, Bousoño M.
Medicine. 7 (106): 4972-4975. 1999.

Protocolo terapéutico del estado de ansiedad generalizada
Bousoño M, Saiz PA, GarciaPortilla MP, Bobes J.
Medicine. 7 (106): 4976-4978. 1999.

Año 1998

Risperidona en el tratamiento de la exacerbación aguda de los síntomas de esquizofrenia
Gutierrez M, Gibert J, Bobes J, Herraiz ML, Fernandez A.
Actas Luso Españolas de Neurología Psiquiatría y Ciencias Afines. 26 (2): 83-89. 1998. FI 2008=0.446

Pautas de antagonización rápida ambulatoria en dependientes de opiáceos. Análisis comparativo
Carreño JE, Bobes J, Sanchez J, Alvarez CE, San Narciso GI, Perez SF, Garcia M.
Revista Española de Drogodependencias. 23 (3): 261-284. 1998.

Trastorno obsesivo-compulsivo
Bousoño M, Saiz PA, GarciaPortilla MP, Bascaran MT, Bobes J.
Masson Newsletter de Psiquiatría. 1: 3-10. 1998.

Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety
Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, Bobes J, Beidel D, Westemberg H.
The Journal of Clinical Psychiatry. 59 (Supl 7): 54-60. 1998. FI 2008=5.053

How is recovery from social anxiety disorder defined?
Bobes J.
The Journal Of Clinical Psychiatry. 59 (Supl 17): 12-19. 1998. FI 2008=5.053

Quality of life in schizophrenia: Long-term follow-up in 362 chronic Spanish schizophrenic outpatients undergoing risperidone maintenance treatment
Bobes J, Gutiérrez M, Gibert J, García-Portilla MP, Herraiz L, Fernández A.
Eur Psychiatry. 13 (3): 158-63. 1998. FI 2008=2.433

Evaluación del impacto de la jubilación anticipada en la calidad de vida
Rodriguez LF, GarciaPortilla MP, Bousoño M, Bobes J.
Actas Luso Esp Neurol Psiquiatr. 26 (1): 1-2. 1998. FI 2008=0.446

Magnitud e impacto de las drogas de síntesis
Saiz PA, GarciaPortilla MP, Bousoño M, Bobes J.
Coloquios En Drogodependencias. 5: 4-7. 1998.

Nuevos fármacos en el tratamiento del alcoholismo
Saiz PA, Alvarez CE, GarciaPortilla MP, Carreño E, Bousoño M, Bobes J.
Medicina del Trabajo. 7 (1): 35-46. 1998.

Naturaleza biológica versus psicológica de los trastornos mentales: ¿Falacia o sesgo de perspectiva?
Bousoño M, Bascaran MT, Saiz PA, GarciaPortilla MP, Bobes J.
Psiquiatría.com (Revista Electrónica). 2 (2): 11 Pantallas. 1998.

De las limitaciones terapéuticas al optimismo preventivo
Bobes J.
Psiquiatría Biológica. 5 (1): 1-2. 1998.

Conductas de uso de alcohol en jóvenes
Saiz PA, Garcia-Portilla MP, Bousoño M, Bobes J.
Psiquiatría Biológica. 5 (1): 24-30. 1998.

Marcadores biológicos de la conducta alcohólica
Saiz PA, Garcia-Portilla MP, Bousoño M, Bobes J.
Psiquiatría Biológica. 5 (1): 35-38. 1998.

Evaluación de la severidad de la conducta alcohólica
Garcia-Portilla MP, Saiz PA, Bousoño M, Bobes J.
Psiquiatría Biológica. 5 (1): 40-43. 1998.

Aproximaciones al tratamiento biológico del alcoholismo
Bobes J, Iglesias C, Saiz PA, GarciaPortilla MP, Bousoño M.
Psiquiatría Biológica. 5 (1): 70-75. 1998.

Discapacidad del paciente esquizofrénico
Bobes J, GarciaPortilla MP, Saiz PA, Bousoño M.
Anales de Psiquiatría. 14 (Supl 2): 26-32. 1998.

Recursos bibliograficos de psiquiatría en internet
Rancaño I, Sáiz PA, González MP, Bousoño M, Bobes J.
Monografias de Psiquiatría. X (2): 29-33. 1998.

Psicofarmacología de la bulimia nerviosa
Bousoño M, Saiz P, GarciaPortilla MP, Bascaran T, Bobes J.
Psicofarmacología. 2: 6-11. 1998.

Evolución de los trastornos de personalidad evaluados mediante el IPDE en una muestra de pacientes heroinómanos en tratamiento con naltrexona
San Narciso GI, Carreño JE, Perez SF, Alvarez CE, González MP, Bobes J.
Adicciones. 10 (1): 7-21. 1998.

Trastornos de personalidad en adictos a opiáceos en tratamiento con agonistas versus antagonistas
Gutierrez E, Saiz PA, GarciaPortilla MP, Fernandez JJ, Bobes J.
Adicciones. 10 (2): 121-129. 1998.

Definición del perfil de buen respondedor a los programas de mantenimiento con Naltrexona
Gutierrez E, Saiz PA, GarciaPortilla MP, Fernandez JJ, Iglesias C, Bobes J.
Adicciones. 10 (Supl 4): 321-333. 1998.

Año 1997

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
Montejo-Gonzalez AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, de la Gandara J , Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E.
J Sex Marital Ther. 23(3): 176-94. 1997. FI 2008=2.214

Quality of life in schizophrenic patients
Bobes J, GarciaPortilla MP, Saiz PA, Bousoño M.
Quality of Life Newsletter. 18: 3-4. 1997.

El sueño en los mayores
GarciaPortilla MP, Saiz PA, Bousoño M, Bobes J.
Así Somos. 7: 32-34. 1997.

Brain glucose metabolism in borderline personality disorder
De la Fuente JM, Goldman S, Stanus E, Vizuete C, Morlan I, Bobes J, Mendlewicz J.
Journal Of Psychiatry Research. 35 (5): 531-541. 1997. FI 2008=4.679

PET neuroimaging with [11C] venlafaxine: serotonin uptake inhibition, biodistribution and binding in living pig brain
Smith DF, Jensen PN, Gee AD, Hansen SB, Danielsen E, Andersen F, Saiz PA, Gjedde A.
Eur Neuropsychopharmacol. 7: 195-200. 1997. FI 2008=3.661

Searching for a predictive peripherical biological model in parasuicidal behaviour
Saiz PA, Bobes J, Garcia-Portilla MP, Cocaña I, Gonzalez-Quiros M, Bousoño M.
Eur Psychiatry. 12: 75-81. 1997. FI 2008=2.433

Experiencia con fluoxetina en el tratamiento de la bulimia nerviosa: relevancia histórico-psiquiátrica
Bousoño M, Bobes J.
Actas Luso Españolas de Psiquiatría. 25 (Supl 1): 29-34. 1997. FI 2008=0.446

Medida de la calidad de vida en la esquizofrenia
Cervera S, Baca E, Bobes J, Leal C, Ibañez E, Giner J.
Actas Luso Esp Neurol Psiquiatr. 25 (Supl 2): 1-10. 1997. FI 2008=0.446

Desarrollo del Cuestionario Sevilla de Calidad de Vida (CSCV)
Giner J, Ibañez E, Baca E, Bobes J, Leal C, Cervera S.
Actas Luso Esp Neurol Psiquiatr. 25 (Supl 2): 11-23. 1997. FI 2008=0.446

El Cuestionario Sevilla de Calidad de Vida: Propiedades psicométricas
Ibañez E, Giner J, Cervera S, Baca E, Bobes J, Leal C.
Actas Luso Esp Neurol Psiquiatr. 25 (Supl 2): 24-31. 1997. FI 2008=0.446

Psicopatología y calidad de vida
Leal C, Cervera S, Giner J, Ibañez E, Baca E, Bobes J.
Actas Luso Esp Neurol Psiquiatr. 25 (Supl 2): 32-36. 1997. FI 2008=0.446

Satisfacción de necesidades individuales y calidad de vida en los pacientes esquizofrénicos
Baca E, Bobes J, Leal C, Giner J, Cervera S, Ibañez E.
Actas Luso Esp Neurol Psiquiatr. 25 (Supl 2): 37-42. 1997. FI 2008=0.446

Discapacidad y calidad de vida en pacientes esquizofrénicos
Bobes J, Leal C, Ibañez E, Cervera S, Giner J, Baca E.
Actas Luso Esp Neurol Psiquiatr. 25 (Supl 2): 43-54. 1997. FI 2008=0.446

Cuestionario Sevilla de Calidad de Vida (CSCV). Conclusiones
Cervera S, Giner J, Ibañez E, Leal C, Baca E, Bobes J.
Actas Luso Esp Neurol Psiquiatr. 25 (Supl 2): 55-57. 1997. FI 2008=0.446

Desarrollo de la versión española del Perfil de Calidad de Vida de Lancashire -LQOLP-
Vazquez-Barquero JL, Gaite L, Ramirez N, Garcia E, Borra C, Sanz O, Bobes J, Oliver J.
Archivos de Neurobiología. 60 (2): 125-139. 1997.

Consumo de tabaco, alcohol y otras drogas en estudiantes de ciencias de la salud de la Universidad de Oviedo
Herreros O, GarciaPortilla MP, Perez de Albeniz CE, Saiz PA, Bobes J.
Adicciones. 9 (3): 363-373. 1997.

Alteraciones del sueño: evolución en una zona básica de salud de Oviedo
Pedregal JA, Bobes J, GarciaPortilla MP, Bousoño M, Diaz J, Saiz PA.
Rev Electrónica de Psiquiatría. Vol. 1, No. 2, ISSN 1137-3148. 1997.

Calidad de vida y depresión
Bobes J, GarciaPortilla MP, Saiz PA, Bousoño M.
Opinion. Actualidad del trastorno depresivo 6 : 10-17. 1997.

Año 1996

Disfunción sexual secundaria a ISRS. Un análisis comparativo en 308 pacientes
Montejo AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Daniel E, de Dios A, de la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E.
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 24 (6): 311-21. 1996. FI 2008=0.446

Estudio multicentrico de eficacia y tolerancia del midazolam en 184 pacientes con insomnio primario
Roca M, Mas A, Bobes J, Gibert J.
1996.

Evolución del suicidio en la población involutiva de Asturias (España)
Diaz J, Lopez B, GarciaPortilla MP, Bousoño M, Hinojal R, Bobes J.
EurPsychiatry Ed. Esp. 3: 177-186. 1996. FI 2008=2.433

Calidad de vida y psiquiatría
Bobes J, GarciaPortilla MP, Bousoño M, Saiz PA.
Rev Med Univ Navarra. 40: 44-49. 1996.

Bienestar psicológico y población involutiva. evaluación a través del PGWB Index de Dupuy
García-Portilla MP, Bobes J, Sáiz P, Pedregal J, Bousoño M.
Rev Gerontol. 6: 232-238. 1996.

Calidad de vida en estudiantes de ciencias de la salud
Herreros O, GarciaPortilla MP, Perez CE, Bousoño M, Bobes J.
Anales de Psiquiatría. 12 (4): 141-148. 1996

Hacia una definición del perfil psicosocial y psicopatológico de los consumidores de éxtasis
Villa A, Saiz PA, GarciaPortilla MP, Fernandez JJ, Bousoño M, Bobes J.
Anales de Psiquiatría. 12 (5): 183-189. 1996.

Calidad de vida en los trastornos esquizofrénicos
Bobes J, GarciaPortilla MP, Bousoño M, Saiz PA.
Anales de Psiquiatría. 12 (Supl. 1): 47-54. 1996.

Actitudes ante el sida en estudiantes de ciencias de la salud
Herreros O, Perez CE, GarciaPortilla MP, Bousoño M, Bobes J.
Adicciones. 8 (4): 513-523. 1996.

Colesterol y «mortalidad no natural»
Saiz PA, GarciaPortilla MP, Bousoño M, Bobes, J.
Psiquiatría Biológica. 3 (1): 21-28. 1996.

Estudio retrospectivo de 99 pacientes en tratamiento con clozapina
Garcia-Quiros P, Bobes J, G.-Quiros M, GarciaPortilla MP, Camporro B, Cocaña I.
Psiquiatría Biológica. 3 (3): 81-84. 1996.

Symptoms of Depression and Psychosis in Alzheimer’s Disease and Frontotemporal Dementia Exploration of Underlying Mechanisms
Lopez OL, GarciaPortilla MP, Becker JT, Reynolds CF, Sudilovsky A, Dekosky S.
Neuropsychiatry. Neuropsychology and Behavioral Neurology. 9 (3): 154-161. 1996.

Bases biológicas de las conductas suicidas y parasuicidas
Bobes J, Saiz PA, GarciaPortilla MP, Bousoño M.
Focus on Psychiatry. 3: 52-64. 1996.

Manifestaciones Psicopatológicas por el abuso de MDMA
Bobes J, Saiz PA, Garcia-Portilla MP, Villa A, Bousoño M
Proyecto Hombre. 21-24. 1996.

Año 1995

Factores ambientales relacionados con drogodependencia-sida
Ordoñez F, Rodriguez J, Bobes J.
Adicciones. 1995.

Características sociales de los suicidios consumados del Partido Judicial de Oviedo
Lopez B, Hinojal R, Diaz J, Suarez E, Bobes J.
Orfila. 7: 351-366. Ed. Univ de Lleida. 1995.

Implicaciones psiquiátricas de los suicidios consumados del Partido Judicial de Oviedo
Lopez B, Hinojal R, Diaz J, Suarez E, Bobes J.
Orfila. 7: 367-381. Ed. Univ de Lleida. 1995.

Symptoms of Depression in Alzheimer’s Disease, Frontal Lobe-type Dementia and SubcorticaI Dementia
Lopez OL, Garcia-Portilla MP, Becker JT, Reynolds CF, Sudilovsky A, Dekosky ST.
Annals of the New York Academy of Sciences. 769: 390-392. 1995. FI 2008=2.303

Entorno y conducta del drogodependiente ADVP-SIDA. Estudio de una muestra asturiana
Ordoñez F, Rodriguez J, Garcia-Portilla MP, Saiz PA, Bobes J.
Adicciones. 7 (3): 329-339 1995.

Evaluación de la calidad de vida en psiquiatría ¿Lujo o necesidad de valoración comprensiva?
Bobes J.
Psiquiatría Biológica 2, 6: 207 (Editorial). 1995.

Calidad de vida en enfermos esquizofrénicos. Desarrollo de un instrumento español para su evaluación: El Cuestionario “Sevilla”. Fases Iniciales
Giner J, Baca E, Bobes J, Ibañez E, Leal C, Cervera S.
Anales de Psiquiatría. 11, 9: 313-319. 1995.

La atención de urgencia en las oficinas de farmacia de problemas agudos por drogas Fernandez JJ, García-Portilla MP, Saiz PA, Bobes J. Farmacéuticos. 194, 25-30. 1995.

Calidad de vida en trabajadores de un hospital general con horario a turnos con noches
Fernandez N, Garcia-Portilla MP, Saiz PA, Hinojal R, Bousoño M, Bobes J.
Medicina de Empresa. Vol. 29 (2): 43-60. 1995.

Año 1994

Diferencias epidemiológicas en delincuentes con relación a sus antecedentes psiquiatricos
Martinez A, Hinojal R, Bobes J, Martinez B.
Actas Luso-Esp Neurol Psiquiatr. Vol Xxii, 2ª Etapa, 4: 153-158. 1994. FI 2008=0.446

Relación entre el diagnóstico y la evolución de los trastornos depresivos
Bobes J, Bousoño M, Fernandez J.
Aula Médica. Monografías de Psiquiatría Vi, 2: 11-12. 1994.

Diagnóstico y clasificación de los trastornos depresivos
Garcia-Portilla MP, Bobes J, Pedregal J, Bousoño M.
Aula Médica. Monografias de Psiquiatría Vi, 2: 13-21. 1994.

Formas de curso y evolución típicos y atípicos de los trastornos depresivos
Bousoño M, Saiz PA, Garcia A, Bobes J.
Aula Médica. Monografias de Psiquiatría Vi, 2: 22-26. 1994.

Evolución, pronóstico y respuesta al tratamiento preventivo en los trastornos depresivos
Bousoño M, GarciaPortilla MP, Bobes J, Saiz PA.
Aula Médica. Monografias de Psiquiatría Vi, 2: 27-36. 1994.

Vejez, espacio y calidad de vida
Rodriguez LF, Perez de Albeniz C, Pedregal J, Reig C, Saiz PA, Bobes J.
Intus 5. 1 y 2: 50-64. 1994.

Conducta parasuicida y marcadores biológicos
Saiz PA, Cocaña I, GarciaPortilla MP, Bousoño M, Bobes J.
Anales de Psiquiatría. 10, 3: 109-114. 1994.

Pruebas funcionales empleadas en el diagnóstico de trastornos psiquiátricos
Saiz PA, GarciaPortilla MP, Bousoño M, Bobes J.
Rev. Diagn Biol. 43: 242-244. 1994.

Lípidos y conducta parasuicida
Saiz PA, Cocaña I, Tascon B, GarciaPortilla MP, Bousoño M, Bobes J.
Psiquiatría Biológica. 1 (1): 9-14. 1994.

Protocolización de hipnóéicos
Gonzalez MP, Saiz PA, Bousoño M, Bobes J.
Psiquiatría Biológica. 1 (4): 165-171. 1994.

Perfil de la población drogodependiente en un programa de mantenimiento con metadona en Asturias
Fernandez JJ, Diaz J, Garcia-Portilla MP, Bobes J.
Adicciones. 6 (1): 61-72. 1994.

Aspectos médico-legales del éxtasis (MDMA)
Bobes J, Saiz PA, GarciaPortilla MP, Bousoño M, Herrero S.
Adicciones. 6 (4): 423-435. 1994.

Año 1993

El suicidio en el Partido Judicial de Gijon desde 1975-1986: aspectos clínico-sanitarios
Diaz J, Rendueles G, GarciaPortilla MP, Pedregal J, Lopez B, Bousoño M, Garcia A, Hinojal R, Bobes J.
Anales de Psiquiatría. 9 (3): 122-127. 1993.

Evaluación de la personalidad de los drogodependientes vía parenteral de una muestra asturiana
Ordoñez F, Bobes J, Rodriguez FJ, Paino S, GarciaPortilla MP
Anales de Psiquiatría. 9 (6): 256-260. 1993.

Moclobemida: estudio de la eficacia y tolerancia en el tratamiento de la depresión en la asistencia primaria
Bobes J, Bousoño M, Serrano F.
Psiquis. Año XV, Vol. 14. 1993.

Situación en el mundo occidental de la psiquiatría forense, en el ámbito penal del derecho
Lopez MB, Hinojal R, Suarez E, Bobes J.
Anales de Psiquiatría. 9 (5): 220-225. 1993.

Desarrollo histórico del concepto de calidad de vida
Bobes J, GarciaPortilla MP, Bousoño M, Suarez E.
Aula Médica. Monografias de Psiquiatría V, 6: 5-11. 1993.

Calidad de vida relacionada con la salud
Bousoño M, Pedregal J, GarciaPortilla MP, Bobes J.
Aula Médica. Monografias de Psiquiatría V, 6: 12-17. 1993.

Modelos de calidad de vida
GarciaPortilla MP, Diaz J, Rodriguez LF, Bobes J.
Aula Médica. Monografias de Psiquiatría V, 6: 18-20. 1993.

Evaluación de calidad de vida
GarciaPortilla MP, Bousoño M, Gonzalez M, Perez C, Bobes J.
Aula Médica. Monografias de Psiquiatría V, 6: 21-32. 1993.

El suicidio: aspectos conceptuales, doctrinales, epidemiológicos y juridicos
Lopez MB, Hinojal R, Bobes J.
Revista de Derecho Penal y Criminología. 3: 309-411. 1993.

Año 1992

Family factors involved in depression
Bobes J, Bousoño M, Garcia-Portilla MP, Garcia A, Fernandez JM.
Actas del 5th Congress of Biological Psychiatry. Ed. Psychiatric Topics. Ny. 1992.

Suicidios con historia de hospitalización psiquiátrica
Diaz J, Rendueles G, Gonzalez P, Pedregal J, Fernandez C, Bousoño M, Hinojal R, Garcia A, Bobes J.
Anales de Psiquiatría. 8 (4): 128-134. 1992.

Delirios gerontopsiquiátricos a nivel ambulatorio
Bobes J, Bousoño M.
Actas de la III Reunión Nacional de la Sociedad Española de Gerontopsiquiatría y Psicogeriatria. Edit. Aran. 1992.

Edad y homeostasis en la evolución de pacientes depresivos
Bousoño M, Bobes J, Martinez A, Garcia A, Fernandez, J.
Actas de la XVI Reunión de la Soc Esp de Psiquiatría Biológica. Ed. Aran (Pp. 671-675). Madrid. 1992.

La fratria como factor protector homeostático en la depresión
Bousoño M, Bobes J, GarciaPortilla MP, Pedregal J, Diaz J.
Actas de la XVI Reunión de la Soc Esp de Psiquiatría Biológica. Ed. Aran (Pp. 676-681). Madrid. 1992.

Firstborns at risk to develop major depression/dysthymia
Bobes J, Bousoño M, GarciaPortilla MP, Garcia A, Fernandez J.
Psichiatric Topics. 4, 1. WCBP. 1992.

Estudio comparativo de las disomnias de un subárea de salud en población adulta e involutiva
GarciaPortilla MP, Pedregal J, Lopez JL, Diaz J, Bousoño M, Bobes J.
Revista de Psiquiatría de la Facultad de Medicina de Barcelona. Nº 2: 59-66. 1992.

El suicidio en el partido judicial de Gijon, 19751986 (II)
Diaz, J.; Rendueles, G.; González, P.; Pedregal, J.; García, A.; Bousoño, M. y Bobes, J.
Anales de Psiquiatría. 1992.

Año 1991

Privación afectiva y acontecimientos vitales en depresivos
Bousoño M, Bobes J, Fernandez A, Martinez A, GarciaPortilla MP.
Actas de la XV Reunión Nac de la Soc Esp de Psiquiatría Biológica. Tomo Ii: 521-27. Aran. Madrid. 1991.

Necesidad de médicación o revisiones en depresivos tras 5 años de tratamiento
Bousoño M, Bobes J, GarciaPortilla MP, Pedregal J, Garcia A.
Actas de la XV Reunión Nac de la Soc Esp de Psiquiatría Biológica. Tomo Ii: 515-520. Aran. Madrid. 1991.

El sueño como marcador biológico en los trastornos afectivos
Bobes J, Bousoño M, Vela A, GarciaPortilla MP, Garcia A, RodriguezVijande B.
Actas del III Symposium Internacional del Sueño: 112-121. Andreu. Barna. 1991.

Epidemiología de los trastornos del sueño en las edades involutivas en una zona básica de salud de Oviedo
GarciaPortilla MP, Pedregal J, Diaz J, Garcia A, Bousoño M, Bobes J.
Actas de la II Reunión Nacional de la Segp: 125-134. Ed. Aran Madrid. 1991.

La ansiedad en psicogeriatría
Bobes J, Bousoño M, GarciaPortilla MP, Pedregal J, Prieto A.
Actas de la II Reunión Nacional de la Segp: 11-18. Ed. Aran Madrid. 1991.

Aspectos epidemiológicos del suicidio en asturias en relación con la climatología, lo estacional y otros factores
Garcia A, Bobes J, Bousoño M, Suarez LA, Gonzalez JM.
Actas Luso-Esp Neurol Psiquiatr. 19 (4): 185-90. 1991. FI 2008=0.446

Sueño, deterioro orgánico y salud general en población involutiva. Estudio en una zona básica de salud de Oviedo
GarciaPortilla MP, Pedregal J, Lopez JL, Bousoño M, Bobes J.
Actas Luso-Esp Neurol Psiquiatr. 19 (4): 191-199. 1991. FI 2008=0.446

El suicidio en el partido judicial de Gijon, 19751986 (i)
Diaz J, Rendueles G, GarciaPortilla MP, Pedregal J, Garcia A, Bousoño M, Bobes J.
Anales de Psiquiatría. 7 (7): 271-278. 1991.

Aspectos psicopatológicos y actitud ante la muerte
Bobes J, Diaz J, GarciaPortilla MP, Pedregal J, Miera G, Ordoñez F, Rodriguez FJ.
Anales de Psiquiatría. 7 (8): 316-322. 1991.

Salud mental y calidad de vida en estudiantes de medicina y enfermería de la Universidad de Oviedo
GarciaPortilla MP, Pedregal J, Lopez JL, Garcia T, Bousoño M, Bobes J.
Intus. 3 (2): 43-66. Cordoba. 1991.

Año 1990

Salud mental. Enfermos terminales por virus lentos. (HIV)
Bobes J.
Abaco. Centro de Estudios Economicos y Sociales Oviedo: 75-81. 1990.

Deterioro familiar, consumo de tabaco y alcohol en niños de octavo de E.G.B. de un orfanato en Oviedo (Asturias)
Garcia MT, Egocheaga A, Martinez C, Bobes J.
Enfermería Cientifica. 97: 1115. 1990.

Evolución clínica de pacientes con trastorno por angustia
Bobes J, Bousoño M, Garcia A, Martinez A, Gonzalez P.
XIV Reunión Nacional de la Soc Esp de Psiquiatría Biológica. Aran. (p 567-570) Madrid. 1990.

Factores clínicos y neuroendocrinos en el pronóstico a 5 años de los trastornos depresivos
Bousoño M, Bobes J, Martinez A, GarciaPortilla MP.
XIV Reunión Nacional de la Soc Esp de Psiquiatría Biológica. Aran. (p 571-572). Madrid. 1990.

T.A.T.: Psicodiagnóstico en pacientes heroinómanos
Cabal JC, Bobes J, Vazquez A, Glez.Quiros P, Bousoño M, García A, GarciaPortilla MP.
Actas Luso Esp Neurol Psiquiatr. 18, 1: 16. 1990. FI 2008=0.446

Epidemiología psicogeriátrica. Estudio de población geriátrica, en un área mixta (urbanarural). Rol de enfermería
Lopez JL, Bobes J, GarciaPortilla MP, Pedregal J.
Enfermería Científica. 103: 25-32. 1990.

Enfermería psicogeriátrica. Rol del profesional de la enfermería
Lopez JL, Bobes J, GarciaPortilla MP.
Enfermería Cientifica. 105: 4-8. 1990.

Año 1989

Drogas, fertilidad y periodo connatal. Estrategias terapéuticas
Bobes J.
Moden. 1: 1922. 1989.

Extent and patterns of drug use by students at a Spanish university
Lopez ML, Gutierrez T, Hernandez R, Bobes J.
Bulletin On Narcotics. Xli, 1 y 2 (Pp 117119). 1989.

Fases depresivas en bipolares y unipolares
Bobes J, Bousoño M, Garcia A, Martinez A.
II Congreso de la Sociedad Española de Psiquiatría Biológica. (p. 490492). Aran. Madrid. 1989.

El tratamiento ambulatorio de la depresión
Bobes J, Bousoño M.
Psicopatología. 9, 4: 201207. 1989.

Rasgos psicopatológicos en pacientes heroinómanos
Cabal JC, Bobes J, Vazquez A, Glez.Quiros P, Bousoño M, Garcia A, GarciaPortilla MP.
Actas Luso Esp Neurol Psiquiatr. 17, 3: 161167. 1989. FI 2008=0.446

Personalidad-dependencia: orientaciones conceptuales
Cabal J, Bobes J, Vazquez A, Glez.Quiros P, Bousoño M, Garcia A, GarciaPortilla MP.
Rev. Esp. Drogodep. 14, 3: 161166. 1989.